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General introduction 7
Chapter 1
General introduction
1.1. Introduction
In 2001 the Institute of Medicine (IOM) published an alarming report on the 
quality of healthcare in the United States, titled ‘crossing the quality chasm: 
a new health system for the 21st century’ [1]. This report suggested that the 
American healthcare system faced major challenges on the aspects of improv-
ing patient-centeredness, improving patient safety and putting scientific knowl-
edge into practice. It stated that especially because of the continuing stream of 
technological and scientific developments, there was not only a gap between 
the optimal quality of care and the current healthcare practices of that time, 
but actually a chasm. A subsequent report that focused on healthcare for 
mental and substance abuse conditions in America, suggested that the quality 
of care for patients suffering from these conditions needed improvement too. 
This report explicitly stated that there was a discrepancy in care that is known 
to be effective and the care that is actually delivered in mental healthcare [2]. 
The above mentioned IOM reports on the quality of healthcare in the United 
States received much attention worldwide. In many governments and inter-
national governmental bodies the IOM reports sparked an interest in issues 
regarding the quality of healthcare, since the failing standard of healthcare are 
not limited to the USA but hold for many other Western countries as well. For 
instance Kelley & Tucci in their article in the British Medical Journal wrote that 
the key message of the alarming IOM report would probably be considered 
“old news” by the public and many healthcare providers [3], thereby providing 
input to the idea that at least the healthcare system in the UK was confronted 
with the same issues. In 2005 the Dutch National Board for Healthcare came 
to the same conclusions about the quality of the healthcare system in the 
Netherlands, especially the speed at which effective treatments found their way 
into daily clinical practice was considered far too slow. Consequently possible 
health gains that could be achieved with the proper implementation of these 
evidence-based interventions could not be reached. Moreover, the wellbeing of 
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the healthcare consumers would fall short of expectations resulting in a unnec-
essarily high financial burden because of the provision of suboptimal care [4]. 
When we consider the existing research on adequacy of care for anxiety 
and depressive disorders at the time of the IOM reports the picture emerges 
of failing standards of quality of care. The U.S. National Comorbidity Survey 
Replication study that was carried out between 2001 and 2003 in the United 
States, reported that in primary care, no more than 14% of the patients with 
anxiety disorders or depressive disorders received adequate treatment. In 
secondary care, only a little over 50% of the patients with an anxiety or depres-
sive disorder in secondary mental healthcare received adequate treatment [5]. 
During the same time period, the situation in Europe was not much better. 
The ESEMeD study that was carried out among the general population of 
six Western European countries, including the Netherlands, showed that in 
primary care only 23% of the patients with anxiety or depressive disorders 
received adequate treatment. According to the same study, in secondary 
mental healthcare 57% of the patients with an anxiety or depressive disorder 
were adequately treated [6]. These figures give quite a sad picture of the quality 
of mental healthcare at that time, certainly when one realizes that only mini-
mal criteria for determining adequacy of care were used. A patient was judged 
to have received adequate treatment, if he/she reported receiving either: anti-
depressant medication (for depressive disorder) or antidepressants or anxio-
lytic drugs (for anxiety disorders) for at least 2 months plus at least four visits 
with a psychiatrist, a GP or any other doctor; or at least eight sessions of talking 
therapy with a psychologist or a psychiatrist lasting an average of 30 minutes 
[5, 6]. This means that details on the type and dosage of the prescribed antide-
pressant or anxiolytic medication were not taken into account nor information 
about the type of psychotherapeutic treatment. 
An important reaction to the slow adoption of evidence-based treatment 
interventions in daily clinical practice was the large-scale development of clin-
ical practice guidelines. Clinical practice guidelines have been defined by the 
Institute of Medicine as “systematically developed statements to assist practi-
tioner and patient decisions about appropriate healthcare for specific clinical 
circumstances” [7; page 38]. In most cases “systematic development” includes 
the comprehensive and rigorous evaluation of scientific and clinical evidence 
according to explicitly stated norms. The aim of publishing these guidelines 
was to increase knowledge about scientific evidence for specific practices, 
thereby hoping that evidence-based treatments would be adopted on a larger 
scale in clinical practice. Furthermore, the expectation was that successful 
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implementation of such guidelines would reduce unwanted variation in health-
care practices and improve the quality of care. Other fields of medicine have a 
longer tradition of producing guidelines for clinical practice. Over the last two 
decades the development of treatment guidelines in mental healthcare also 
expanded and continuous to expand.  
1.2. Clinical Practice Guidelines in Mental Healthcare
The development and dissemination of guidelines in Mental Health started 
in the US in the early nineties of the former century and in the Netherlands 
about 10 years later. The first guidelines were mono-disciplinary and focused 
primarily on pharmacotherapeutic treatment. In the late 1990s the UK also 
started with the development and dissemination of guidelines for psychologists 
and psychotherapists [8]. The precursor to UK guidelines for psychologists 
and psychotherapists was a strategic review of policy on psychotherapy services 
published by the Department of Health in 1996. The rationale for developing 
these guidelines for psychologists was to ensure a proper place for psycho-
logical therapies in the treatment of mental conditions, besides the different 
available evidence-based pharmacotherapeutical treatment options. Another 
important goal was to promote the actual use of empirically supported psycho-
logical therapies [8]. 
By order of the Ministry of Health, Welfare and Sports in the Netherlands 
a National Steering Group for Multidisciplinary Guideline Development in 
Mental Health (NSGMH) and the Trimbos-institute delivered 15 guidelines 
for Mental Health between the period of 2003 and 2013 and even more are 
being developed [9]. At the beginning of this century the process of guideline 
development that was followed in the Netherlands was unique. From the start, 
the guidelines were to be multidisciplinary. The ambitious goal was to make 
sure that they would ultimately reflect the consensus of all different profes-
sional groups involved in the care for the particular condition. In addition to 
this it was explicitly stated they should also adequately incorporate the patient 
perspective. Delegates of all professional groups and patient organizations 
where involved in the process of developing these guidelines, ensuring broad 
support of all parties involved and thus promoting their actual use in daily 
clinical practice.  
The NSGMH also made great efforts to promote the use of the guidelines 
in the Netherlands. A lot was done to ensure that general practitioners and 
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professionals working in the field of mental healthcare became acquainted 
with these new guidelines. Particularly the first guidelines on anxiety disor-
ders and depressive disorders received attention in the media, and a broad 
outline of these guidelines was presented in Dutch scientific journals for 
psychiatrists and psychologists. Furthermore a website (www.ggzrichtlijnen.
nl) served as a free database for professionals and patients, and presented 
the scientific background, recommendations and algorithms of the 15 guide-
lines that were published. The guidelines were sold as printed booklets by 
the Trimbos-institute and were freely available to be downloaded from the 
website of the Dutch Institute for Healthcare Improvement CBO (www.cbo.nl) 
and the websites of professional societies such as the Netherlands Psychiatric 
Association (Nederlandse Vereniging voor Psychiatrie) (www.nvvp.net). Other 
platforms such as conventions and educational programmes were also used to 
raise awareness among clinicians about the launch of the guidelines [10]. 
Despite all efforts in the Netherlands, the multidisciplinary guidelines for 
mental healthcare were not received well by all professionals. Fundamental 
points of critique were: the DSM-IV classification as a starting point for devel-
opment of the guidelines [11] and the medical perspective with a primary focus 
on symptom reduction. Some non-medical professions considered the focus 
of the guidelines to be too narrow [12, 13]. Another point of critique formed 
the importance of scientific evidence as the primary selection criterion for the 
treatment interventions included in the guidelines. This selection criterion 
strongly favoured treatments investigated in randomized controlled trials 
(RCTs), while less thoroughly investigated forms of treatment were excluded 
from these guidelines. This practice sometimes contrasted experiences of 
healthcare providers in the field, who regarded these treatments to be valuable. 
[12, 13, 14]. Finally, many healthcare providers doubted the applicability of the 
guideline recommendations in clinical practice, because of the suspected bias 
of the research populations used in RCTs.  
Despite all the efforts made by the NSGMH to promote guideline adherence, 
daily clinical practice showed to be very unruly. A survey on the use of national 
guidelines developed for mental healthcare, conducted among a representative 
sample of 406 Dutch mental healthcare professionals in 2009, showed that 
although 91% of these professionals reported being familiar with these guide-
lines, only 28% said that they actually used them [12]. The implementation of 
guidelines appeared to be a challenging task. An important question remained 
whether the development and implementation of these guidelines is worth the 
effort. 
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1.3. Effectiveness of adhering to mental health guidelines 
The successful implementation of mental health practice guidelines is expected 
to improve the quality of care by promoting the use of ‘evidence-based’ prac-
tices. At the time of completing the first draft of the research proposal that 
formed the basis for this thesis, there was little research to support the claim 
that adherence to guidelines would yield superior results compared with 
“treatments as usual”. Now, a decade later, this evidence is still largely absent. 
Very few evaluations have been made. This is rather strange, if one takes into 
account the enormous amounts of money and efforts that have been put in 
developing the guidelines. 
Indirect evidence for improved quality of care if all patients receive 
‘evidence-based’ treatments is however provided by a publication of Andrews 
and colleagues [15]. Andrews and colleagues used epidemiological data from 
the ‘Australian National Survey of Mental Health and Wellbeing’, to calculate 
the number of years lived in disability (YLDs) that was averted by Australian 
healthcare system for mentally ill patients [15]. This given the actual treat-
ments for ten different mental disorders as offered at that time. Based on esti-
mates of the effectiveness of available evidence-based treatment interventions 
for these ten mental disorders, averted YLDs of the hypothetical scenario that 
these same patients would only receive optimal care, according to the prin-
ciples of evidence-based medicine at the same coverage, was also calculated. 
Furthermore, the same calculations were performed for the scenario that this 
type of optimal care was provided at 100% coverage. Additionally, for all three 
scenarios the direct treatment costs were calculated, so as to be able to obtain 
a cost-effectiveness estimate in Australian dollars per YLD. Summarizing the 
final results for the total group of mental disorders, the authors concluded 
that, compared to current treatments, the scenario of provision of optimal 
treatments would avert a greater proportion of the burden of mental disorders 
without higher costs, even when taking into account the fact that optimal care 
was more comprehensive. According to the authors, optimal care would result 
in lower costs due to fewer in-patient stays. Furthermore it was presumed that 
the health expenses would be limited because costly treatments that are not 
expected to generate any benefit would no longer be used [15]. 
It was established that in Australia 1 086 331 people suffered from an anxiety 
disorder at the time of the survey. This group of people counted for a total of 
201 547 YLDs. With the practices used at that time, the Australian healthcare 
was able to avert a little over 26 000 YLDs for this group of patients. According 
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to the estimations of the authors, this figure could beat least 40 000 YLDSs if 
the same patients that now received treatment would only be given an evidence-
based form of treatment [15]. 
The conclusions of the above-mentioned study, however, were based on 
modelled scenarios. Because of the theoretical nature of the study, quite a 
large number of assumptions were made. For instance, from the publications it 
appears that in identifying the YLDs averted with the mix of healthcare services 
provided to the prevalent cases, only information on the effect-sizes of evidence-
based treatments were used. The assumption was that non-evidence-based 
treatments included in this mix did not have any effect at all because of a lack of 
scientific evidence. As a result the found increase in averted YLDs in the study, 
for the scenario that only evidence-based treatments would be provided, may 
actually have been overestimated. 
Statements about improved effectiveness when implementing ‘evidence-
based’ interventions in daily clinical practice, really requires research in which 
direct comparisons are made between the treatment results obtained through 
usual care and the treatment results obtained when optimal care is provided 
according to the principles of evidence-based medicine. 
A publication of Bauer that was published in 2002 sheds further light on the 
effectiveness of guidelines [16]. Bauer provided the first overview of quantitative 
studies evaluating outcome and treatment adherence to Mental Health Clinical 
Practice Guidelines that were published before the year 2000. His literature 
search yielded 41 studies. These studies can be subdivided into three categories: 
26 were cross-sectional investigations performed after the release of guidelines, 
6 were conducted before and after release of guidelines without a specific 
intervention and 9 involved a controlled trial of a specific implementation inter-
vention. The investigated guidelines dealt with a diverse set of topics, ranging 
from antipsychotic use, smoking cessation, and the treatment of specific mental 
conditions such schizophrenia and bipolar disorders. Most studies did however 
investigate adherence to guidelines specific for the treatment of depression. 
Only 15 (37%) of the studies identified by Bauer were conducted in the mental 
health specialty sector. Adequate adherence was found in 27% of the cross-sec-
tional and the pre-post studies versus 67% of the controlled trials. In only 13 of 
the 41 studies included, data on treatment outcome had been collected as well 
as data on guideline adherence. In only 6 of these 13 studies (46%), greater 
guideline adherence was actually associated with better treatment results. 
Weinmann and colleagues in 2007 published a review that included only 
comparative studies on the effects of psychiatric guideline implementation on 
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provider performance and treatment outcome only [17]. They identified 18 
studies (9 randomized-controlled trials, 6 nonrandomized-controlled studies 
and 3 quasi experimental pre-post studies) published between 1966 and 2006. 
Most studies included focused on the guidelines for depressive disorder. Other 
studies dealt with guidelines for schizophrenia, bipolar disorder, delirium or 
dementia and smoking cessation. The review showed that effects of guideline 
implementation on provider performance or patient outcomes were moderate 
at best and of temporary duration in most cases. It was also found that the imple-
mentation of guidelines can have a negative effect on treatment outcome, as was 
the case in one study that focused on prescribing antidepressant medication in 
primary care for patients with depressive disorder [18]. The authors of this study 
suggest that the negative effect on the functional status of the patients might be 
due to the chronicity of depressive symptoms of the patient group under study. 
In addition, the authors suggest that new research and special guidelines are 
needed to improve the treatment of patients suffering from chronic or recur-
ring major depressive disorder [18].
So far, the results on the effectiveness of implementing guidelines do not look 
convincing. Weinmann and colleagues suggested however, that the type of diag-
nosis could critically influence the magnitude of treatment outcome obtained 
by successful implementation of guidelines [17]. In contrast to severe mental 
illness (SMI), such as schizophrenia and dementia, (non-chronic) depressive 
disorders could be a more favourable area of mental healthcare for improving 
outcomes through the implementation of guidelines [17]. According to the 
authors, the treatment of SMI could be more complex than that of depressive 
disorders, and thus, improving treatment outcome for SMI might be more diffi-
cult to achieve [17].
Since the publication of the reviews of Bauer and Weinmann and colleagues 
at least three more studies have confirmed the positive effects of implementing 
treatment guidelines for depressive disorders [19, 20, 21]. In the first of these 
studies, depressed inpatients were randomized to either an algorithm-guided 
standardized stepwise drug treatment regimen or treatment as usual (TAU). 
The probability of remission was found to be higher in patients receiving care 
according to the medication algorithm. In the condition in which the algo-
rithm was followed, the average time to remission was 5 weeks shorter [19]. 
The second study that evaluated another medication algorithm, found a higher 
remission rate (60.2%) in depressed outpatients who were randomized to an 
algorithm of guided treatment (AGT) vs. treatment as usual (TAU) (49.7%). 
The median number of days to achieve remission in the AGT group (93 days) 
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was half as long as that in the TAU group (191 days) [20].The third study 
evaluated the systematic implementation of guidelines for depression and 
suïcidality in 6 psychiatric clinics, of which two served as controls. Guideline 
adherence was found to be higher in the clinics in which the guidelines were 
systematically implemented and not only disseminated. Furthermore, patients 
treated in clinics in which the guidelines were systematically implemented, 
showed greater treatment gains at lower cost compared to patients treated in 
the control clinics [21].
These studies [19, 20, 21] provide evidence that implementing guidelines is 
an endeavour worth pursuing, at least in affective disorders. Findings such as 
these also warrant additional research into the effectiveness of implementing 
guidelines for other common mental disorder for which potent evidence-based 
treatment options exist. This thesis will focus on such an endeavour in the 
treatment of patients with an anxiety disorder. It was, however, stated that the 
evidence of the effects of a specific guideline could not be separated from the 
evidence concerning the effectiveness of specific implementation strategies 
[17]. The important question which implementation strategies are effective will 
be addressed in this thesis as well. 
1.4. Implementation strategies
The review of Bauer [16] included several studies in which guideline adherence 
levels were compared before and after publication of guidelines without further 
intervention. Results of these studies in terms of changing provider behaviour 
were generally poor. The results suggest that if one aims to implement guide-
lines, active intervention is necessary. Both reviews [16, 17] conclude that it is 
not possible yet to identify one single strategy for guideline implementation 
that is most effective. However, studies that reported positive outcomes were 
found to have used so-called “complex multifaceted interventions”, or certain 
psychological methods that are used to overcome specific barriers to change in 
the process of guideline implementation. 
Certainly at the time of the publication of these two reviews, no “ready-made” 
implementation strategy could be viewed as superior for mental healthcare in 
all types of situations. The same held for changes in the somatic healthcare 
system [22]. The use of a tailor-made implementation program is therefore 
suggested [22], matching the specific setting and needs of the target group 
among which changed behaviour is sought. Developing such a tailor-made 
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implementation program seemed to be a promising strategy when implement-
ing guidelines for anxiety disorders too. Since studies focusing on the imple-
mentation of guidelines for anxiety disorders had never been performed, we 
thereby also wanted to study the feasibility of implementing these guidelines 
when using such a tailor-made implementation approach. 
1.5. Anxiety disorders and the use of practice guidelines
Anxiety disorders cover a phenomenological diverse group of mental disor-
ders that share a core feature of excessive or unreasonable anxiety and/or 
fear experienced by the patient. The various anxiety disorders differ in focus 
and pattern of anxiety, the avoidance of feared situations and the presence of 
specific symptoms like excessive worrying or obsessive behaviour.
In the Netherlands about 1.3 million people suffer from an anxiety disorder 
[23]. Anxiety disorders are known to markedly compromise quality-of-life and 
psychosocial functioning in several functional domains [24]. Anxiety disor-
ders, with a lifetime prevalence of 19.6% as a group, belong to the most preva-
lent mental disorders in the Netherlands. Being surpassed only slightly by the 
mood disorders, for which a life-time prevalence of 20.2% was found. The life-
time prevalence of anxiety disorders appears to have been quite stable during 
the last decennium [25]. It is estimated that each year about 180 million Euros 
are spent on healthcare for patients suffering from anxiety disorders in the 
Netherlands [23]. However, the indirect costs to society have been estimated 
much higher. Untreated anxiety disorders mostly run a chronic course [26], 
resulting in an increased non-psychiatric medical consumption and ongoing 
costs due to absenteeism and loss of productivity at work [27]. 
The ESEMeD study [6] showed that, compared with 5 other European coun-
tries, the Netherlands performed best with an overall proportion of 55.4% 
adequate care for depressive or anxiety disorder patients. This proportion is 
still rather low, especially when you consider that only minimal criteria for 
judging adequacy of care were used (the prescription of antidepressant of anxi-
olytic medication, or having had 8 contacts with a psychiatrist or psychologist 
for psychotherapeutic treatment). Such an estimation is considered far too low, 
because 8 sessions of psychotherapeutic treatment does not necessarily mean 
that the psychotherapeutic care has been optimal. Research carried out in the 
Netherlands around 2000 showed that although about 90% of anxiety disorder 
patients treated in the Netherlands were offered some form of psychotherapy, 
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only one third of them actually received an evidence based form of psychotherapy 
in the form of directive therapy [28]. 
A more recent cross-sectional study performed by Bet and colleagues (2013) 
showed that these figures on adequacy of care have only improved very little over 
the years [29] even despite the publication of the Dutch multidisciplinary guide-
lines for mental healthcare. This study used the baseline measurement data from 
the NESDA study [30] to assess treatment inadequacy in primary and secondary 
care in patients suffering from major depressive disorder (MDD) or an anxiety 
disorder (n=1662). For the anxiety disorders patients with a panic disorder with or 
without agoraphobia, social anxiety disorder or generalized anxiety disorder were 
included. Adequacy of care was judged according to the recommendations of the 
guidelines. In case of pharmacotherapy not only the right type of medication, 
but also the right type of medicine that was prescribed, and adequate medication 
usage were assessed. In judging adequacy of psychological treatment a very rough 
estimate was used. A patient was considered to have received adequate psycholog-
ical treatment if the patient had at least had 5 visits to a professional for ‘conversa-
tions about causes of and dealing with emotional problems’ in the last 6 months. 
This professional could be a psychiatrist, psychotherapist, trained psychologist, 
but also a trained social worker or social psychiatric nurse. It was found that in 
subjects with moderate to severe anxiety disorder (without a comorbid depressive 
disorders), overall only 56% of the subjects were treated sufficiently with antide-
pressants, benzodiazepines or psychological treatment. Treatment inadequacy 
was more prominent in primary care (60%) than in specialized care (30%) [29]. 
All of the above mentioned findings suggest anxiety disorders to be a very rele-
vant group with regards to improving quality of care. The systematic implemen-
tation of anxiety disorder guidelines may be a means to that end. Recent figures 
on quality of care suggest that the “passive” dissemination of these guidelines has 
little to no effect. A result that could be expected, because of the findings from 
Bauer’s review, which suggest that often more “active” intervention is necessary to 
successfully implement guidelines [16]. Strong evidence regarding the feasibility 
and the effectiveness of implementing such guidelines is yet to be found. 
1.6.  Predicting non-response and persisting disability when 
adhering to anxiety disorder guidelines 
In clinical practice it would be valuable to be able to identify risk factors for 
non-response to care which is delivered according to the multidisciplinary 
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guidelines. If these risk factors were known, the clinician would be able to 
make proper treatment adjustments in an early stage of treatment. An import-
ant question therefore is “if it is possible to predict in advance for which 
patients adhering to the anxiety disorder guideline recommendations will not 
be beneficial?”. However, so far research has yielded few reliable predictors of 
treatment prognosis. 
After studying the literature, Taylor and colleagues conclude that in the 
treatment of anxiety disorder patients, factors such as low treatment motiva-
tion, hidden secondary motives for seeking treatment, experienced barriers 
that hamper in attending treatment, pre-treatment symptom severity and the 
presence and severity of possible comorbid psychopathology could be relevant 
for predicting the course of treatment and treatment outcomes [31]. 
When looking at treatment predictors, another important long-term treat-
ment outcome to consider might be persisting functional impairments. 
Especially from a societal perspective where such impairments could predict 
continued need for treatment and a decreased ability to participate in society. 
A systematic review on prognostic factors of long term disability in mental 
disorders performed by Cornelius et al [32] sheds light on some factors that 
may be of interest when studying persisting functional impairments despite 
provision of adequate care. In this review strong evidence was found for age 
as a relevant factor for continuous disability. Limited evidence was found for 
gender, education, unemployment, and socio-economic status. 
The above-mentioned predictor variables have never been specifically stud-
ied in a treatment situation when evidence-based practice guidelines for anxi-
ety disorders are properly delivered. The question to be answered is whether 
clinical risk factors may be identified which will allow to predict in advance 
which patients will show treatment non-response or which patients run the risk 
of persisting functional impairments when treated according to these guide-
lines.
1.7. Research questions and outline of this thesis
From the paragraphs above it can be concluded that there is a clear need to 
improve the quality of care for patients with an anxiety disorder. As suggested, 
the implementation of anxiety disorder practice guidelines may be an answer 
to that need. However, it remains largely unknown which implementation 
methods may be effective and whether the implementation of clinical guide-
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lines for this group of patients is actually feasible. In addition, the question is 
not resolved whether successful implementation of these guidelines improves 
treatment outcomes. Finally, it is largely unknown whether there are any 
patient characteristics that could predict treatment non-response or persisting 
functional impairments when adhering to the guidelines. These research ques-
tions will be addressed in the following chapters 2 to 5.
Chapter 2 describes the results of a case study, in which the Dutch anxiety 
disorder guidelines were implemented in the community mental healthcare 
centre of Almelo. Changes in provider behaviour in response to guideline 
implementation activities, before and after the start of implementation activ-
ities were closely monitored. As described in chapter 2, the study’s focus was 
answering the question whether the implementation of the anxiety disorder 
guidelines in mental healthcare was feasible and finding out which implemen-
tation strategies can prove helpful in doing so.
In chapter 3 the results of a study are presented that focused on treatment 
results of the cohort of anxiety disorder patients, included after the start of 
the implementation activities in the community centre of Almelo. At 1-year 
follow-up treatment results of patients whose treatment adhered to the guide-
lines were compared to patients whose treatment did not adhere to these 
guidelines, thereby answering the research question whether adherence to 
such guidelines yields superior results to non-adherence.
In chapter 4 the results of a study are presented in which the cohort of anxi-
ety patients treated in the community centre of Almelo after the start of the 
implementation activities, was compared to a control cohort from another 
treatment setting in which the guidelines were only passively disseminated. For 
this control cohort, the data from the Netherlands Study on Depression and 
Anxiety (NESDA) study was used [30]. Guideline adherence rates and treat-
ment outcome at 1- and 2- year follow-up of the two cohorts were compared. 
In chapter 5 it is described how in a subsample of patients whose treatments 
were found to adhere to the guidelines, risk factors of non-response and persist-
ing disability were studied as determined at 1-year follow-up. In this study many 
predictors of treatment outcome in anxiety disorders were included in concert. 
Finally, in chapter 6 the findings of the chapters 2 to 5 will be discussed and 
recommendations for future research will be described. 
Chapter 7 gives a summary of the complete dissertation. 
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Abstract
Background: Recent years have seen the large-scale development of clinical prac-
tice guidelines for mental disorders in several countries. In the Netherlands, 
more than fifteen multidisciplinary guidelines for mental health care have 
been developed since 2003. The first dealt with the treatment of anxiety 
disorders. An important question was whether it is feasible to implement 
these guidelines because implementing practice guidelines is often difficult. 
Although several implementation interventions have proven effective, there 
seems to be no ready-made strategy that works in all circumstances.
Case description: The Dutch multidisciplinary guidelines for anxiety disorders 
were implemented in a community mental health care centre, located in the 
east of the Netherlands. The centre provides secondary outpatient care. The 
unit within the centre that specializes in the treatment of anxiety disorders has 
16 team members with diverse professional backgrounds. Important steps in 
the process of implementing the guidelines were analysing the care provided 
before start of the implementation to determine the goals for improvement, 
and analysing the context and target group for implementation. Based on 
these analyses, a tailor-made multifaceted implementation strategy was devel-
oped that combined the reorganization of the care process, the development 
of instruction materials, the organization of educational meetings and the use 
of continuous quality circles to improve adherence to guidelines.
Discussion and evaluation:Significant improvements in adherence rates were 
made in the aspect of care that was targeted for change. An increase was 
found in the number of patients being provided with recommended forms of 
psychotherapeutic treatment, ranging from 43% to nearly 55% (p < 0.01). The 
delivery of adequate pharmacological treatment was not explicitly targeted for 
change remained constant.
Conclusion: The case study presented here shows that the implementation of 
practice guidelines for anxiety disorders in mental health care is feasible. 
Based on the results of our study, the implementation model used offers a 
useful approach to guideline implementation. By describing the exact steps 
that were followed in detail and providing some of the tools that were used in 
the study, we hope the replication of this implementation methodology is made 
more practical for others in the future.
Keywords
Anxiety disorders, Practice guidelines, Implementation strategy, Tools for 
implementation
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2.1. Background
Recent years have seen the large-scale development of clinical practice guide-
lines for mental disorders in several countries. Based on a systematic evaluation 
of the existing scientific literature, these guidelines provide recommenda-
tions for clinical practice under specific clinical circumstances. By promot-
ing evidence-based practice, these guidelines are expected to improve the 
quality of care [1]. The Netherlands was among the first countries to develop 
guidelines for mental health care, with over fifteen different multidisciplinary 
guidelines published since 2003 [2]. The first guideline that was published 
concerned the treatment of anxiety disorders [3]. Anxiety disorders constitute 
a highly prevalent group of mental disorders which are known to significantly 
compromise quality of life [4]. Despite the availability of effective psychother-
apeutic and pharmacological treatments in Western countries, a large propor-
tion of patients with anxiety disorders still do not receive an evidence-based 
form of treatment [5-7]. Implementing guidelines for the treatment of anxiety 
disorders will change that, but to date little is known on how to achieve effec-
tive implementation.
The implementation of guidelines is often a difficult process. From other 
fields of medicine where there is a longer tradition of producing guidelines 
for clinical practice, we know that the actual use of these guidelines often 
lags behind their availability [8]. The same holds true within mental health 
care. A survey on the use of national guidelines developed for mental health 
care, conducted among a representative sample of 406 Dutch mental health 
care professionals in 2009, showed that although 91% of these professionals 
reported being familiar with these guidelines, only 28% said that they actually 
used them [9].
From the existing studies on implementing guidelines in mental health care, 
we know that active intervention is necessary to promote adherence to these 
guidelines [10]. Two meta-reviews on guideline implementation within mental 
health care show that studies which use complex multi-faceted interventions 
produce the best results [10, 11]. There is a lack of convincing evidence favour-
ing one type of intervention or a specific combination of interventions when 
implementing guidelines, however. Based on studies into changing medical 
care within the somatic health care system, Grol and Grimshaw also conclude 
that no ready-made implementation strategy is superior in all situations [12]. 
They therefore suggest an implementation model that is to be tailor-made 
matching the specific setting and the needs of the target group among which 
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changed behaviour is sought. In our study we use such an implementation 
model described by Grol and Wensing [13] which, because of its global and 
transparent structure, offers the possibility to tailor-make the implementation 
strategy.
This implementation model of Grol and Wensing consists of several steps that 
help to plan, execute and evaluate implementation systematically. The model 
suggests beginning by determining the goals for improvement by analysing 
current practices, and then analysing the context in which a change of practice 
routines is expected to take place. We developed two practical tools that help to 
provide input for these two diagnostic steps. One is a set of process indicators 
to measure guideline adherence. The second is a questionnaire that helps to 
detect factors that can impede or promote guideline adherence. By describing 
these diagnostic tools in combination with the resulting interpretation of the 
steps in the implementation model, we hope to provide an example of a sound 
implementation methodology that can easily be replicated by others. In our 
case, following this methodology proved very useful. Implementing the multi-
disciplinary guidelines for anxiety disorders led to a significant increase in 
guideline adherence.
2.2. Case description
2.2.1. The treatment setting
The community mental health centre in which the multidisciplinary guidelines 
for anxiety disorders was implemented is located in the Dutch provincial town 
of Almelo which has around 78, 000 inhabitants. It also serves the residents 
from the surrounding rural area with around 60, 000 inhabitants. The centre 
is part of a larger mental health institution, also containing (semi-)clinical 
facilities, being the main provider for mental health care in the region. The 
community mental health centre provides outpatient care and is structured 
according to several disorder-specific units. After being referred to the centre 
by their general physician, patients undergo a standard clinical interview to 
determine their diagnosis. According to the primary diagnosis, patients are 
allocated to the appropriate disorder-specific treatment unit.
The unit responsible for treating patients with anxiety disorders consisted 
of 16 team members when the study began. At that time, the team included: 
1 psychiatrist, 1 psychiatrist in training, 1 clinical psychologist, 1 clinical 
psychologist in training, 2 psychotherapists, 2 health psychologists, 3 health 
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psychologists in training and 1 junior psychologist waiting to start training, 3 
psychiatric nurses, and 1 psychiatric nurse in training. So the team members’ 
experience as health care professionals ranged from beginners to the very 
experienced. The mean age of the team members was 35 years (range 24–53).
The goals of the organization were to improve transparency and the quality 
of care provided by the unit for anxiety disorders by implementing national 
practice guidelines. Implementing multidisciplinary guidelines for anxiety 
disorders was pursued against the background of a scientific study that as 
well as investigating the feasibility of implementing the guidelines, also aimed 
to assess the effectiveness of working according to the guidelines by using a 
prospective cohort design. At the start of this study, guideline adherence was 
too low to be able to make any meaningful comparison between the treatment 
results of patients that received guideline adherent care and those who did not. 
Successful implementation was thus a necessary step in performing this cohort 
study.
The treatment coordinator of the anxiety disorder unit was closely involved 
with this study and a key figure during the process of implementation. During 
the course of the study, a PhD student supervised by the treatment coordinator 
had an average of 16 hours per week available for facilitating the process of 
guideline implementation and the collection of data.
2.2.2. Dutch multidisciplinary guidelines for anxiety disorders
The multidisciplinary guidelines for anxiety disorders were first published by 
the workgroup for anxiety disorders in 2003. Based on a systematic evaluation 
of the scientific literature, the guidelines provide an overview of the state-of-
the-art of care for patients with anxiety disorders, including hypochondriasis, 
ultimately reflecting the consensus of the expert group. As such, the guidelines 
for clinical practice are described for adult patients with a DSM-IV diagnosis 
of panic disorder with/without agoraphobia, social phobia, obsessive compul-
sive disorder (OCD), generalized anxiety disorder (GAD), posttraumatic stress 
disorder (PTSD), specific phobia and hypochondriasis.
Overall, the main evidence-based treatment steps recommended for the 
various anxiety disorders can be summarized as follows. According to the 
Dutch treatment guidelines for anxiety disorders both psychotherapy and 
pharmacotherapy count as equally valid treatment options. Recommended 
psychotherapeutic treatment steps consist of cognitive interventions or specific 
forms of exposure interventions. In cases of posttraumatic stress disorder, eye 
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movement desensitization reprocessing (EMDR) is also considered a valid first-
choice treatment option. The first two or three treatment steps in pharmaco-
therapy consist of prescribing antidepressant medication. The guideline favors 
selective serotonin reuptake inhibitors (SSRIs) over tricyclic antidepressants 
(TCAs). In most cases, if an SSRI produces an insufficient result, switching to a 
second SSRI is recommended before prescribing a TCA. In cases of social anxi-
ety disorder the third pharmacological treatment step is the prescription of a 
benzodiazepine or monoamine oxidase inhibitor (MAOI). In cases of obses-
sive-compulsive disorder that are resistant to treatment, the third step consists 
of augmentation of SSRI therapy with an atypical antipsychotic.
2.2.3.  Measuring guideline adherence with the use of process indicators
One of the activities in the first phase of our project was the development of a 
set of process indicators as one of the two practical tools that help to provide 
input for the diagnostic steps in the implementation model. These indicators 
were developed [14] to gain an understanding of the degree of guideline 
adherence before the start of implementation and to monitor changes during 
the process of implementing the anxiety disorder guidelines. These process 
indicators reflect the percentage of patients receiving recommended care 
according to a specific guideline recommendation. However, the various anxi-
ety disorder guidelines published in 2003 contained over 134 recommenda-
tions for clinical practice. The goal was to arrive at a workable number of indi-
cators, based on the recommendations most relevant to improving the quality 
of care. An iterative consensus procedure was followed for this. The first step in 
developing the set of indicators was to select those recommendations that were 
based on the highest level of scientific evidence. This meant that only recom-
mendations supported by the results of a systematic review, or by the results of 
at least two independently performed randomized clinical trials with sufficient 
sample size, were selected. Excluding four recommendations that related to 
the timing of a specific intervention, the number of selected recommendations 
was reduced to 38. These 38 recommendations were then reformulated into a 
preliminary set of indicators.
For instance, for patients suffering from a panic disorder with agoraphobia, 
the following recommendation: ‘Exposure in vivo is an extremely effective 
intervention in the treatment of a panic disorder with agoraphobia. In those 
cases where avoidance plays an important part in the clinical picture of the 
disorder, there is no reason to apply a different psychological intervention than 
exposure in vivo a priori’; was reformulated into the process indicator: ‘The 
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percentage of patients with panic disorder with (moderate) severe agorapho-
bia, indicated for treatment with exposure in vivo, that is offered exposure in 
vivo’.
In the next step a group of 18 expert clinicians, all members of institutions 
participating in the Dutch Knowledge Centre for Anxiety and Depression, 
were asked to judge this preliminary set of process indicators. The definite 
set of process indicators contained only the preliminary indicators that were 
judged relevant to clinical practice by 80% of those expert clinicians, and of 
which at least 60% said that the aspect of care covered by the indicator needed 
improvement in clinical practice. In this way, a set of 34 process indicators was 
obtained. These 34 indicators related almost exclusively to pharmacotherapy 
or cognitive-behavioural treatment of anxiety disorders. It was these forms of 
treatment that (besides EMDR for patients suffering from PTSD) survived the 
selection procedures, based on the level of scientific evidence and relevance to 
improving the quality of care as assessed by the expert group. This selection 
of indicators coincides with the first two or three steps of the psychotherapeu-
tic and pharmacotherapeutic branches of the treatment algorithms for the 
various anxiety disorders. Thus the final selection of process indicators helps 
to measure whether the first two or three recommended treatment steps have 
been followed in each condition, if indicated.
For this study, the adequacy of psychotherapeutic treatment steps was assessed 
not only by looking at the percentage of patients receiving the right sort of 
treatment method. Three additional parameters were brought into the picture 
by using three supplementary help indicators, to measure the proper execu-
tion of each of these treatment steps. If the recommended psychotherapeutic 
treatment had been offered, these supplementary help indicators reflected: 1) 
whether a treatment rationale had also been given; 2) whether the accompany-
ing homework assignments had been provided during at least half the sessions, 
where relevant, and; 3) whether the minimum recommended number of treat-
ment sessions had been provided. The adequacy of the pharmacological treat-
ment was not only assessed by looking at the prescription of the right category 
of medication. Here, three types of supplementary help indicators were also 
used. If the recommended type of medicine was prescribed, these reflected: 
1) whether one of the specific drugs mentioned in the guideline had also been 
chosen (e.g. fluoxetine as one of the recommended SSRIs for patients with 
panic disorder); 2) whether the recommended dosage was prescribed and; 3) 
whether the drug was maintained long enough to be able to evaluate effective-
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ness (to view an English translation of the final set of process indicators, and 
the corresponding supplementary help indicators see Appendice 1).
2.2.4.  The development of a questionnaire to identify factors that could 
promote or impede guideline adherence
To gain an understanding of factors that could impede or promote the imple-
mentation of the guidelines from the professional’s viewpoint, we developed 
a questionnaire [15] inspired by the theory of planned behaviour (TPB) [16]. 
We found inspiration in the example of Rebergen and colleagues [17], who 
developed a TPB-based questionnaire to examine predictors of adherence to 
guidelines for occupational physicians treating employees with mental health 
problems. The aim was to develop yet another tool, alongside the set of process 
indicators, that could be used in the diagnostic phase of implementing the 
multidisciplinary guidelines for anxiety disorders in other settings too.
To simplify, the TPB states that: 1) if people’s attitude towards the suggested 
behaviour is more positive; 2) if they think that significant others want them 
to adopt the behaviour (subjective norm); 3) if they believe they are able to 
adopt the behaviour this results in; 4) then they will have a stronger intention 
(motivation) to adopt that behaviour, which makes it more likely that they 
will actually behave in that way. According to our application of the TPB, the 
target behaviour is adherence to the Dutch practice guidelines for anxiety 
disorders by the health care professional. We expected that knowledge of the 
position of the team members regarding each of the four TPB factors would 
be helpful when choosing concrete interventions to implement these anxiety 
disorder guidelines. Several items were formulated to measure each of these 
TPB constructs. To determine item topics relevant for the use with the anxiety 
disorder guidelines, 7 health care professionals from the anxiety disorder team 
were interviewed about factors that from their point of view could impede 
or promote the actual usage of the guidelines. Topics matching the TPB 
constructs were then reformulated into 58 items. Most of these took the form of 
concrete propositions, where the respondent was asked to rate his or her level 
of agreement on a five-point Likert scale (ranging from “I strongly disagree” to 
“I strongly agree”). Four of these 58 items asked whether the respondent actu-
ally possessed a copy of the multidisciplinary guidelines of anxiety disorders or 
a summary of it; whether the respondent had read the guidelines; and how the 
respondent rated his or her knowledge of the content of the guidelines. The 
answer to these questions were needed to assess how much effort should be put 
into disseminating the multidisciplinary guidelines for anxiety disorders.
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To arrive at a more compact version of the questionnaire and establish the 
reliability of the different subscales, the original 58-item version of the ques-
tionnaire was distributed among 89 health care professionals that worked for 
one of the institutions participating in the Dutch Knowledge Centre for Anxiety 
and Depression. In analysing the data it was established that we succeeded in 
developing a reliable scale to measure the intention of the health care profes-
sionals to use the guidelines. After removing two items to further improve 
the reliability of the scale, we derived an ‘intention’ subscale consisting of five 
items. Subsequently, for the other three TBP based subscales, the five items 
that showed the best correlation with this intention scale were selected to form 
the definite scale of the corresponding construct. As such, three additional 
subscales were formed as follows: 1) ‘Perceived behavioural control’; a scale 
that reflects the degree to which the health care professional expects to be 
able to arrange his or her work so that he or she can adhere to the recommen-
dations in the guidelines. 2) ‘Attitude’; a scale that reflects whether someone 
holds a positive or negative view of using the guidelines. 3) ‘Social pressure’; a 
subscale that reflects the perceived social normative pressure to adhere to the 
guidelines. By doing this, together with the four questions about the posses-
sion, and knowledge of the guidelines and one question about how often the 
professional thought that he or she already used the guidelines, we derived a 
final 25-item version of the questionnaire to assess factors that could influence 
use of the guidelines by the professional. This 25-item version was considered 
to be short enough to be used easily in different treatment settings (to view an 
English translation of this version of the TPB questionnaire, see Appendice 2). 
Ultimately, it was this 25-item version of the questionnaire that was used within 
the anxiety disorder team of the community mental health centre of Almelo as 
part of the second diagnostic step of the implementation model see reference 
[15] for more details on the development of the questionnaire.
2.3. The process of implementing the guidelines
Following the steps suggested by Grol and Wensing , an implementation 
programme was designed specifically tailored to the situation in Almelo [13, 
18]. The subheadings described below summarize the subsequent steps taken. 
For each subheading a description is given on how the corresponding step was 
developed for the anxiety disorder team.
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Step 1: Analysing current practices and determining goals for improvement
We analysed the provision of care within the anxiety disorder team before 
starting to implement the guidelines by reviewing the medical records of 150 
patients suffering from an anxiety disorder or hypochondriasis, who were 
treated between 2002 and the beginning of 2004. Checklists were used to 
assess the adherence to the relevant guidelines. The data collected in this way 
was used to score the set of process indicators described previously.
After reviewing the medical records of these 150 patients and scoring the 
appropriate indicators, the analysis showed that improvement was most needed 
on the adequate provision of cognitive interventions and exposure treatment. 
Relatively large numbers of patients received a positive indication for being 
offered this kind of treatment. However, only 15 per cent of patients in the 
case of cognitive interventions and only 17 per cent of patients in the case of 
exposure interventions did actually receive these kinds of treatment as they 
should have. A large number of patients that were being offered these kinds of 
interventions did not receive the corresponding homework assignments and 
did not undergo enough treatment sessions. So these aspects of care needed 
improvement. Also, improvement was necessary in the provision of EMDR for 
patients with PTSD. Compared to the provision of adequate psychotherapeutic 
treatment as first line of treatment, there was more adequate provision of the 
first step of pharmacological treatment. The most significant improvement in 
pharmacological treatment was deemed necessary in the more advanced steps 
of the medication algorithms, which however concerned only a small number 
of patients. Improving the number of patients receiving a recommended form 
of psychotherapeutic treatment was therefore considered to be the primary 
aim of implementing the guidelines.
Step 2: Analysing the context and target group for implementation
After analysing the actual provision of care and setting goals for improvement, 
we identified factors that could impede or promote guideline adherence at the 
level of the organization, the level of the health care providers and the level 
of the patients. A selection of seven team members with different professional 
backgrounds, were interviewed in depth about their opinion towards the anxi-
ety disorder guidelines and factors that they thought may possibly impede their 
adoption. In addition, as part of the second step all of the team members were 
also asked to fill in the final 25-item version of this TPB questionnaire. The 
purpose of this was to assess the intentions of health care providers in using the 
van Dijk_Proefschrift Anxiety Disorders_v5_170x240.indd   32 03/10/2014   23:46
Implementing practice guidelines for anxiety disorders 33
guidelines and to get a rough idea of the position of the team on each of the 
other three TPB constructs.
During the interviews, concerns were raised about two points. First the qual-
ity of the unit responsible for diagnosing newly referred patients and devising 
their treatment plans. The members of the anxiety disorder team had to 
adhere to this treatment plan to which patients had consented. Therefore it 
was deemed crucial that these treatment plans had to reach a higher standard 
and were to be modelled more according to the guideline recommendations. 
Second the interviewees also had the impression that they treated many 
patients with complex problems. They thought that the guideline recommen-
dations would be difficult to apply to these patients and that this would impede 
guideline adherence.
Based on the data gathered using the TPB questionnaire, we were able to 
conclude that the team members held rather positive attitudes toward the 
guidelines in general. On the other hand they did not appear to feel much 
social pressure to follow guideline recommendations. Some of the team 
members also reported being unfamiliar with the exact content of the guide-
lines and many of the team members did not feel overly confident about being 
able to apply the guideline recommendations in daily clinical practice.
Step 3: The selection and development of implementation strategies
In step 2 we identified factors and circumstances that could impede or promote 
guideline adherence. These factors were found at different levels: organiza-
tional (the process of care and foremost the intake, diagnosing and choice of 
the treatment), patients (the matter of informed consent) and professionals 
(attitude towards the guidelines, the (felt) autonomy and the limited social 
pressure). Working on the different facets is one of the main characteristics 
of the overall approach and so we had to direct interventions on each of these 
facets.
At the organizational level it was obvious to us that some changes had to be 
made in how the intake procedure was organized. To improve the reliability 
of the diagnostic process, the idea was to make it compulsory to use the MINI, 
a semi-structured interview to derive at a DSM-IV diagnosis [19, 20], during 
the intake phase. It was also thought that it would be better if the treatment 
coordinator of the anxiety disorder team was made responsible for devising 
treatment plans for patients with an anxiety disorder or hypochondriasis. 
Consequently, the decision was taken that as soon as the member of the intake 
team had established an anxiety disorder or hypochondriasis as the primary 
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diagnosis, the patient would be referred to the anxiety disorder unit and 
scheduled for a meeting with the treatment coordinator to discuss the various 
treatment options. Doing this was expected to have two important advantages: 
1) It would provide the best guarantee that the treatment plan would match 
the recommendations of the corresponding practice guideline, because the 
treatment coordinator would be involved in the process of implementing the 
guidelines; 2) The treatment coordinator would have an impression of all the 
patients treated within the unit, which could have added value when evaluating 
the course of treatment for individual patients during the bilateral treatment 
evaluations which were scheduled regularly. The expectation was that the 
treatment coordinator would be better able to help identify possible solutions 
for the problems mentioned by the therapist with applying the guideline 
recommendations, if he himself had also met the patient. This should lead to 
better guideline adherence.
At the patients level the intention was also to develop special patient instruc-
tion materials to educate the patient about their disorder and the various treat-
ment options recommended in the corresponding practice guideline. This 
information was to be sent to patients prior to their meeting with the treat-
ment coordinator. It was expected that it would be more difficult for the team 
members to ignore or overlook the course of action set out in the treatment 
plan if they knew that the method of treatment recorded in the plan reflected 
a considered patient choice.
At the level of professionals several interventions were planned to inform, 
instruct and commit. Two team meetings were organized to discuss the content 
of the guidelines. Educational materials for health care professionals, such as 
desktop versions of the guidelines summarizing the most important points of 
every guideline and the different treatment algorithms were developed. The 
purpose of this would be to improve the knowledge of the guideline recom-
mendations considered most important for improving the quality of care on 
the part of the team members involved. We also intended to develop a treat-
ment folder consisting of the psychological evidence-based treatment manuals 
that would be used the most frequently by the psychologists in the team, so that 
they would become accessible to all. Here the expectation was that this would 
make it easier for the psychologist to apply the recommended treatment meth-
ods. Several psychologists would also be sent for training in the use of EMDR 
because too few of the psychologists on the team were skilled in the use of this 
intervention. Finally, from the start of implementation, the health care profes-
sionals would also be asked to use a checklist with guideline recommendations 
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as the basis for the evaluation of the treatment progress of individual patients 
in the care of the team. This was to help keep the recommended treatment 
steps clearly in mind when deciding on a subsequent course of action.
Step 4: Executing the implementation plan
The health care professionals in the intake team were trained in using the 
MINI [19, 20]. The process of care was reorganized as suggested in step 3. 
Two team meetings were held to familiarize the health care providers with 
the content of the guideline. The first meeting was opened by the manager 
of the community mental health care centre to stress the importance of the 
implementation project. The development of the guidelines and its recom-
mendations were both discussed at the meeting. It was emphasized that the 
guidelines had received the approval of the various professional bodies and 
the patient organization for people with anxiety disorders. Feedback was also 
given regarding the current provision of care within the anxiety disorder team 
by presenting the data derived from the medical records, and the goal for the 
future was explained: increasing the number of patients who receive a recom-
mended form of psychotherapeutic treatment. It was explained that retaining 
positive scores on the defined supplementary help indicators was important to 
obtain a positive score on the main process indicator, by providing the corre-
sponding homework assignments and sufficient number of treatment sessions 
in case of psychotherapeutic treatment. For pharmacological treatment, the 
importance of a positive score on the parameters covered by the pharmaco-
therapeutic help indicators was also emphasized.
Before the second meeting, the health care providers were asked to bring 
examples of patients from their caseload for whom they thought the guidelines 
would be difficult to apply. The purpose was to reach a consensus about the 
practical scope of the guideline recommendations and to reach a consensus 
about what would constitute legitimate reasons for deviating from the recom-
mendations in the guidelines. By discussing the applicability of the guideline 
recommendations in these ‘complex’ cases, the opinion that the guideline 
recommendations could not be applied to most of the patients seen by the 
anxiety disorder team members also became less credible. The aforemen-
tioned instruction materials for patients and the different educational mate-
rials for the health care professionals in the anxiety disorder team were devel-
oped, tested and distributed according to plan. After the first team meeting, an 
evaluation of the treatment progress of individual patients in the regular team 
meetings on patient progress was carried out with guideline recommendations 
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clearly in mind. From that moment onwards, during each treatment evaluation 
the health care provider explained the course of treatment for the patient 
along the lines of the algorithms and the treatment coordinator would check 
guideline adherence. This was an aspect of quality assurance for the provision 
of optimal care. Also, several psychologists were invited to participate in a 
course about the use of EMDR with patients suffering from PTSD, as specified 
in the plan.
Step 5: Evaluating progress, and adjusting the original implementation plan
The last step of Grol and Wensing’s model [13] consists of continuously moni-
toring the progress made. Six months after the start of the implementation, a 
third meeting was held to share experiences using the guidelines, get an impres-
sion of the team members’ opinions about the course of the implementation 
project, and give feedback on the progress made in implementing the guide-
lines. At the time of this third meeting, most team members still had a positive 
attitude towards working according to the guidelines. However, some openly 
complained about having less autonomy and being less satisfied with their job 
since the start of the project. The impression was given that this was merely due 
to the increased supervision of their performance. Literature on this subject also 
shows a significant association between job autonomy and job satisfaction among 
health care professionals [21]. These signals were taken seriously. The treatment 
coordinator changed his style of asking about guideline adherence during treat-
ment evaluations within the team, and the good intentions of the team members 
wanting to follow the guideline recommendations were taken more seriously. 
They were asked to talk about treatment progress and indicate themselves 
whether there were any difficulties in applying the guideline recommendations, 
without the treatment coordinator asking about guideline adherence proactively 
and most team members were satisfied with this arrangement. The first signals of 
an increase in the number of patients receiving the recommended psychothera-
peutic care became apparent.
After one year, a sample of medical files was taken from fifty patients who 
had begun treatment after the implementation of the guidelines to evaluate 
the progress of implementation in greater detail. The data collected showed 
that the application of specific cognitive-behavioural techniques still seemed to 
pose a problem for some team members, although an overall increase in guide-
line adherence could already be discerned. Two additional team meetings were 
held. One focused on the use of behavioural experiments in cognitive therapy, 
in which automatic thoughts had already been tested several times with the use 
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of thought records and Socratic dialogue. This resulted in a first shift in the 
credibility of the anxious thoughts. The other meeting focused on new insight 
into the mechanisms of exposure treatment. In this meeting, the way this new 
insight could be translated into concrete homework assignments for patients 
with the various anxiety disorders was discussed from the start of therapy. 
The importance of motivating the patient to complete such assignments was 
emphasized.
Two years after the official start of implementing the guidelines, another 
review of medical files was carried out for 181 patients referred to the anxiety 
disorder team after October 2005 for a final evaluation of the implementation 
efforts. To assess changes in guideline adherence, a cross-section of the medi-
cal files from this second group of patients was taken midway through 2008. 
The original process indicators were scored once again. To increase power, 
aggregated information from the disorder-specific indicators was used where 
possible to reflect general changes in adherence to the recommended treatment 
steps. Table 1 reflects the patient characteristics of those patients included in the 
reviews of medical files before and after start of the implementation of the guide-
lines. As Table 2 shows, there is a significant difference in the number of asylum 
Table 1.  Socio-demographic and clinical characteristics of patients in the pre- 
and post-implementation group
Pre-implementation 
group (n=150)
Post-implementation 
group (n=181)
p
Age: mean (SD) 34.0 (11.0) 33.9 (11.0) 0.94
Gender (female): n (%) 93 (62.0) 111 (61.3) 0.90
Living alone: n (%) 32 (21.5) 25 (15.7) 0.19
Educational level; elemen-
tary school, at max: n (%)
29 (19.3) 22 (13.9) 0.20
Foreign origin: n (%) 44 (29.3) 40 (22.1) 0.13
Asylum seeker: n (%) 24 (16.0) 12 (6.6) < 0.01
Panic disorder: n (%) 58 (38.7) 71 (39.2) 0.92
Social anxiety disorder: 
n (%)
25 (16.7) 29 (16.0) 0.87
Obsessive-Compulsive 
disorder: n (%)
23 (15.3) 14 (7.7) 0.03
Generalized Anxiety disor-
der: n (%)
11 (7.3) 17 (9.4) 0.50
PTSD: n (%) 30 (20.0) 39 (21.5) 0.73
Specific phobia: n (%) 3 (2.0) 6 (3.3) 0.52
Hypochondriasis: n (%) 0 (0.0) 5 (2.8) 0.07
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Table 2. Guideline adherence in the pre- and post-implementation group
Guideline recommendation Pre-implemen-
tation group 
(n=150)
Post-implemen-
tation group 
(n=181)
Differ-
ence 
(%)
p
Number of patients indicated 
for cognitive interventions and 
the percentage that actually 
received it: n (%)
124 (15.3) 109 (69.7) +54.4 <0.01
Number of patients indicated 
for exposure interventions and 
the percentage that actually 
received it: n (%)
81 (17.3) 50 (60.0) +42.7 <0.01
Number of patients indicated 
for treatment with EMDR and 
the percentage that actually 
received it: n (%)
23 (43.5) 30 (96.7) +43.2 <0.01
Number of patients indicated 
for medication step 1 and 
the percentage that actually 
received it: n (%)
54 (55.6) 59 (61.0) +5.4 0.56
Number of patients indicated 
for medication step 2 and 
the percentage that actually 
received it: n (%)
15 (20.0) 20 (45.0) +25.0 0.12
Number of patients indicated 
for medication step 3 and 
the percentage that actually 
received it: n (%)
11 (45.5) 12 (16.7) −28.8 0.19
seekers treated within the anxiety disorder unit before and after implementation 
of the guidelines, probably due to the closure of a nearby refugee centre during 
that period. Also, fewer patients with OCD were seen for treatment after the start 
of implementation. Neither of these two variables were shown to be significantly 
associated with differences in guideline adherence however.
Table 2 shows the percentage of patients receiving treatment according to the 
recommended general treatment steps, before and after implementation of the 
guidelines and the change in percentage over time.
As can be seen in column 4 of Table 2, there were significant changes in the 
percentage of patients receiving cognitive interventions (+54.4%, p < 0.01) 
and the percentage of patients receiving the recommended form of exposure 
interventions (+42.7%, p < 0.01). Additionally, the percentage of patients with 
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posttraumatic stress disorder who were treated with EMDR, if indicated, was 
significantly higher (+43.2%, p < 0.01). Even though there were changes in the 
percentage of the patients being given adequate pharmacological treatment, 
the number of cases indicated for the different consecutive steps was too small 
to justify further statistical analyses.
2.4. Discussion and Evaluation
After drawing up a tailor-made implementation plan and using multifaceted 
implementation strategies, significant improvements in adherence rates to the 
Dutch multidisciplinary guidelines for anxiety disorders were found to have 
occurred. An increase was found in the number of patients being provided the 
recommended forms of psychotherapeutic treatment, which was the primary 
aim of the implementation activities. The delivery of adequate pharmacologi-
cal treatment was not explicitly targeted for change and remained fairly stable. 
Generally, it seems that we may safely conclude that the implementation of 
evidence-based practice guidelines for anxiety disorders within mental health 
care is feasible.
Based on the experiences in our study, the implementation model of Grol and 
Wensing offers a useful approach to guideline implementation. It helps to plan 
and execute implementation activities systematically, and helps to develop imple-
mentation interventions that match the requirements of the target group. In our 
study, the factors that improved guideline adherence were interventions aimed 
at reorganizing the process of care, greater dissemination of knowledge about 
the guidelines (including the distribution of training materials to aid in follow-
ing the guideline recommendations), and measures aimed at increasing norma-
tive social pressure in favour of adherence to the anxiety disorder guidelines.
The method of implementation described in this study appears to be effec-
tive, and can be easily copied by others. The preparation of implementation 
aids such as desk-top guides and the patient information materials is an idea 
that could easily be ‘borrowed’ from this study for use elsewhere. The same is 
true of the format of the team meetings and the training materials used. The 
questionnaire used to assess the health care providers’ intention of beginning 
to use the guidelines can also be lend. Instead of the large sample needed for 
scientific research purposes, in daily practice small samples of about ten medi-
cal records can be used as input for the plan-do-check-act cycle to monitor 
progress in implementing the guidelines.
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One limitation of the study is the use of before-and-after design to evaluate 
the effect of our implementation activities. Without the use of a control group 
and proper randomization procedures, we cannot conclude definitively that 
the changes in behaviour that we observed resulted from the efforts aimed at 
implementing the guideline. They may well simply reflect the passing of time 
and the fact that the use of guidelines became slowly more established in the 
Netherlands. Studies by Bauer [10] and Weinmann et al. [11] show, however, 
that without active efforts to ensure the implementation of a guideline, they 
will only be marginally adhered to. This casts doubt on the idea that the 
changes achieved merely reflect a process that would have happened anyway. 
Nevertheless, a controlled design is necessary to draw more firm conclusions 
about the effectiveness of the implementation activities such as those described 
here. Besides the evidence of the feasibility of implementing evidence-based 
guidelines for anxiety disorders, our results only allow the conclusion that the 
tailor-made approach presented here seems promising from the point of view 
of implementing evidence-based practice guidelines within mental health care.
A significant challenge however will be the maintenance of performance 
rates in the longer term. Health care professionals leaving the team and new 
personnel starting, and constantly changing organizational priorities will 
make this a difficult task. The treatment coordinator – a key figure in ensuring 
proper guideline adherence – left at the end of the study. The impression was 
that adherence rates dropped slightly after this. It is very important to continue 
monitoring guideline adherence and provide continuous feedback. With new 
personnel coming in, it is necessary to hold regular training days such as those 
held at the start of the implementation. Our impression is that doing so would 
prove very worthwhile. The multifaceted approach also seems to be specifically 
relevant in meeting this challenge because of the different factors which inter-
vene and interact: organizational (for instance organizational rules and lead-
ership), professionals (information, education, instruction and commitment) 
and the patients level (information, participation). Measures have to be taken 
at the different facets to maintain the necessary change.
2.5. Conclusions
The case study presented here shows that the implementation of practice 
guidelines for anxiety disorders in mental health care is feasible. After drawing 
up a tailor-made plan for implementation and using multi-faceted implemen-
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tation strategies, significant differences were found on those aspects of care 
that were targeted for change in the community mental health care centre 
in which this type of guidelines were implemented. The study also shows, 
however, that it is important to think about ways to maintain changes made 
in the provision of care in the longer term. An important question remains 
whether following such anxiety disorder guidelines does indeed lead to better 
treatment outcomes, as expected. A future publication will report on the rela-
tionship between adherence to such guidelines and treatment outcomes, based 
on the treatment results gained in patients treated in the community mental 
health care centre after the start of the activities aimed at implementing the 
guidelines.
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Abstract 
Background: While studies into the implementation of clinical practice guide-
lines for mental health care are scarce, studies on the effectiveness of imple-
menting practice guidelines for anxiety disorders appear to be entirely nonex-
istent.
Objective: To examine whether adherence to anxiety disorder clinical practice 
guidelines in secondary mental health care yields superior treatment results 
than non-adherence.
Method: A closed-cohort study of 181 outpatients with an anxiety disorder or 
hypochondriasis who were treated in a routine mental health setting. Preceding 
the inclusion of these 181 patients, a start was made on the implementation of 
the Dutch national multidisciplinary practice guidelines for anxiety disor-
ders. Patients were asked to complete several questionnaires before the start 
of treatment and again one year later. The medical records of these patients 
were reviewed to assess guideline adherence. Ultimately, adherence or non-ad-
herence to the different treatment algorithms described in the guidelines was 
related to changes in the severity of psychiatric symptomatology, psychiatric 
functioning, general well-being and satisfaction with treatment.
Results: Compared with patients whose treatment did not adhere to the guide-
lines, those whose treatment adhered to the guidelines were found to have 
greater symptom reduction after one year (p<0.01). The latter group of patients 
also rated their satisfaction with their treatment significantly higher (p=0.01). 
No significant differences were found after one year with respect to changes 
in impairment of functioning and quality of life in the two groups of patients.
Conclusions: Adherence to anxiety disorder guidelines yields superior treat-
ment results and increased patient satisfaction with treatment when compared 
with patients whose treatment did not adhere to the clinical guidelines. These 
results should encourage a more widespread implementation of such guide-
lines in mental health care facilities.
 
Keywords
Anxiety disorders, guidelines, effectiveness
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3.1. Introduction 
In order to reduce unwanted variance in the provision of care and to promote 
the use of empirically supported treatment methods, clinical practice guide-
lines for mental health care have been developed in many countries over the 
last decade. The use of these guidelines is expected to improve the quality 
of care by promoting evidence-based practice. However, few studies have 
been conducted into the implementation of such guidelines. Two reviews on 
the effect of implementing guidelines on provider performance and patient 
outcomes within mental health care found that various implementation strat-
egies are moderately effective, at best [1, 2]. The best results seem to be 
produced by implementation studies that use complex multi-faceted inter-
ventions and have been developed specifically to overcome certain barriers 
to change in the context of the particular implementation study. However, 
many studies conclude that the positive results on provider behaviour are only 
temporary [1, 2]. These results show that implementing treatment guidelines 
within psychiatry often proves difficult, despite the potential for improvements 
to the quality of care. 
The Netherlands was among the first countries to develop practice guide-
lines for mental health care, with more than ten different multidisciplinary 
guidelines published since 2003 [3]. The first guidelines that were published, 
under the auspices of the Dutch national steering committee for multidisci-
plinary guideline development in mental health care, concerned the treatment 
of anxiety disorders and hypochondriasis [4]. Despite the availability of effec-
tive psychotherapeutic and pharmacological treatments, a large proportion of 
patients with anxiety disorders still do not receive an evidence-based form of 
treatment in the Netherlands [5-7], as is true in many countries. Implementing 
evidence-based clinical practice guidelines should change that.
While studies on implementing clinical practice guidelines in mental health 
care are scarce, studies on the effectiveness of implementing practice guide-
lines for anxiety disorders appear to be nonexistent. Recently, we performed 
a study that showed that it is feasible to implement such guidelines [8]. After 
drawing up a tailor-made implementation plan and using multifaceted imple-
mentation strategies, significant improvements in adherence rates to the Dutch 
multidisciplinary guidelines for anxiety disorders were found in the commu-
nity mental health care centre in which these guidelines were implemented [8]. 
However, the question of whether implementing such anxiety disorder guide-
lines yields better treatment results remained unanswered. We hypothesized 
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that the use of treatment guidelines should improve treatment outcomes. As 
part of the evaluation of the implementation of the anxiety disorder guidelines 
within the fore mentioned health care centre, we investigated whether there 
was any relationship between guideline adherence and treatment response one 
year after the start of the treatment. This when the data about the treatment 
results gained became available. 
3.2. Methods
3.2.1. Study design
A cohort was formed of patients who were registered at the community mental 
health care centre in Almelo (a town in the east of the Netherlands) after start 
of the implementation of the Dutch multidisciplinary practice guidelines for 
anxiety disorders within this centre. Activities aimed at implementing the 
guidelines began in October 2005. From that moment, 181 newly registered 
patients with an anxiety disorder or hypochondriasis were included. The last 
patient was included in July 2007. Of this group of 181 patients, those who were 
sufficiently fluent in Dutch were asked to fill in several questionnaires before 
beginning treatment and again one year later. The medical records of these 
patients were reviewed to assess adherence to the treatment guidelines. In this 
cohort, adherence to the treatment guidelines correlated with a reduction 
in the severity of the patient’s psychiatric symptomatology, decreases in the 
impairment of social functioning, improvements in general well-being and 
satisfaction with treatment.
3.2.2. Research setting
The community mental health centre where the Dutch multidisciplinary prac-
tice guidelines for anxiety disorders were implemented is located in the town of 
Almelo in the east of the Netherlands. The treatment centre is part of a larger 
organization, including (semi-)clinical settings, which is the main provider of 
mental health care in the region. The community mental health care centre 
provides ambulatory care and is structured into several disorder-specific units. 
After being referred to the centre by their general physician, patients undergo 
a general intake procedure. On the basis of the primary diagnosis, the patient 
is allocated to a disorder-specific unit where treatment takes place. The unit 
responsible for the treatment of anxiety disorders has 16 team members, 
including a psychiatrist and several psychologists and psychiatric nurses. The 
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experience of the team members in providing health care ranged from begin-
ner’s level to very experienced. The mean age of the team members was 35 
years (range 24-53 years). 
In implementing the anxiety disorders guidelines the steps as suggested by 
Grol and Wensing were followed [8, 9]. The preparations for implementing 
the guidelines began at the end of 2004, almost a year before the official kick-
off for the start of the implementation of the guideline and the inclusion of 
patients that formed the cohort in which the effectiveness of using the guide-
lines was investigated. Ultimately, based on a diagnostic analyses of possible 
barriers for implementation in the target setting a tailored made plan for 
implementation was designed that comprised the following main interven-
tions: 1) the reorganization of the care process in which the treatment coordi-
nator –an experienced cognitive behaviour therapist- of the anxiety disorder 
team would see all patients allocated to the unit at the start of their treatment. 
So, the treatment coordinator was made responsible for devising the treatment 
plan for all patients allocated to the unit instead of the intake professional. 
This to ensure that the treatment plan would match the recommendations of 
the corresponding practice guideline. 2) The development and distribution 
of instruction materials for patients and health care providers 3) The organ-
isation of two educational meetings in which the content of the guidelines 
were discussed. 4) The training in the skills needed to perform treatments 
suggested in the guidelines e.g. a selection of the psychologists were trained 
in the use of eye movement desensitization reprocessing (EMDR) for patients 
suffering from posttraumatic stress disorder [8]. 
During the time the patients were included in the study, activities aimed at 
implementing the guidelines were continued to further promote guideline 
adherence. The evaluation of treatment progress of individual patients in 
the regular team patient-progress meetings was done with help of a guide-
line recommendations checklist. Further, additional educational meetings 
were held in the team to improve the knowledge and use of specific cognitive 
behavioural techniques and corresponding homework assignments. As part 
of the cycle for continuous quality improvement for which at regular intervals 
data about guideline adherence was collected, it was found that these aspects 
of care needed extra attention in our treatment setting.
3.2.3. Patients
All consecutively referred patients between 18-65 years with a primary DSM-IV 
diagnosis of panic disorder with/without agoraphobia, social phobia, OCD, 
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generalized anxiety disorder, PTSD, specific phobia or hypochondriasis were 
eligible for inclusion in the study. In accordance with the guidelines, no further 
exclusion criteria were formulated. The Mini International Neuropsychiatric 
Interview (M.I.N.I.) [10, 11] was used to assess DSM-IV diagnoses. Patients were 
asked to provide informed consent in writing. The study was approved by the 
medical ethics committee of the VU University Medical Center.
3.2.4. The Dutch multidisciplinary guidelines for anxiety disorders
The Dutch anxiety disorder guidelines are based on evidence based principles. 
According to these guidelines, anxiety disorder patients may be treated with 
either psychotherapy or pharmacotherapy, both of which count as equally 
valid options [4]. Regardless of the specific anxiety disorder, recommended 
psychotherapeutic treatments consist of cognitive therapy or behaviour ther-
apy (e.g. exposure in vivo). In post-traumatic stress disorder (PTSD), eye 
movement desensitization reprocessing (EMDR) is also considered to be a 
valid first-choice treatment option. Applied relaxation is recommended for 
patients suffering from panic disorder or generalized anxiety disorder that do 
not respond to cognitive-behavioural interventions. According to the Dutch 
anxiety disorder guidelines, the first three treatment steps in pharmacotherapy 
consist of prescribing three types of antidepressants. The guidelines favour 
selective serotonin reuptake inhibitors (SSRIs) over tricyclic antidepressants 
(TCAs). If an SSRI proves insufficient, switching to a second SSRI is recom-
mended before prescribing a TCA. However, for a patient suffering from 
generalized anxiety disorder (GAD) the prescription of the SNRI venlafaxine 
is recommended instead of a second SSRI. In social phobia, the third pharma-
cological treatment step is the prescription of a benzodiazepine or monoamine 
oxidase inhibitor (MAOI) rather than a TCA. In treatment-resistant obses-
sive-compulsive disorder (OCD), the third step consists of augmenting SSRI 
therapy with an atypical antipsychotic. 
3.2.5. Measuring guideline (non-)adherence 
We used process indicators that reflected the percentage of patients receiving 
the recommended care according to a specific guideline recommendation. 
These indicators represented guideline recommendations based on scientific 
evidence of the highest quality and of the most relevance to improving the 
quality of care. The indicators were selected by consensus by senior profes-
sionals at the Dutch knowledge centre for anxiety and depressive disorders 
[8, 12]. The selected indicators coincide with the first two or three steps of 
van Dijk_Proefschrift Anxiety Disorders_v5_170x240.indd   50 03/10/2014   23:46
The effectiveness of adhering to guidelines for anxiety disorders 51
the psychotherapeutic and pharmacotherapeutic branches of the treatment 
algorithms for the various anxiety disorders. Effectively, then, the indicators 
measure whether the first two or three recommended psychotherapeutic and 
pharmacotherapeutic treatment steps have been followed adequately for each 
anxiety disorder. 
During the review of the medical files, a specially developed checklist was 
used to determine the scores on relevant process indicators. This checklist 
was applied to the first 100 medical files by two assessors. Differences between 
the coding forms were resolved by reviewing the original files, leading to one 
coding form per medical file. In the case of uncertainty about how to score a 
certain process indicator, a consensus was reached through discussion with 
members of the study group (MKvD and DBO). Applying the same decision 
rules as with the first 100 files, an additional 81 medical files were reviewed by 
one of the assessors.
The adequacy of psychotherapeutic treatment steps was assessed not only 
by looking at whether the right sort of treatment was provided, but also other 
criteria such as the presence of a treatment rationale, accompanying homework 
assignments, and the recommended minimum number of treatment sessions. 
In assessing the adequacy of the cognitive-behavioural treatment provided for 
anxiety disorders, the use of this kind of minimal therapy criteria have also 
been used by others (see [13, 14]). The adequacy of the steps in the pharma-
cological treatment was assessed on whether the right category of medication 
had been prescribed and whether one of the specific drugs mentioned in the 
guidelines had been chosen. Then the dosage and maintenance of the medica-
tion were evaluated. If a positive score was obtained for each of the parameters 
mentioned above, an overall score for the relevant treatment step was given. 
When assessing adherence to the treatment guidelines, an indicator was only 
scored if the guideline recommendation on which it was based was indicated 
for that specific patient at that particular time. The specific recommendation 
could also be judged to be inapplicable or even contraindicated. For instance, 
a specific recommendation was contraindicated in the following cases: when 
the primary diagnosis was revised; when a patient refused care; when another 
recommended form of treatment had just started; when a sufficient response 
to the treatment had already been achieved; or when psychosocial problems, 
suicidality or addiction problems had to take priority. In cases of pharmaco-
logical treatments, too, severe side effects or somatic contraindications were 
legitimate reasons for deviating from recommendations of the treatment 
guidelines. It was also possible that patients could drop out of therapy, render-
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ing it impossible for the professional to provide adequate care. In all of these 
instances, the specific guideline recommendation was deemed inapplicable 
and the corresponding indicator was left without a score. Ultimately, adher-
ence to the treatment algorithms described in the treatment guidelines was 
defined dichotomously (yes or no). If the algorithm was followed correctly and 
all the necessary steps in the treatment had been taken, the case would receive 
the label “adherent”.
 
3.2.6. Outcome variables 
The severity of psychiatric symptoms was measured using the Symptom 
Checklist (SCL-90-R) [15, 16]. Changes to the total score on the SCL-90-R 
from baseline to one year after the start of treatment constituted the primary 
measure of outcomes in this study. Three secondary outcome measures were 
also used: changes in the impairment of functioning were measured using the 
Sheehan Disability Scale (SDS) [17]; changes in reported quality of life were 
assessed with the use of the World Health Organization Quality Of Life ques-
tionnaire (WHOQOL- BREF) [18]; and finally, the Dutch national instrument 
for measuring patient satisfaction with mental health care was used one year 
after the start of treatment (GGZ Thermometer) [19]. 
3.2.7. Potential confounders and effect modifiers 
Demographic variables such as age, gender, ancestry and educational level 
were considered as potential confounders or effect modifiers. Other co-vari-
ables that were considered were: 1) co-morbid depressive symptomatology, 
measured with the 30-item Inventory of Depressive Symptomatology (Self-
Report) [20], and 2) the presence and severity of symptoms of a personality 
disorder, assessed with the use of the Personality Diagnostic Questionnaire 
(PDQ-4) [21, 22]. 
3.2.8. Statistical analysis
Standard descriptive statistics were used to describe the study population. At 
baseline, the group of patients who were not treated in adherence with the 
treatment guidelines were compared with t-tests for continuous variables and 
χ2 tests for proportions with the group of patients who were treated in adher-
ence with the guidelines on characteristics that could affect outcome. The 
influence of adherence on outcomes was assessed using regression analyses. 
Because change in the severity of symptoms expressed as a raw change score 
from baseline to one-year follow-up may not be reliable [23], a “residual gain 
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score” was calculated on the outcome variables [24, 25]. To do this, a simple 
regression analysis was performed first, with the test score at baseline as the 
independent variable and the test score at one-year follow-up as the dependent 
variable. This procedure was repeated for the three outcome measures. In 
each case, the residual gain score was used as the dependent variable in multi-
ple regression analyses to determine the impact of guideline adherence, the 
central independent variable. To rule out possible bias through confounding, 
variables by which the treatment-adherent and treatment-non-adherent groups 
differed from one another were added to the regression analysis, in addition to 
the central independent variable. If adding one of these variables led to a 10% 
change in the regression coefficient of the central independent variable, this 
variable was designated as a relevant confounder that needed to be accounted 
for. All calculations in this study were performed with SPSS, version 15.0 (SPSS 
Inc., Chicago IL).
3.3. Results
Figure 1 shows the number of patients found to be eligible for inclusion in the 
study after the start of the implementation of the treatment guidelines in the 
community mental health care centre. A total of 181 patients gave informed 
consent for participation in the study. Twenty-one of these patients (11.6%) 
were not fluent in Dutch and were therefore unable to fill in the question-
naires. Of the remaining 160 patients, the treatment guidelines turned out to 
be inapplicable to 21 patients, because of an early revision of their diagnosis or 
because they dropped out of therapy. This left 139 patients (86.9%), in which 
one or more of the recommended treatment steps in the guidelines should 
be followed and to which the guideline recommendations were considered 
applicable. Of these 139 patients, 58 patients (41.7%) belonged to the guide-
line-non-adherent group, while 81 (58.3%) patients belonged to the guide-
line-adherent group.
Table 1 shows the characteristics of the guideline-adherent group and the 
guideline-non-adherent group in the sample of 139 patients. Patients in the 
non-adherent group lived alone significantly more often than patients in 
the guideline-adherent group. Age, gender, educational level or ethnic back-
ground did not differ significantly between the two groups. Adherence to 
the treatment guidelines was significantly lower in patients with more severe 
psychopathology, as reflected by higher scores on SCL-90-R, IDS and PDQ-4. 
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It was also found that non-adherent treatments comprised significantly more 
treatment sessions compared to guideline-adherent treatments. Because of 
these differences between the adherent and non-adherent groups, we carried 
out a check on whether these variables were confouding the relationship 
between guideline adherence and treatment outcomes. Only the number 
of treatment sessions proved to be a relevant confounder for the different 
outcome measures of the study. On average, patients whose treatment did not 
adhere to the guidelines were seen more often in the period of sample. A nega-
tive correlation was found between the number of treatment sessions spent on 
a patient and treatment outcome. 
3.3.1. Primary outcome measure 
The multiple regression analysis examining the association between guideline 
adherence and changes in general psychopathology (i.e. the residual gain 
score for changes in SCL-90-R total score), after partialling out the effect of 
number of treatment sessions, produced a β= -32.14 (p=0.02). This indicates 
that the average treatment gain on the SCL-90-R total score was more than 
Figure 1. Flow chart for patient inclusion
Informed consent
n=181 (76.7%)
Completed baseline questionnaires
n=160 (88.4%)
n=81 (58.3%)
Guideline applicable
n=139 (86.9%)
Eligible for inclusion
n=236
. 
Refusals: n=55 (23.3%)
n=58 (41.7%)
n=68 (84.0%)
1-year follow-up 1-year follow-up
n=51 (87.9%)
Guideline inapplicable
n=21 (13.1%)
Reasons:
Diagnosis revised: n=9
Early therapy drop out:  n=12
Non - fluent in Dutch: 
n=21 (11.6%)
Guideline-non-adherent Guideline-adherent
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32 points greater among the group of patients whose treatment had adhered 
to the treatment guideline recommendations compared to the patients in the 
non-adherent group. 
3.3.2. Secondary outcome measures
Adherence to the guidelines did not significantly influence the change in the 
global impairment of functioning, quality of life and general health. None of 
the multiple regression analyses reached significance. On all these variables a 
significant improvement was found (all p < 0.01); however, this improvement 
was not significantly related to guideline adherence. 
At one-year follow-up, the patients in the adherent group were significantly 
more satisfied with their treatment than patients in the non-adherent group 
(7.73 versus 7.17; t=2.545, df=115, p=0.01).
Table 1.  Characteristics of the patients in which the treatment guidelines were 
adhered to or not (n=139)
Non-adherent
(n=58)
Adherent
(n=81)
p
Age: mean (SD) 33.86 (10.8) 33.51 (12.0) 0.86
Gender (female): n (%) 30 (51.7) 52 (64.2) 0.14
Living alone: n (%) 13 (22.8) 8 (9.9) 0.04
Educational level; only elementary 
school. or less: n (%)
7 (12.5) 11 (13.6) 0.85
Foreign origin: n (%) 9 (15.5) 8 (9.9)  0.32
Panic disorder: n (%) 22 (37.9) 31 (38.3) 0.97
Social anxiety disorder: n (%) 10 (17.2) 16 (19.8) 0.71
Obsessive-Compulsive disorder  
(OCD): n (%)
5 (8.6) 5 (8.6) 0.97
Generalized Anxiety disorder (GAD): n (%) 6 (10.3) 6 (7.4) 0.54
Post-Traumatic Stress Disorder  
(PTSD): n (%)
13 (22.4) 16 (19.8) 0.70
Specific phobia: n (%) 1 (1.7) 3 (3.7) 0.64
Hypochondria: n (%) 1 (1.7) 2 (2.5) 1.00
SCL-90 T0 score: mean (SD) 216.9 (77.4) 192.8 (60.8) 0.04
IDS score T0; severe depression yes: 
n (%)
20 (35.1) 14 (17.3) 0.02
PDQ-4 score; personality disorder 
 probable: n (%)
29 (58.0) 29 (40.3) 0.05
Number of face to face contact with 
members of the anxiety disorder team: 
mean (SD)
25.9 (17.3) 17.4 (12.0) <0.01
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3.4. Discussion
Patients who received guideline-adherent treatment showed significantly 
greater symptom reduction as measured with the SCL-90-R. It seems that 
omitting or withholding a recommended treatment step can be viewed as a 
missed opportunity to improve a patient’s general psychopathology. On aver-
age, a significant improvement in functioning, patient-reported quality of life 
and general health was achieved across the total sample of patients. The influ-
ence of guideline-adherent care concerning these aspects was not significant, 
however. The fact that patients who received guideline-adherent treatment 
reported more satisfaction with their treatment can be seen as an incentive to 
follow the guidelines more often in routine practice. 
The results of our study therefore show that guideline adherence does 
matter, not only with regard to alleviating symptoms, but also when it comes 
to treatment satisfaction and possibly also treatment efficiency too. In our 
sample, which is representative of routine secondary mental health care in the 
Netherlands, it was also established that the guidelines should be applicable to 
87% of the patients seeking help. All these findings should encourage the more 
widespread implementation of the guidelines in mental health care facilities. 
Some of the Dutch multidisciplinary guidelines for anxiety disorders that 
were investigated in this study have been recently revisited [26]. This has 
led to some minor adjustments mainly concerning the provision of so-called 
basic interventions, self-help methods and sometimes e-health as first line of 
treatment. These are usually provided in primary care for patients seeking 
help, and some of the more advanced steps in the medication algorithms. The 
implications of these adjustments for clinical practice within secondary care, 
as provided within the community mental health care centre, is limited. This 
study is therefore still deemed relevant for secondary care, although its focus 
is the implementation of the original anxiety disorder guidelines that were 
published in 2003. 
Because this study found that adherence to the treatment guidelines was 
significantly lower among patients suffering from more severe psychopathol-
ogy, one could conclude that guidelines can only be delivered in a sample of 
patients with less severe symptoms or without comorbidity. However, within the 
sample of patients whose treatment adhered fully to the guidelines, no differ-
ences were found between the subgroups with milder and more severe symp-
toms with respect to treatment results gained. This suggests that the use of 
the guidelines to treat more severe patients is not necessarily contraindicated. 
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In some cases, however, it is necessary to provide additional help or support 
in clinical practice in addition to the recommended treatment options. The 
help of a psychiatric nurse may be warranted to prevent problems relating 
to the social environment of the patient from becoming a problem. Offering 
admission to a crisis support service is also a prerequisite for patients who are 
suicidal. The provision of this type of additional support does not preclude 
adherence to the anxiety disorder guidelines. From the perspective of the 
health care provider, applying the recommendations in the guidelines to these 
patients does seem especially challenging, however. More knowledge of how 
this can best be achieved is still to be uncovered. 
A limitation of the study is the uncontrolled design that we used. In cohort 
studies, the influence of confounding factors must be taken into account. 
We corrected for demographic variables and comorbidity of depression and 
symptoms of a personality disorder. However, in uncontrolled cohort studies, 
one should be cautious of making causal inferences about the effectiveness of 
the intervention, e.g. the provision of treatment according to the guidelines. 
To our knowledge, this is the first study that has looked at the added value of 
guidelines for anxiety disorders in clinical practice. The study results justify 
further investigation of the effectiveness of implementing anxiety disorder 
guidelines in a controlled design. 
This study also used reports in the medical files as a proxy for guideline 
adherence. It is possible that these notes will only provide an indirect impres-
sion of the treatment actually delivered. However, this proxy measure of 
guideline adherence was chosen because it is less invasive than more direct 
measures in which audio or video recordings of treatment sessions are used 
to assess treatment integrity. Similar measures to those used in this study were 
also recently used by the Department of Veteran Affairs in the United States for 
a comprehensive evaluation of its mental illness and substance use treatment 
system [27] and the use of performance indicators based on data from the 
patient’s medical records would seem to provide an acceptable way of making 
global judgements of the quality of care. 
We assessed the quality of treatment using a number of clinically important 
variables, such as the provision of an accompanying treatment rationale, the 
provision of adequate homework assignments in half of the sessions and the 
provision of sufficient treatment sessions in cases where cognitive or behaviour 
therapy had been included in the patient’s treatment plan. As mentioned 
earlier, this type of assessment has been used before to assess CBT. To ensure 
the reliability of the adherence scores, we used standardized checklists.
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Future research into the effectiveness of guideline adherence should also 
investigate factors that influence treatment prognosis. A percentage of patients 
who received guideline-adherent treatment showed no significant symptom 
reduction; the symptoms of some patients even deteriorated. Knowledge about 
how prognostic factors influence outcome will help to make the provision of 
care more efficient, especially where it is known which recommended treat-
ment steps would most benefit patients with certain symptoms, and which steps 
should be avoided. At a time of increasing health care expenditure and shrink-
ing budgets, this is the type of research that is needed most.
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Abstract
Objective: To examine the effect of implementing anxiety disorders guidelines 
on guideline adherence and patient outcomes in specialised mental health care. 
Method: A treatment setting in which guidelines were implemented (interven-
tion condition) was compared to one in which guidelines were only dissemi-
nated (control condition). 
Results: 61.7% of 81 intervention-condition patients received treatment accord-
ing to the guidelines vs. 40.6% of 69 control-condition patients (p=.01). At 
1-year follow-up, intervention-condition patients showed a greater decrease in 
anxiety symptoms (d=.48, p<.05); higher percentages of response (52.6% vs. 
33.8%;p=.025) and remission (33.3% vs.16.9%;p=.026); and a greater decrease 
in the rate of phobic avoidance (d=.34, p<.05). At 2-year follow-up, control-con-
dition patients had experienced a longer period of treatment, which had 
eroded most of these differences, except for phobic avoidance.
Conclusion: Systematic guideline implementation results in earlier gains and 
shorter treatment times. 
Significant Outcomes
¡	 	Systematic implementation, in addition to passive dissemination of guide-
lines for anxiety disorders, seems to promote guideline adherence and 
improve treatment outcomes.
¡	 	Small to medium between group effect-sizes were found on measures of 
anxiety and avoidance behaviour at 1-year follow-up, when comparing the 
intervention and control condition.
¡	 	At 2-year follow-up, due to continuous treatment patients in the control 
condition seem to largely catch up in terms of the obtained treatment 
results. From a long-term perspective, anxiety disorder guideline imple-
mentation might improve efficiency of care.
Limitations
¡	 	Due to the observational nature of this study and the lack of a proper random-
ization procedure, this limits the possibility of making firm causal inferences. 
¡	 	Although additional check-ups for the influence of bias by confounding 
yielded that the measured variables did not really threaten validity of the 
study results, both study conditions cannot be said to be completely similar 
with respect to the setting and patients treated there. 
¡	 	The method of reviewing the patient’s medical record to assess guideline 
adherence, can only provide an indirect estimate of the actual performance of 
the involved healthcare providers, and requires interpretation by the reviewer.
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4.1. Introduction
Despite the existence of a large number of evidence-based treatment guide-
lines for mental health care, only a few studies have evaluated the effectiveness 
of implementing these guidelines. A recently performed systematic review 
concluded that the effectiveness of implementing psychiatric guidelines was 
not unequivocal [1]. This review included 18 comparative guideline imple-
mentation studies concerning a range of psychiatric diagnoses, and of diverse 
methodological quality. From this review it appeared that the effects on 
provider behaviour and patient outcome were at best modest and in most 
cases of limited duration [1]. Furthermore, the type of diagnosis seemed to 
critically influence the magnitude of treatment outcome obtained by successful 
implementation. According to the authors, in contrast to severe mental illness 
(SMI), such as schizophrenia and dementia, depressive disorders could be a 
more favourable area of mental health care for improving outcomes through 
the implementation of guidelines [1]. They suggested that the treatment of SMI 
is more complex than that of depressive disorders and improving treatment 
for SMI might therefore demand more effort. Indeed, three recent studies 
have confirmed the positive effects of implementing treatment guidelines for 
depressive disorders [2, 3, 4].
Since anxiety disorders have many clinical characteristics in common with 
depressive disorders, implementing treatment guidelines for these types of 
disorders might also be a successful way of improving outcomes. Anxiety disor-
ders constitute a highly prevalent group of mental disorders and are known to 
compromise quality of life markedly [5]. A significant proportion of patients 
with anxiety disorders do not receive an evidence-based form of treatment [6, 
7, 8]. A study by Andrews et al (2004) suggests that providing optimal care for 
anxiety disorders to all patients would improve the cost-effectiveness of health-
care [9]. This study however was based on a modelled scenario, so further 
research is necessary to support such a claim. It was only recently found to be 
feasible to actually implement treatment guidelines for this group of patients in 
specialised mental health care [10]. 
Because the effect of implementing anxiety disorders guidelines on outcomes 
at the patient level has not yet been empirically assessed, we compared the 
effects of implementation vs. dissemination of these guidelines in two settings. 
We hypothesized that the implementation of anxiety disorders guidelines 
in specialised mental health care would lead to higher degrees of guideline 
adherence and to superior outcomes. 
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Aims of the study
To examine the effect of implementing anxiety disorders guidelines on guide-
line adherence and patient outcomes in specialised mental health care
4.2. Method
4.2.1. Design
In this 2-year implementation study, we compared two types of strategies to 
promote guideline adherence in two specialised mental health care centres 
and studied (i) the adherence to the anxiety disorders guidelines by profession-
als and (ii) the effect on the presence and severity of anxiety and depressive 
symptoms in patients. Outcome measurements took place at baseline and at 
a 1-year and 2-year follow-up. The study was approved by the medical ethics 
committee of the VU University Medical Centre Amsterdam.
The anxiety disorder guidelines were implemented in a specialised mental 
health care centre in Almelo (intervention condition). Implementation was 
defined as ‘a planned process and systematic introduction of innovations and/
or changes of proven value, in the function of organizations; the aim being 
that these are given a structural place in professional practice, in the function-
ing of organizations or in health care structures’ [11]. The control condition, 
in which the guidelines were only disseminated, took place in a specialised 
mental health care centre in Amsterdam. Dissemination was defined as ‘the 
process of communicating information to care providers only, this to increase 
their knowledge and skills’ [12]. The data from the control condition were 
derived from the Netherlands Study on Depression and Anxiety (NESDA), a 
naturalistic cohort study on the long-term course and consequences of depres-
sive and anxiety disorders [13]. Data from the control and intervention condi-
tions were gathered using the same procedure during the same period.
4.2.2. Comparability of the two treatment settings 
Around the time of the start of the patient inclusion for the study from the 
beginning of 2005, the community of Almelo contained 72, 293, and the 
community of Amsterdam 742, 783 inhabitants. Of the population of 15 till 65 
year-olds in Almelo, 36% had a lower educational level, 45% a middle educa-
tional level and 19% a higher educational level. In Amsterdam, 24% had a 
lower educational level, vs. 33% with a middle educational level, and 41% with 
a higher educational level (2% unknown). The average disposable income per 
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household was euro 26, 200 in Almelo vs. euro 26, 100 in Amsterdam (exclud-
ing students) (www.cbs.nl). 
The two participating treatment centres of the study were both specialised 
in treating anxiety disorders. The centres were comparable in terms of the 
number (16 vs. 17 persons), age (mean 35 years (range 24-53) vs. 41 years 
(range 26–57)) and type (psychiatrists, psychologists and psychiatric nurses) of 
health care professional staff. In the intervention condition, the percentage of 
male professionals was 43.8% vs. 25.0% in the control condition. The profes-
sionals working in the two units included the complete range from novice to 
very experienced health care providers, although in the control condition the 
staff had slightly more seniority, especially the psychologists working there.
Using a specially developed questionnaire [10, 14], data on additional factors 
that may have a positive or negative effect on guideline adherence were 
collected from the health care professionals in both conditions before the 
start of implementation in the intervention condition. This questionnaire was 
inspired by the theory of planned behaviour (TPB) [15] and consisted of four 
subscales assessing (i) the attitude towards the guideline, (ii) the intention to 
use it, (iii) the perceived social pressure to adhere to the guideline and (iv) 
perceived control over work processes in order to be able to adhere to the 
guideline. These subscales represented the main TPB constructs, with possible 
scores ranging from 1 to 5 (with 5 signifying a higher score). In addition, the 
questionnaire also asked the professional to rate his or her knowledge of the 
content of the guidelines. 
The results showed that the professionals in both conditions held an equally 
positive view of the use of guidelines (‘attitude’ subscale: intervention: Mean 
4.1 (SD=.63) vs. control: Mean 4.3 (SD=.36); t=.71;df=20;p<.485) and expressed 
equally strong intentions to continue or start working according to the guide-
lines (‘intention’ subscale: intervention: Mean 4.0 (SD=.50) vs. control: Mean 
4.1 (SD=.28); t=.46, df=22;p=.652). The professionals in the intervention condi-
tion judged their knowledge of the content of the guidelines to be significantly 
inferior to the professionals of the control condition (Mean 2.3 (SD=1.19) vs. 
Mean 3.4 (SD=.51); Mann-Whitney U=33.0; p=.017). They also perceived signifi-
cantly lower social pressure to adhere to the guidelines (intervention: Mean: 
3.4 (SD=.47) vs. control: Mean 3.9 (SD=.36); t=.2.83, df=21;p=.01). Finally, the 
professionals in the control condition expected to be better able to arrange 
their work so that they could easily adhere to the guideline recommendations 
(‘perceived behavioural control’ subscale: intervention: Mean 3.7 (SD=.54) vs. 
control: Mean 4.3 (SD=.29); t=.3.52, df=21;p<.01). 
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4.2.3. Eligibility criteria
As part of everyday care, after referral by their general practitioner, patients in 
both the intervention and control conditions underwent a standardized intake 
procedure. In this study we included outpatients aged 18 through 65 years 
who were (i) diagnosed with the Composite Interview Diagnostic Instrument 
(CIDI [16]) with one of the following DSM-IV anxiety disorders as primary 
diagnosis: panic disorder with or without agoraphobia, social phobia or gener-
alised anxiety disorder (GAD) and who (ii) gave written informed consent 
for participation. Co-morbidity with other mental disorders was allowed. In 
patients with co-morbid mental disorders the primary diagnosis was defined 
as the psychiatric disorder with the most associated suffering for the patient. 
In order to maintain representativeness, only two exclusion criteria were 
used: (1) a primary clinical diagnosis of a psychiatric disorder other than one 
of the anxiety disorders described above; and (2) not being fluent in Dutch 
since language problems would harm the validity and reliability of the data 
collected. However, during the intake phase in clinical practice at both of the 
participating treatment centres, patients who were also found to suffer from 
severe mental conditions such as psychotic disorder, bipolar disorder or severe 
addiction disorder, were directly referred for specialised treatment outside 
the anxiety disorder treatment unit and were thereby automatically excluded 
from participation in the study. When a comorbid personality disorder was also 
present, only the presence of a borderline personality disorder was reason to 
directly refer the patient for specialised treatment outside the anxiety disorder 
treatment unit.
4.2.4. Content of the anxiety disorder treatment guidelines
The Dutch treatment guidelines for patients with panic disorder with or 
without agoraphobia, social anxiety disorder or generalized anxiety disorder 
resemble the NICE (National Institute for Health and Care Excellence) guide-
lines and the guidelines from the British Association for Psychopharmacology 
with respect to the medication algorithms [17], and were first published in 
2003 and were last updated in 2012, with no major changes regarding the first 
recommended treatment steps for secondary care [18, 19]. Both psychotherapy 
(mainly cognitive behavioural therapy) and pharmacotherapy (mainly selec-
tive serotonin reuptake inhibitors or serotonergic tricyclic antidepressants) 
count as equally valid treatment options. The recommended psychothera-
peutic treatment steps consist of cognitive therapy and behaviour therapy. In 
addition, applied relaxation is recommended for patients with panic disorder 
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or GAD who do not respond to cognitive-behavioural interventions. The 
first three treatment steps in pharmacotherapy consist of three types of anti-
depressants. The guidelines favour selective serotonin reuptake inhibitors 
(SSRIs) over tricyclic antidepressants (TCAs). If an SSRI proves to be insuffi-
cient, switching to a second SSRI is recommended before prescribing a TCA. 
However, for a patient suffering from GAD the prescription of venlafaxine or 
buspirone is recommended instead of a second SSRI and before switching to 
the TCA imipramine. In social phobia, the third pharmacological treatment 
step is the prescription of a benzodiazepine or monoamine oxidase inhibitor 
(MAOI) rather than a TCA. 
At any moment during treatment, if after the recommended period of time 
a chosen treatment step yields insufficient results, the recommendation is to 
switch to another treatment step within the same treatment modality (psycho-
therapeutic or pharmacotherapeutic) or to switch to treatment with a recom-
mended treatment step of the other treatment modality.
4.2.5. Interventions
Control condition: dissemination
In 2003, as part of a Dutch national strategy to promote the use of newly devel-
oped guidelines, it was made widely known to general practitioners and profes-
sionals working in specialised mental health care that treatment guidelines for 
anxiety disorders had been developed. A broad outline of the guidelines was 
presented in Dutch scientific journals for psychiatrists and psychologists. A 
website (www.ggzrichtlijnen.nlwww.ggzrichtlijnen.nl) served as a free database 
for professionals and patients and presented the scientific background, recom-
mendations and algorithms of the guidelines. In addition, the guidelines were 
available as a printed booklet. In the control condition, the guidelines were 
only disseminated and no further implementation took place.
 
Intervention condition: implementation
In the intervention condition, in addition to the general dissemination process 
described above, the guidelines were implemented following the steps devel-
oped by Grol and Wensing [20]. Based on a diagnostic analysis of possible 
barriers to implementation, an implementation plan was designed on three 
levels: patient, professional and organisation. This plan comprised the follow-
ing interventions: (i) re-organisation of care: after the general intake proce-
dure, the treatment coordinator of the treatment centre –an experienced 
cognitive behaviour therapist- would see all patients allocated to the anxiety 
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disorder treatment centre at the start of their treatment. So, the treatment 
coordinator was made responsible for devising the treatment plan for all 
patients allocated to the unit instead of the intake professional. During a 
process of shared decision making, this treatment coordinator and the patient 
designed a treatment plan according to the guidelines before the start of 
treatment; (ii) development and distribution of instruction materials for 
patients (patient folders on the description of recommended care according 
to the guidelines, from which patients could choose their preferred type of 
treatment) and professionals (desktop versions of the guidelines summarizing 
recommended treatment steps and essential treatment ingredients; treatment 
folders containing the available recommended evidence-based psychological 
treatment manuals); (iii) organisation of three educational meetings at which 
the content of the guidelines were discussed, that taken together took up about 
12 hours of time; (iv) training of professionals in the skills needed to perform 
treatment as suggested in the guidelines; and (v) on-going monitoring of 
guideline adherence. Regular patient evaluations were held in which treatment 
progress was discussed from the perspective of the guideline algorithms. Also, 
one year after the start of the implementation, 50 medical files were reviewed 
and feedback on team performance was given by presenting the scores on key 
process indicators, and further goals for improvement were communicated. 
The implementation process is described in detail elsewhere [10].
4.2.6. Measurements
Data collection took place between the beginning of 2005 and July 2009. The 
lag-time between dissemination of the guidelines and the actual start of the 
implementation in the intervention condition was two years. In the interven-
tion condition after a year of preparations, directly after the first educational 
meeting, the first patient was included for participation in the study.
Adherence to the guidelines 
A review of each participating patient’s medical files established whether 
treatment had been delivered according to the guideline algorithms or not, 
yielding a proportion of patients in both settings that had been receiving 
recommended care that was classified according to the following labels: ‘adher-
ent’, ‘non-adherent’ and ‘inapplicable’. The medical files were reviewed by 
means of specially developed process indicators. These indicators were selected 
by consensus by senior professionals from the Dutch Knowledge Centre for 
Anxiety and Depressive Disorders (www.nedkad.nl) [10, 21]. The selected 
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indicators coincided with the first two or three steps of the psychotherapeu-
tic and pharmacotherapeutic branches of the treatment algorithms for the 
various anxiety disorders and measured whether these treatment steps had 
been followed adequately. For each patient, only the first year of treatment was 
assessed because all recommended treatment steps that were measured should 
have been applied during this first year, if indicated.
The adequacy of psychotherapeutic treatment steps was assessed by: (i) the 
delivery of the correct type of treatment; (ii) the presence of a treatment ratio-
nale; (iii) the assignment of homework; and (iv) the minimum recommended 
number of treatment sessions. In the same vein, the adequacy of pharmacolog-
ical treatment steps was assessed by: (i) the prescription of the correct category 
and type of drug; (ii) prescription of the correct dosage and (iii) the correct 
minimum duration of the medication before evaluation. The process indicator 
was scored positively, when all these assessments were fulfilled according to 
guideline recommendations. In cases when there was one or more negative 
assessment, the process indicator was scored negatively. 
In addition, a specific recommendation could also be judged as ‘inapplicable’ 
in the following cases: (i) when the primary diagnosis was revised; (ii) when a 
patient refused a specific intervention; (iii) when another recommended form 
of treatment had just started; (iv) when a sufficient response to the treatment 
had already been achieved; (v) when severe and acute psychosocial problems, 
suicidality or comorbid substance dependence had to take priority; (vi) in the 
case of severe side effects or somatic contraindications in psychopharmacolog-
ical treatment; and (vii) when patients dropped out of treatment prematurely, 
rendering it impossible for the professional to provide adequate care. In these 
cases the corresponding process indicator was not scored and was omitted 
from the evaluation of adherence to the guidelines treatment algorithms.
If an algorithm was followed correctly and all the necessary steps in the treat-
ment had been taken, the case would receive the label ‘adherent’. If a single 
necessary treatment step in the algorithm had not been properly applied, the 
case would receive the label ‘non-adherent’. If none of the treatment steps 
appeared to be applicable, the case would receive the label ‘inapplicable’ over-
all. 
Two different assessors reviewed the medical files of patients in both condi-
tions. During the review of the medical files, a specially developed checklist 
was used to determine the scores on relevant process indicators. To calibrate 
the judgement of each assessor, in both conditions, 30% of the files were inde-
pendently coded twice. Differences between the coding forms were resolved 
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by reviewing the original files, leading to one coding form per medical file. In 
cases where there was uncertainty about how to score a certain process indica-
tor, consensus was reached through discussion with two other members of the 
study group (DBO and AvB). The same decision rules that were derived from 
this consensus process were applied to all other medical files. Because of the 
differential layout of the medical files, the assessors were not blind to the condi-
tion under which a patient belonged. However, they were blind for treatment 
outcome. 
Patient outcomes 
Patients were assessed at baseline and at 1-year and 2-year follow-ups with 
validated self-rating scales. The primary outcome measure was the mean differ-
ence from baseline of the Beck Anxiety Inventory total score (BAI; total score 
range 0-63 [22]). Secondary outcome measures were: (i) the percentage of patients 
responding and achieving remission on the BAI according to the criteria 
of Jacobson and Truax [21] after 1-year and 2-year follow-ups. Response was 
defined as the presence of reliable change (decrease > 10 points) on the BAI, 
while remission was defined as the presence of reliable change (decrease > 10 
points) on the BAI plus an absolute BAI score < 11. This cut-off point was the 
calculated mean between the BAI score of the participants in the NESDA study 
[13] with or without an anxiety disorder.
(ii) presence and severity of phobic avoidance behaviour measured with the 
Fear Questionnaire (FQ; range 0 -120) [23]. (iii) co-morbid depressive symp-
toms measured with the Inventory of Depressive Symptoms (IDS; range 0-84) 
[24]. 
4.2.7. Sample size considerations
For sample size computations, we assumed that the effect of the implementa-
tion of the treatment guidelines for anxiety disorders on the BAI, the primary 
outcome measure, would have a medium effect size (Cohen’s d=.5). In a 
randomised controlled trial the number of patients required to obtain a power 
of .80 to detect a medium effect size is 42 per condition for longitudinal data 
analysis having three measurements and assuming a correlation coefficient of 
the repeated measures of .3 and alpha=.05 [25]. Since the respondents in the 
current study were not randomly allocated, we wanted to at least be able to use 
statistical techniques that allowed us to control for differences in patient char-
acteristics that may affect the score on the BAI; i.e. to control for confounding 
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bias, which cost some power. Therefore the aim was to include at least 84 
respondents per condition. 
4.2.8. Statistical methods
Standard descriptive statistics were used to describe the study population. To 
check whether patients in the two conditions differed, t-tests for continuous 
variables and χ2 tests for proportions were used. Difference in guideline adher-
ence between the two treatment centres was analysed with χ2 or Fisher exact 
tests. 
The effect of systematic guideline implementation on the continu-
ous outcome measures of the study was analysed with mixed-effects linear 
models that use all available information of the intention-to-treat sample. The 
random-intercept model included measurement (baseline, 1-year and 2-year 
follow-up), condition (intervention vs. control condition) and the measure-
ment-by-condition interaction as fixed effects and patients (first level) as 
random effects. The effectiveness of implementing the guidelines was studied 
using the entire group of patients originally included in the study (divided into 
adherent, non-adherent cases and cases in which the guidelines were judged to 
be inapplicable). 
Due to the observational nature of the design of the study, differences in 
baseline characteristics of patients in the intervention and control conditions 
were expected to exist. Out of methodological considerations, we chose to 
primarily investigate raw change scores to detect longitudinal changes on 
the dependent outcome variables and not to correct for possible differences 
in baseline symptom severity. Research has shown that the inclusion of such 
baseline covariates in linear models will have only a slight impact on the infer-
ences for longitudinal effects [26]. However, because correction for baseline 
differences is common practice, the same data was also analysed using residual 
change scores, thus correcting for baseline differences on the dependent vari-
ables. Since both types of analyses yielded the same results, only the results of 
the mixed-model approach using the raw changes scores are reported. 
To rule out possible bias through confounding by factors other than base-
line symptom severity, the variables of age, gender, national origin, educa-
tional level, and number of treatment sessions received during the first year 
were added to the regression analysis, in a step-by-step fashion. If adding 
one of these variables led to a 10% change in the estimation of the effect of 
measurement-by-condition interaction, this variable was designated as a rele-
vant confounder. However, none of these variables appeared to confound the 
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relationship between the central independent variable and the dependent 
outcome variables. 
To study further whether the difference in treatment outcome between the 
two study conditions could be related to the difference in guideline adherence, 
a second set of multilevel linear regression analyses were performed post hoc, 
using a model that regressed the measurement-by-guideline adherence inter-
action on measurement (baseline, 1-year and 2-year follow-up) and guideline 
adherence (yes/no) as fixed effects and patients (first level) as random effects. 
We calculated within group pre-post effect sizes by dividing the differences 
of follow-up and baseline means by baseline standard deviations. We calculated 
between group pre-post effect sizes by dividing the between group (experimen-
tal vs. control) differences of pre-post differences by the pooled (experimental 
and control group) baseline standard deviation and using a bias adjustment 
factor (see d-ppc2 in Morris, 2007) [27].
All tests of treatment effects were conducted at a two-sided alpha level of 
0.05. All basic statistical calculations in this study were performed with SPSS, 
version 17.0 (SPSS Inc., Chicago IL, US). The multilevel linear regression anal-
yses were performed using Stata 12.1 (Stata Corp., College Station TX, US).
4.3. Results
4.3.1. Patient inclusion and attrition rates
The study flow diagram (Figure 1) shows participant recruitment, the number 
of patients that were finally included for analysis in the intervention and the 
control condition and retention at 1-year follow-up and 2-year follow-ups. Of 106 
patients assigned to the intervention condition, having a primary diagnosis of 
panic disorder with or without agoraphobia, social phobia or generalized anxi-
ety disorder and providing written informed consent, diagnosis was confirmed 
in 90.6% (n=96) by an independent assessor using the CIDI [15]. Ten patients 
with no CIDI-confirmed anxiety disorder diagnosis were excluded. These 
did not differ significantly in their BAI, FQ and IDS baseline scores from the 
patients who were included in the study. Of 108 patients assigned to the control 
condition, 23.1% (n=25) has incomplete medical records. These patients were 
excluded from the analyses and did not significantly differ in their BAI, FQ 
and IDS baseline scores from the included patients. Two patients who did not 
return their baseline questionnaires were also excluded from further analyses. 
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Figure 1.  Diagram showing flow of participants through the implementation 
study
Demographic characteristics and clinical status variables at baseline and the 
number of treatment contacts received within the first year of treatment for 
patients in the intervention and control conditions are shown in Table 1. As 
follows from this table, patients from the intervention condition had signifi-
cantly less education and scored significantly higher on BAI and FQ, suggest-
ing that there were more severe anxiety and avoidance symptoms in the inter-
vention condition.
Data on primary outcome measures were obtained from 143/177 (80.8%) 
of the total number of patients at 1-year follow-up and 126/177 (71.2%) at 
2-year follow-up (Figure 1). Data dropout was significantly greater at 2-year 
follow-up in the intervention condition (38.9%) vs. the control condition 
(17.1%;χ2(df=1)=10.27;p=.001). Data completers did not differ significantly from 
data dropouts on the baseline variables presented in Table 1, except that they 
 
Intervention condition  Control condition  
 
 
 
(Active implementation of the treatment
guidelines for anxiety disorders)
Patients eligible for inclusion in the 
study n=106
(Dissemination of the treatment 
guidelines for anxiety disorders only)
Patients eligible for inclusion in the 
study n=108
Patients included in the intervention
condition
total n=95
- cases in which the guideline algorithms
   were inapplicable: n=14
- cases non-adherent to guidelines: n=31
- cases adherent to guidelines: n=50
Patients included in the control
condition
total n=82
- cases in which the guideline 
   algorithms were inapplicable: n=13
- cases non-adherent to guidelines: 
   n=41
- cases adherent to guidelines: n=28
- Non-matching CIDI diagnosis
   (n=10)
- Missing baseline question-
   naires (n=1)
- Medical record incomplete
   (n=25)
- Missing baseline question-
   naires (n=1)
1-year follow-up
n=78
 1-year follow-up
n=65
 2-year follow-up
n=58
 3-year follow-up
n=68
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had significantly less education (number of years of education: Mean 11.8 vs. 
10.8; t=2.22;df=153.9;p=.028).
4.3.2. Adherence to guidelines and long-term health care usage
The guideline algorithms proved to be inapplicable to 14/95 (14.7%) of the 
patients in the intervention condition vs. 13/82 (15.9%) of the patients in 
the control condition (χ2=0.42;p=.837), leaving 81 patients and 69 patients 
respectively for whom the guidelines could be considered applicable. The most 
important reasons why the guidelines proved to be inapplicable were (in order 
of frequency): (i) revision of the primary diagnosis shortly after start of treat-
ment; (ii) the patient dropped out shortly after start of treatment, which made 
it impossible to carry out proper care; (iii) acute crisis situations, or serious 
psychosocial problems, which required urgent attention and made it impossi-
ble to apply any of the guideline recommendations. 
In 50/81 (61.7%) of the cases in the intervention condition, treatment was 
adherent to the treatment guidelines vs. 28/69 (40.6%) of the cases in the control 
Table 1.  Comparison of demographic and clinical status variables at baseline, 
and number of received treatment contacts of patients included in the 
intervention and control conditions
Intervention con-
dition (n=95 )
Control condition 
(n=82 )
p-value
Age: Mean (SD) 34.06 (11.7) 35.90 (10.7) .281
Gender (female): n (%) 52 (54.7) 54 (65.9) .132
Northern European ancestry: n (%) 84 (89.4) 73 (89.0) .943
Having no partner: n (%) 43 (45.3) 34 (41.5) .611
Education in years: Mean (SD) 10.07 (2.3) 12.95 (3.4) <.001 **
Main diagnosis panic disorder: n (%) 55 (57.9) 45 (54.9) .686
Main diagnosis social phobia: n (%) 28 (29.5) 24 (29.3) .976
Main diagnosis GAD: n (%) 12 (12.6) 13 (15.9) .539
BAI Mean (SD) 24.28 (12.9) 20.29 (11.3) .031 *
FQ Mean (SD) 48.35 (24.6) 35.13 (18.7) <.001 **
IDS Mean (SD) 28.35 (12.9) 26.46 (11.1) .306
Number of treatment contacts within 
the first year of treatment
17.38 (13.9) 15.93 (10.4) .442
SD = Standard Deviation; GAD= generalized anxiety disorder; BAI = Beck Anxiety Inven-
tory; FQ = Fear Questionnaire; IDS = Inventory of Depressive Symptoms
** significant difference p<.001, * significant difference p<.05
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condition (χ2(df=1)=6.68;p=.01). Table 2 presents adherence rates to the different 
recommended treatment steps, which help explain the greater adherence rate 
to the guidelines’ algorithms in the intervention condition when compared to 
the control condition. The results suggest that the difference can mainly be 
attributed to the number of patients who received adequate cognitive therapy. 
Although many patients in the control condition received cognitive therapy this 
process indicator was frequently scored negatively because no adequate home-
work assignments were given or the duration of treatment was too short. 
At 2-year follow-up, patients were asked whether they had received treatment 
contacts for secondary mental health care during the past half year. Patients 
from the control condition 55/72 (76.4%) vs. 25/56 (44.6%) from the interven-
tion condition reported they had had such treatment contacts within this time 
period (χ2(df=1)=13.54; p<.001).
4.3.3. Outcome on clinical ratings 
Table 3 depicts the predicted means and SDs on the BAI, FQ and IDS of 
patients in the intervention condition (n=95) and control condition (n=82), 
derived from multilevel linear regression analyses conducted on the intention-
to-treat sample. 
Primary outcome measure: Compared to the control condition, the decrease 
in anxiety symptoms from baseline to 1-year follow-up on the BAI was 4.1 
points larger in the intervention condition (95%CI: 0.84-7.34;p<.05;d=.45). 
The decrease in anxiety symptoms from baseline to 2-year follow-up yielded a 
non-significant difference of 3.0 points on the BAI in favour of the interven-
tion condition (95%CI -0.35-6.44;p=.08;d=.36). 
Secondary outcome measures: Compared to the control condition, the percent-
age of patients responding at 1-year follow-up was significantly higher in the 
intervention condition (52.6% vs. 33.8%; χ2(df=1)=5.04;p=.025). The percent-
age of patients achieving remission at 1-year follow-up was also significantly 
higher in the intervention condition (33.3% vs.16.9%; χ2(df=1)=4.98;p=.026). 
At 2-year follow-up these significant differences disappeared: the percentage 
of responders in the intervention condition was 48.3% vs. 44.1% in the control 
condition; χ2(df=1)=.22;p=.641 and the percentage of patients achieving remis-
sion in the intervention condition was 32.8% vs. 29.4% in the control condi-
tion; χ2(df=1)=.16;p=.685.
Phobic avoidance behaviour (FQ): at 1-year follow-up improvement in the 
intervention condition was 5.6 points greater than the improvement in the 
van Dijk_Proefschrift Anxiety Disorders_v5_170x240.indd   77 03/10/2014   23:46
78 Multidisciplinary Guidelines for the  treatment of Anxiety Disorders
control condition (95%CI 0.10-11.02;p<.05;d=.34). At 2-year follow-up this 
difference was 11.0 points greater in the intervention condition (95%CI 
5.27-16.74;p<.05;d=.68). 
Co-morbid depressive symptoms (IDS): No significant differences between 
the two conditions were observed for IDS at 1- and 2-year follow-ups. At 1-year 
follow-up the decrease was 2.26 points greater in patients in the intervention 
condition (95%CI -0.95-5.48;p=.167;d=.26), while at 2-year follow-up a small 
difference of 1.3 points more in the intervention condition was found (95%CI 
-2.05-4.69;p=.441;d=.15). 
4.3.4. Guideline adherence and treatment outcomes
To further study whether the differences in treatment outcome between the 
two study conditions were critically dependent on differences in guideline 
adherence, a second set of multilevel linear regression analyses were performed 
post hoc, using all patients from both intervention and control condition. First, 
Table 2. Adherence to the different recommended treatment steps
Guideline recommendation Intervention
condition
Control
condition
Difference in 
percentage 
receiving 
treatment as 
indicated
p-value
Number of patients indicated 
for cognitive intervention and 
the percentage that actually 
received it
71 77.5% 54 59.3% 18.2% p=.028*
Number of patients indicated 
for exposure intervention and 
the percentage that actually 
received it
16 50% 36 41.7% 8.3% p=.577
Number of patients indicated 
for medication step 1 and 
the percentage that actually 
received it
24 66.7% 32 71.9% 5.2% p=.675
Number of patients indicated 
for medication step 2 and 
the percentage that actually 
received it
9 44.4% 9 44.4% 0.0% p=.999
Number of patients indicated 
for medication step 3 and 
the percentage that actually 
received it
5 40.0% 8 25.0% 15.0% p=.999
* significant difference p<.05
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a check was made whether patients whose treatment did adhere (n=78) and 
patients whose treatment did not adhere to the guidelines (n=72) differed 
critically from another in terms of certain patient characteristics, which could 
influence treatment results. With respect to all variables as also mentioned in 
table 1, patients whose treatment did adhere to the guidelines significantly 
differed from the group of patients whose treatment did not, only in terms 
of the following three aspects: the percentage of patients being single (32.1% 
vs. 50.0%;χ2(df=1)=4.99;p=.025 ); educational level (number of years of educa-
tion: Mean 11.1 vs. 12.2;t=2.13;df=148;p=.035), and; the percentage of patients 
diagnosed with panic disorder (64.1% vs. 45.8%;χ2(df=1)=5.06;p=.025). None 
of these variables were found to be significantly related to treatment outcome, 
indicating that they did not confound the relationship of guideline (non)-ad-
herence and treatment outcome. Multilevel linear regression analyses were 
performed on BAI, FQ and IDS, using a model that regressed the measure-
ment-by-guideline adherence interaction on measurement (baseline, 1-year 
and 2-year follow-up) and guideline adherence (yes/no) as fixed effects and 
patients (first level) as random effects. The outcome is presented in Table 4. 
The data suggest that on all three measurements after 1-year and 2-year follow-
Table 3.  Predicted Means and Standard Deviations (SD) on the BAI, FQ and IDS 
of patients in the intervention condition (n=95) vs. the control condition 
(n=82), at baseline, the 1- and 2-year follow-ups, based on multilevel 
linear regression analysis in the intention-to-treat sample
Baseline 1-year follow-up 2-year follow-up
Mean (SD) Mean (SD) ES Mean (SD) ES
BAI Intervention condition 24.3 (8.1) a 14.1 (8.6) b 1.3 12.9 (9.4) c 1.4
Control condition 20.3 (8.7) 14.2 (9.3) 0.7 12.0 (9.2) 1.0
FQ Intervention condition 47.6 (15.8) d 33.0 (16.1) b 0.9 28.5 (17.3) e 1.2
Control condition 35.1 (16.5) 26.1 (17.4) 0.5 27.1 (17.3) 0.5
IDS Intervention condition 28.3 (8.4) 18.4 (8.8) 1.2 17.8 (9.6) 1.3
Control condition 26.5 (9.0) 18.8 (9.6) 0.9 17.3 (9.4) 1.0
SD = Standard Deviation; ES = (baseline to follow-up) Effect Size; BAI = Beck Anxiety 
Inventory; FQ = Fear Questionnaire; IDS = Inventory of Depressive Symptoms
a Baseline intervention vs. control condition p<0.05 
b Pretest - 1-year follow-up improvement intervention vs. control condition p<0.05
c Pretest - 2-year follow-up improvement intervention vs. control condition p<0.10
d Baseline intervention vs. control condition p<0.001 
e Pretest - 2-year follow-up improvement intervention vs. control condition p<0.001
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ups adherent treatments yielded superior results compared to non-adherent 
treatments with medium between group effect sizes.
Table 4.  Predicted Means and Standard Deviations (SD) on the BAI, FQ and IDS 
of treatments adherent (n=78) vs. non-adherent to the anxiety disorders 
guidelines algorithms (n=72), at baseline, the 1- and 2-year follow-ups, 
based on multilevel linear regression analysis 
Baseline 1-year follow-up 2-year follow-up
Mean (SD) Mean (SD) ES Mean (SD) ES
BAI Adherent 21.3 (8.3) 10.3 (8.8) a 1.3 8.9 (9.2) b 1.5
Non-adherent 22.6 (8.6) 17.3 (9.1) 0.6 15.3 (9.1) 0.8
FQ Adherent 37.5 (15.3) c 21.7 (16.0) d 1.0 21.0 (16.6) e 1.1
Non-adherent 43.9 (15.8) 36.2 (16.4) 0.5 34.4 (16.6) 0.6
IDS Adherent 25.3 (8.3) 14.5 (8.8) f 1.3 13.3 (9.3) b 1.4
Non-adherent 28.5 (8.7) 21.2 (9.1) 0.8 21.2 (9.2) 0.8
SD = Standard Deviation; ES = (baseline to follow-up) Effect Size; BAI = Beck Anxiety 
Inventory; FQ = Fear Questionnaire; IDS = Inventory of Depressive Symptoms
a Baseline - 1-year follow-up improvement adherence vs. no adherence p<0.001
b Baseline - 2-year follow-up improvement adherence vs. no adherence p<0.01
c Baseline adherence vs. no adherence p<0.10 
d Baseline - 1-year follow-up improvement adherence vs. no adherence p<0.01
e Baseline - 2-year follow-up improvement adherence vs. no adherence p<0.05
f Baseline - 1-year follow-up improvement adherence vs. no adherence p<0.05
4.4. Discussion
In this study guideline adherence rates and treatment outcomes between 
two treatment centres for anxiety disorders were compared. The guidelines 
were implemented in one of these centres (the intervention condition). In the 
control condition, the guidelines were only disseminated. Guideline adherence 
rates, as measured during the first year of each patient’s treatment, were found 
to be significantly higher in the intervention condition. Patients in this condi-
tion also showed superior treatment gains on anxiety and avoidance symptoms 
at the 1-year follow-up. At the 2-year follow-up, however, the difference on 
anxiety symptoms between the two conditions was not significant, while the 
difference on avoidance symptoms remained. 
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Since a significantly larger percentage of patients in the control condition 
continued treatment during the second treatment year, treatment gain in the 
control condition measured as the decrease in anxiety symptoms from baseline 
to 2-year follow-up improved relative to the intervention condition. This where 
the decrease in avoidance behaviour as measured from baseline to 2-year 
follow-up still remained greater in the intervention condition. Overall the 
data suggest that the implementation of guidelines leads to somewhat greater 
treatment gains with respect to anxiety symptomatology. Moreover, treatments 
which were adherent to the guidelines were shorter, indicating that the care 
was more efficient. 
We could demonstrate in both conditions that adherent treatments yielded 
superior outcomes than non-adherent treatments. It is thus plausible that the 
difference in outcome found between the two conditions could be attributed 
to the difference in adherence. Indeed, except for guideline adherence, the 
conditions did not differ very much with respect to the composition of profes-
sionals working in both treatment settings. Unfortunately however, the patients 
included in the intervention condition had more severe scores on anxiety 
outcome variables than those in the control condition. For methodological 
considerations we initially choose not to correct for baseline differences in 
symptom severity in our analyses [26]. All the analyses were repeated, correct-
ing for baseline differences by using residual change scores, which did not 
critically affect our results. 
There are some limitations to this study that have to be recognised however. 
First, because of the non-randomised nature of the ‘double cohort’ study 
design, we had to take into account the chance that our findings might be 
influenced by confounders. We therefore investigated many putative confound-
ing variables, also in addition to baseline symptom severity. None of these 
appeared to be a relevant confounder, providing assurance that the observed 
effect may indeed be an effect caused by the difference in implementation 
between the two conditions. Second, a point of criticism is the use of patient 
files as a source of information when determining guideline adherence. This 
method of data collection was chosen because it is rather easy to carry out. In 
addition, because in both centres the professionals were not aware of this eval-
uation type, we excluded what is known as the ‘Hawthorne effect’. Had we used 
audio or video tapes of treatment sessions, the content of these sessions could 
possibly have been compromised by the fact that the professional would exhibit 
behaviour thought to be more ‘desirable’ because he/she felt under scientific 
scrutiny.
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The methodological strengths of our study include the use of two well-diag-
nosed, representative clinical cohorts of secondary mental health care patients 
with anxiety disorders. We included ‘real-life’ patients because we applied 
only one exclusion criterion (insufficient proficiency in the Dutch language), 
enhancing the external validity of our study results.
The present study showed that there is room for improvement in dissem-
ination, a typical strategy for the implementation of guidelines, in order to 
enhance quality of care and outcomes at the patient level. Implementation, 
in addition to dissemination, yielded superior performance with regard to 
adherence levels and treatment results in a 2-year period and especially in the 
short run, with small to medium between-group effect sizes on the anxiety 
disorder-specific outcome measures. The results also make clear however, that 
quite a number of patients fail to show sufficient treatment response when 
treated in a specialized treatment setting in which evidence-based guidelines 
are implemented. Since implementing guidelines is a continuous process, the 
expectation is that more time and efforts spend on implementing the guide-
lines, could have further improved adherence levels and treatment outcomes. 
With the effectiveness of current evidence-based treatment options however, 
even in patients receiving 100% guideline concordant care, not every patient is 
expected to show remittance. A recent published study shows that at this time 
it is hard to predict which anxiety disorder patients will or will not profit from 
guideline-adherent treatment in terms of demonstrating adequate treatment 
response [28]. Efficiency of healthcare for patients with an anxiety disorder, 
could be greatly improved if one would be better able to predict in advance 
which patients will or will not benefit from a certain type of treatment. More 
research is needed to allow for such personalized medicine in line with direc-
tions which are for example given for the treatment of unipolar depression 
[29], These directions help to guide the patient to the treatment method 
with the highest chance of success. Notwithstanding, the present results do 
suggest that the systematic implementation of available practice guidelines 
may improve quality of care, and therefore should encourage more widespread 
initiatives aimed at the systematic implementation of guidelines in mental 
health care. 
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Abstract
Background: Several countries have developed guidelines for anxiety disorders 
containing algorithms that summarize the recommended treatment steps for 
these disorders. It is important to know which patients have a poor prognosis 
for treatment according to such algorithms. 
Aims: To investigate the predictive power of variables known to be able to influ-
ence treatment prognosis in situations where practice guidelines for anxiety 
disorders are adhered to. 
Method: To study the predictive power of variables that are known to be able 
to influence treatment prognosis, 81 patients who participated in a guideline 
implementation study and whose treatment was found to adhere to avail-
able guidelines were selected. Using logistic regression analysis two models 
were constructed: one to predict treatment non-response; another to predict 
persistent functional impairments at the 1-year follow-up. 
Results: The final prediction model for treatment non-response contains only 
gender and secondary gain variables. It appears that: males have a higher 
likelihood (p=.074), and patients that report hopes of obtaining external 
benefits by seeking treatment have a lower likelihood (p=.054) of showing 
treatment non-response at the 1-year follow-up. The discriminatory power of 
this model was found to be poor, however. The model for persistent functional 
impairments includes gender, satisfaction with the accessibility of healthcare 
services and the presence of a comorbid anxiety disorder. It appears that: males 
(p=.087) and patients who express dissatisfaction with the accessibility of care 
(p=.008) have a higher likelihood, and that; patients who suffer from an addi-
tional comorbid anxiety disorder have a lower likelihood (p=.079) of persistent 
functional impairments. The discriminatory power of this model is excellent. 
Conclusion: It remains difficult to predict which anxiety disorder patients will 
not benefit from treatment that is tailored according to available practice 
guideline recommendations, therefore no one should be prevented from being 
offered such treatment, if one removes barriers in attending treatment.
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5.1. Introduction
A recent cohort study carried out among outpatients in a mental health care 
setting showed that outpatients suffering from an anxiety disorder whose treat-
ment adhered to the available clinical-practice guidelines had greater symp-
tom reduction after one year, compared to patients whose treatment did not 
adhere to these guidelines [1]. However, some patients remain non-responsive 
to treatment, even when their treatment was found to adhere to the guidelines 
and despite the fact that they were able to receive multiple recommended 
evidence-based treatments. The ability to identify such patients before treat-
ment begins is an important challenge in clinical practice. The ability to do 
so could lead to improvement of the guidelines at a more individualized level, 
which would directly benefit patients.
Recently Taylor and colleagues [2] provided an overview of what is known 
about factors that influence non-adherence and non-response in anxiety 
disorder patients receiving either antidepressant medication or cognitive-be-
havioural interventions. Based on the existing literature, they suggest that 
factors relevant to predicting treatment outcome include: low treatment moti-
vation, hidden secondary motives for seeking treatment, encountering barriers 
that hamper treatment attendance (e.g. transportation problems or difficulties 
arranging for childcare), pre-treatment symptom severity and the presence 
and severity of possible comorbid psychopathology [2]. Many of these factors 
have been investigated as part of intervention studies examining the effects of 
monotherapies. In these studies patients were randomly allocated to an exper-
imental condition or a control condition. Therefore patients lacked the oppor-
tunity to select a treatment of their own choice. This may adversely affect the 
generalizability of the findings to daily practice. None of the studies mentioned 
by Taylor et al. [2] investigated the influence of all of the above-mentioned 
factors, in concert, on treatment outcome. Thus, the question of what the 
predictive power of these prognostic factors, alone or in combination, would be 
on the treatment outcome for the patient is still operative. 
A systematic review of the prognostic factors of long term disability in mental 
disorders performed by Cornelius et al. [3] sheds light on some additional 
factors. In this review strong evidence was found for age as a relevant factor 
for continuous disability. Limited evidence was found for gender, education, 
unemployment, and socioeconomic status in general. Also, a patient’s cultural 
background should be considered an additional putative factor predicting 
non-response and continuous disability, especially because of established 
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higher drop-out rates from general mental health treatment for ethnic minori-
ties in the Netherlands [4]. 
The aim of the present study is to investigate the predictive value of the 
factors described above in predicting non-response and long-term disability. 
In the present study these factors will be explicitly studied in conjunction with 
one another. The context of this study is an outpatient clinical setting where 
treatment is optimized according to the available evidence-based treatment 
guidelines, and where patients were encouraged to choose their own preferred 
methods of treatment. 
5.2. Method
5.2.1. Study participants and procedure
The present study used data collected as part of a study that investigated the 
feasibility and effectiveness of adhering to clinical-practice guidelines for anxi-
ety disorders in secondary mental health care [1, 5]. This study was approved by 
the medical ethics committee of the VU University Medical Centre Amsterdam. 
Detailed information about study design and measurement procedures can be 
found in the two aforementioned references. A general description of the rele-
vant research procedures is given here. 
A cohort for the study was formed of patients who were registered at the 
community mental health care centre in Almelo, the Netherlands, after the 
implementation of the Dutch multidisciplinary practice guidelines for anxiety 
disorders was begun [5, 1]. For the present study we included patients aged 
18 years or older who i) were diagnosed with a primary DSM-IV diagnosis of 
panic disorder with/without agoraphobia, social phobia, obsessive compulsive 
disorder (OCD), generalized anxiety disorder (GAD), posttraumatic stress 
disorder (PTSD), specific phobia or hypochondriasis; ii) gave written informed 
consent for participation, and iii) received treatment according to the Dutch 
anxiety disorder guidelines recommendations (see: www.ggzrichtlijnen.nl). 
Co-morbidity with other mental disorders was allowed. 
In order to maintain representativeness, only two exclusion criteria were 
used for the current study: (1) a primary clinical diagnosis of a psychiatric 
disorder other than one of the anxiety disorders described above; and (2) not 
being fluent in Dutch since language difficulties would harm the validity and 
reliability of the data collected.
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5.2.2.  Investigated practice guidelines and measure of adequate guideline 
adherence
The Dutch multidisciplinary guidelines for anxiety disorders contain recom-
mendations for both psychotherapy (mainly cognitive behavioural therapy, 
but also EMDR for PTSD) and pharmacotherapy (mainly selective serotonin 
reuptake inhibitors or serotonergic tricyclic antidepressants). These options 
are counted as equally valid. 
A review of each participating patient’s medical file was used to establish 
whether treatment had actually been delivered according to the guideline 
algorithms, originally yielding a proportion of patients who had been receiving 
recommended care that was classified according to the following labels: “adher-
ent”, “non-adherent” and “inapplicable” [1]. The medical files were reviewed 
by specially developed process indicators. A checklist was used to score the 
different indicators [5]. Ultimately, if an algorithm was followed correctly and 
all the necessary steps in the treatment had been taken, the case would receive 
the label “adherent.” If a single necessary treatment step in the algorithm had 
not been properly applied because of a failure on the part of the responsible 
health care provider, the case would receive the label “non-adherent.” If none 
of the treatment steps appeared to be applicable, the case would receive the 
label ‘inapplicable’ overall. For the present study only the ‘adherent’ cases were 
included for further analyses [1]. Measurements relevant to treatment outcome 
were performed at baseline and at a 1-year follow-up.
5.2.3. Outcome measures
We sought to construct two models to predict non-response with respect to 
clinical symptoms and to functional limitations. (i) Clinical symptoms were 
measured with the Symptom Checklist (SCL-90-R) [6, 7]. A patient’s overall 
score on the SCL-90-R reflects his or her general level of psychopathology 
(range 0–360). Non-response was operationalized as not showing reliable 
change on the SCL90-R total score from baseline to 1-year follow-up, accord-
ing to the Reliable Change Index (RCI) criteria defined by Jacobson and Truax 
[8]. Applied to the SCL90-R total score, this means that reliable change on 
the SCL-90-R is indicated by a score of at least 30 points. Thus, all cases with 
a change score of less than 30 points were defined as non-responders. (ii) 
To assess functional impairments at baseline and at the 1-year follow-up the 
Sheehan Disability Scale (SDS) [9] was used. This patient-rated measure asks 
the subject to rate on a scale ranging from 1 (“not at all”) to 10 (“extremely”): 
1) the extent to which symptoms have disrupted work / school work; 2) the 
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extent to which symptoms have disrupted social life/leisure activities, and 3) 
the extent to which symptoms have disrupted family life/home responsibili-
ties. The sum of the scores on these three subscales yields the SDS total score 
(range 3 to 30), and provides a general impression of the level of functional 
impairment experienced by the patient. The persistence of functional impair-
ment was also defined dichotomously. A patient with an SDS total score of 6 
or higher at the 1-year follow-up was considered to suffer from persistent func-
tional impairments. In the literature on anxiety disorders an SDS total score of 
5 or less has been used to signal functional recovery [10, 11].
5.2.4. Predictors
Demographic variables
The patients’ gender and age were derived from the medical files. Patients 
were asked to report their country of birth and also the birth countries of both 
of their parents, their educational level, employment status and monthly net 
income. In the present study a patient is considered to have a foreign back-
ground if at least one of his or her parents was born outside the Netherlands 
or its former colonies. Ultimately, the patients’ educational level was operation-
alized dichotomously, as having completed only primary education (yes/no). 
This where the level of education in the cohort of patients studied was already 
relatively low on average. It was hypothesized that reaching adequate treatment 
effect when adhering to the guidelines, would be especially challenging in 
patients that only finished elementary school at best.
Assessment of DSM-IV axis I disorders
The presence of a DSM-IV axis I disorder was assessed by the Mini International 
Neuropsychiatric Interview (M.I.N.I.) [12, 13], administered by a trained clini-
cian as part of the standardized intake procedure at the community mental 
health care center. In patients with co-morbid mental disorders the primary 
diagnosis was defined as the psychiatric disorder associated by the patient with 
the greatest degree of suffering. In determining the influence on treatment 
outcome and persistent functional impairments, the presence of a comorbid 
secondary anxiety disorder, and the influence of a comorbid depressive disor-
der were separately investigated.
Psychiatric status variables
The Personality Diagnostic Questionnaire-4+ was used as a screener for the 
presence of comorbid DSM-IV axis II personality disorders, at baseline [14, 
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15]. The PDQ4+ is a self-administered, true/false screening questionnaire. 
The PDQ4+ total score, the sum of the scores of the individual items, can be 
used as an index of overall personality disturbance (range 0-99), with a total 
score of 30 or higher indicating a substantial likelihood that the subject has a 
significant personality disturbance [16]. This 30 point cut-off value was used as 
a dichotomous measure for the absence or presence of personality disturbance. 
  To assess patient motivation the Nijmegen Motivation List 2 (NML2) was 
administered at baseline [17]. Only the preparedness subscale (range: 10 to 60) 
of the NML2, which consists of 10 items that express the patient’s preparedness 
to actively invest in treatment and to make sacrifices for the sake of treatment, 
was investigated for its predictive value on treatment outcome. Research has 
shown this NML2 subscale to be the most significantly related to treatment 
outcome in outpatient mental health care of the subscales in the NML2 [17].
Secondary gain was operationalized in accordance with the DSM-IV defini-
tion of “obtaining external benefit” [18; p. 453]. Patients were explicitly asked 
to indicate whether special support and mediation by therapists was expected 
(yes/no) and the aspects for which they expected support and mediation. 
Patients could tick the following items, where appropriate: job, social security 
claims, budget for getting help from relatives, financial problems, compensa-
tion for unusual healthcare costs, legal/police matters, accommodation, insur-
ance, other. 
To assess practical barriers that could hamper treatment attendance the 
item from the Dutch version of the World Health Organization Quality Of Life 
questionnaire (WHOQOL- BREF) [19] was used and administered at baseline. 
This item asks the patient to rate on a scale ranging from 1 (“very dissatisfied”) 
to 7 (“very satisfied”), their degree of satisfaction with the accessibility of the 
health services. In order to facilitate interpretation, ultimately this variable was 
also dichotomized. Scores ranging from 1 to 4 were recoded to 1, indicating 
that the patient was less than satisfied with the accessibility of the healthcare 
services. Scores 5 to 7 were recoded to 0, indicating that the patient was satis-
fied or very satisfied with the accessibility of the health services used. 
 
5.2.5. Statistical analyses
Standard descriptive statistics were used to describe the study population. 
To check whether attrition bias posed a threat to the validity of the study 
results differences between study completers and study drop-outs, t-tests for 
continuous variables and χ2 tests for proportions were used on the original (i.e. 
non-imputed) data. Ultimately, missing data resulting from patients dropping 
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out of the study were handled by using multiple imputation by chained equa-
tions (MICE), which operates under the assumption that given the variables 
used in the imputation procedure, the missing data are Missing At Random 
(MAR). There were three sets of variables selected for the imputation model 
[20]: all variables that appeared in the complete data model, all variables that 
related to dropping out of the study, and all variables that related to the two 
main outcome variables (the severity of psychiatric symptoms (SCL-90-R) at 
follow-up measurement and the score for functional impairment (the Sheehan 
Disability Scale). Data imputations were performed with chained equations 
method in Stata 12.1 using predictive mean matching (PMM) as the imputa-
tion method with 20 imputations.
All final analyses were carried out on the multiple imputed data set, using all 
cases originally included in the study that were judged to have been adequately 
treated according to the guideline algorithms (guideline adherent; n=81). In 
constructing a prediction model for “non-response” and “functional impair-
ment” we used a model-building strategy called “purposeful selection of 
covariates” [21]. After a careful bivariate analysis of each independent vari-
able, retaining any variable whose bivariate test has a significance level below 
0.25 (step 1), a multivariate model is fitted (step 2) retaining all variables with 
significance levels below 0.10, checking that none of the coefficients changed 
markedly in magnitude (i.e. ∆β̂	 >	20%) and re-entering a predictor if necessary 
in order to prevent such a change (step 3), and finally evaluating the possible 
addition of each independent variable individually (step 4). Non-linearity 
(step 5) and interaction effects (step 6) are evaluated, and ultimately the “final 
model” obtained is evaluated in terms of model fit by pseudo R-square and 
“area under the receiver operating characteristic (ROC) curve” (step 7).
The basic statistical calculations in this study were performed with SPSS, 
version 17.0 (SPSS Inc., Chicago IL, US). The multiple imputations and analy-
ses using logistic regression on the imputed data were performed using Stata 
12.1 (Stata Corp., College Station TX, US). 
5.3. Results
As can be seen from the flowchart (Fig. 1), 81 patients from the group initially 
included in the study were recommended for treatment according to the 
treatment guidelines and were judged to have received such treatment (guide-
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line adherent cases). The attrition rate of patients in this group at the 1-year 
follow-up was 16%.
Figure 1. Flow chart for patient inclusion
Tables 1 and 2 present demographic and clinical characteristics, respectively, 
of the 81 adherent cases and characteristics of the study completers vs. patients 
lost to follow-up.
As shown in tables 1 and 2, the proportion of males was higher in the group 
of patients who were lost to follow-up compared with the study completers. 
Furthermore, patients lost to follow-up were less educated than study completers 
and were less motivated to complete treatment. Moreover, somewhat more 
patients lost to follow-up were diagnosed with a social phobia. 
At the 1-year follow-up the estimated overall percentage of non-responders 
on the SCL-90-R among patients whose treatment adhered to the guidelines 
was 40%, while 63% experienced persistent functional impairments. 
Informed consent
n=181 (76.7%)
Completed baseline questionnaires
n=160 (88.4%)
n=81 (58.3%)
Guideline applicable
n=139 (86.9%)
Eligible for inclusion the cohort
study
n=236
Refusals: n=55 (23.3%)
n=68 (84.0%)
1-year follow-up
Guideline inapplicable
n=21 (13.1%)
Reasons:
Diagnosis revised: n=9
Early therapy drop out:  n=12
Non - fluent in Dutch: 
n=21 (11.6%)
Guideline-adherent
n=58 (41.7%)
Guideline-non-adherent
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Table 3 depicts the results of the bivariate analyses as a sub-step of the study 
analyses and the final results of the procedure using the multivariate logistic 
regression analyses, performed with non-response as the dependent variable
As shown in table 3, only the “gender” and “secondary gain” variables were asso-
ciated with non-response measured with the SCL-90-R. Patients that at base-
line reported hopes to obtain external benefits by seeking treatment, appear 
to have a lower chance of showing non-response to treatment as measured at 
1-year follow-up when looking at the final results of the multivariate regression 
analyses (p=.054). This while males tend to have a higher chance of showing 
non-response (p=.074). No interaction effects were found. However, the fit 
statistics for this model are low: Mc Fadden’s pseudo R-square equals 0.07 and 
Table 1.  General characteristics of the study sample of completers and patients 
lost to follow-up (original data)
Total Sample 
(n=81)
Study com-
pleters 
(n=68)
Patients lost 
to follow-up 
(n=13)
P-values 
between group 
differences: 
Study com-
pleters vs. 
Patients lost 
to follow-up
Age: Mean (SD) 33.5 (11.9) 33.49 (11.4) 33.62 (15.2) .972
Gender (male): n (%) 29 (33.8) 20 (29.3) 9 (69.2) .006 **
Foreign background (yes): 
n (%)
11 (13.6) 8 (11.8) 3 (23.1) .275
Educational level; only pri-
mary school or less: n (%)
11 (13.6) 7 (10.3) 4 (30.8) .048 *
Unemployed (yes): n (%)
Missing item values: n 
38
1a
(46.9) 30
1a 
(44.8) 8
0a
(61.5)
 
.268
Net monthly income in 
Euros: mean (SD)
Missing item values: n
877.4
19a
(602.7) 914.3
18a
(611.4) 723.4
1a
(562.8) .329
NML2 preparedness score: 
mean (SD)
47.4 (8.1) 48.2 (7.6) 43.3 (9.6) .059 §
Secondary gain (yes): n (%)
Missing item values: n (%)
33
3a
(40.7) 27
2a
(41.5) 6
1a
(50.0) .586
Satisfaction with ac-
cessibility of health care 
services: mean (SD) 
3.7 (.7) 3.7 (.7) 3.9 (.7) .341
* significant difference p<.05, ** significant difference p<.01, § difference p<.1
a Excluded pairwise from further analysis
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ROC = 0.66, which indicates that the discrimination between responders and 
non-responders based on this model is rather poor. 
Table 4 presents the results of the bivariate and multivariate analyses with 
persistent functional impairments measured with the SDS as the dependent 
variable. 
Table 2.  Clinical characteristics of the study sample of completers and patients 
lost to follow-up (original data)
Total Sample 
(n=81)
Study com-
pleters 
(n=68)
Patients lost to 
follow-up 
(n=13)
P-values be-
tween group 
differences: 
Study com-
pleters vs. 
Patients lost 
to follow-up
Primary diagnosis: n (%)
Panic disorder 31 (38.3) 27 (39.7) 4 (30.8) .54
Social phobia 16 (19.8) 11 (16.2) 5 (38.5) .064 §
OCD 7 (8.6) 6 (8.8) 1 (7.7) .894
GAD 6 (7.4) 5 (7.4) 1 (7.7) .966
PTSD 16 (19.8) 14 (20.6) 2 (15.5) .666
Specific phobia 3 (3.7) 3 (4.4) 0 (0.0) .999
Hypochondria 2 (2.5) 2 (2.9) 0 (0.0) .999
Comorbid axe I Diagnosis 
(yes): n (%)
30 (37) 27 (39.7) 3 (23.1) .255
Total number of axe I diag-
noses: mean (SD)
1.41 (.6) 1.4 (.6) 1.2 (.4) .150
Comorbid anxiety disorder 
(yes): n (%)
9 (11.1) 9 (13.2) 0 (0.0) .164
Comorbid mood disorder 
(yes): n (%)
17 (21.0) 14 (20.6) 3 (23.1) .840
PDQ-4 score; personality 
disorder probable (yes): n (%) 
Missing item values: n 
29
9a
(35.8) 27
6a
(43.5) 2
3a
(20.0)b .159
SCL-90-R total-score: 
mean(SD) 
192.8 60.8 195.7 (63.1) 177.9 (46.1) .336
Treatment drop-out: n (%) 23 (28.4) 19 (27.9) 4 (30.8) .836
§ difference p<.1
a Excluded pairwise from further analysis
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As shown in table 4, the variables of “satisfaction with accessibility of health 
services”, “gender” and “presence of comorbid anxiety disorder” were asso-
ciated with persistent functional impairments. The results show that when 
comparing patients that express being less than content with the accessibility 
of care, with patients that express being content or even more satisfied with 
the accessibility, the first group has a higher chance of showing persisting 
functional impairments at 1-year follow-up. A result that is highly significant 
(p=.008). Also, males tend to have a higher chance of persisting functional 
impairments as measured at 1-year follow-up (p=.087). Surprisingly, compared 
to patients without such comorbid condition, patients who were at baseline 
found to suffer from another comorbid anxiety disorder appear to have a lower 
chance of persisting functional impairments (p=.079). Again, no interaction 
effects were found. The fit statistics for this model, predicting functional 
impairment based on these three predictor variables, are quite good: Mc 
Fadden’s pseudo R-square equals 0.30 and ROC = 0.82, indicating an excellent 
Table 3.  Predictors of non-response on the SCL-90-R (change score less than 30 
points), with estimated values based on the imputed dataset (n=81). 
Determinants Bivariate Multivariate 
OR 95% CI p OR 95% CI p
Age in years 1.03 0.99-1.07 .211 X
Gender (male vs. female) 2.18 0.78-6.12 .139 2.80 0.91-8.66 .073
Background (foreign vs. native) 2.12 0.53-8.49 .289 X
Having completed only primary 
school or less (yes vs. no)
1.22 0.28-5.38 .789 X
Employment status (unemployed 
vs. employed) 
0.59 0.23-1.58 .298 X
Net monthly income in Euros 1.00 0.99-1.001 .783 X
NML2 preparedness score 0.96 0.90-1.02 .215 X
Secondary gain (yes/no) 0.42 0.15-1.18 .100 0.33 0.11-1.02 .054
Satisfaction with accessibility 
health care services: (less than 
satisfied vs. satisfied or very 
satisfied)
1.57 0.59-4.18 .365 X
Comorbid anxiety disorder 
 present (yes/no)
0.73 0.17-3.18 .671 X
Comorbid mood disorder present 
(yes/no)
0.57 0.16-1.97 .370 X
PDQ-4 score; personality disor-
der probable (yes/no)
0.67 0.24-1.85 .434 X
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degree of discrimination between patients with and without persistent func-
tional impairments as measured at the 1-year follow-up. 
To further study the results with respect to the predictive value of “gender”; 
“secondary gain” and “presence of a comorbid anxiety disorder”, we compared 
baseline scores on the SCL-90-R of the predictor variables. It was found that 
males scored significantly lower on the SCL-90-R at baseline than females 
(mean total score= 173.56 versus mean total score= 203.60; t=-2.52, df=78.88, 
p=.014). Also, patients who at baseline reported their hope of obtaining 
external benefits by seeking treatment scored significantly higher on the 
Table 4.  Predictors of persistent functional impairments (a total score of 6 
or higher on the Sheehan Disability Scale at 1-year follow-up), with 
estimated values based on the imputed dataset (n=81).
Determinants Bivariate Multivariate 
OR 95% CI p OR 95% CI p
Age in years 1.05 0.99-1.11 .067 X
Gender (male vs. female) 2.68 0.84-8.53 .096 3.84 0.82-17.89 .087
Background (foreign vs. native) 0.82 0.17-3.94 .800 X
Having completed only primary 
school or less (yes vs. no)
4.06 0.45-36.62 .212 X
Employment status (unemployed 
vs. employed) 
0.81 0.28-2.34 .699 X
Net monthly income in Euros 1.00 0.99-1.001 .463 X
NML2 preparedness score 0.97 0.91-1.04 .436 X
Secondary gain (yes/no) 1.02 0.36-2.87 .972 X
Satisfaction with accessibility of 
health care services: (less than 
satisfied vs. satisfied or very 
satisfied)
18.29 2.49-134.56 .004 27.84 2.38-
325.46
.008
Comorbid anxiety disorder pres-
ent (yes/no)
0.26 0.05-1.33 .105 0.11 0.01-1.29 .079
Comorbid mood disorder present 
(yes/no)
1.77 0.47-7.21 .423 X
PDQ-4 score; personality disor-
der probable (yes/no)
1.33 0.46-3.89 .600 X
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SCL-90-R at baseline, compared to the patients who did not (mean=211.62 
vs. mean=179.38; z=-2.39, p=.017; calculations based on the imputed data). 
Baseline severity scores were found to be significantly related to symptom sever-
ity at the 1-year follow-up (r= .479, p<.001). Differences in baseline symptom 
severity thus might be a relevant confounding factor when studying the rela-
tionship between gender, secondary gain and treatment (non-)response.
Additional analyses of the results on functional impairment did not reveal 
differences on the SDS on the predictor variables of “gender”, “comorbid 
anxiety disorder” and “accessibility of health care services”, suggesting no 
confounding due to baseline differences. 
5.4. Discussion
This practice-based study examined the predictive value of variables that are 
known to be able to influence treatment prognosis in anxiety disorder patients. 
These variables were examined in concert in a sample of 81 patients treated 
in a specialized mental health care setting who were judged to have been 
adequately treated according to evidence-based guidelines. We tried to develop 
a prediction model that allowed the identification of patients who run the risk 
of showing treatment non-response or who will continue to experience func-
tional impairments when being provided guideline concordant care. 
Of the demographic variables considered (age, gender, foreign background, 
educational level, employment status and income) only gender was identified 
as a potentially relevant predictor variable for both treatment non-response 
and persistent functional impairments. Males had a higher chance of showing 
treatment non-response and also a higher chance of having persistent func-
tional impairments at the 1-year follow-up. However, males were found to have 
lower baseline symptom severity scores than females which might explain the 
results pertaining to treatment non-response. The data suggest that gender as a 
predictor of persistent functional impairments may have something to do with 
a subgroup of males quitting treatment prematurely. Of the patient character-
istics, hope of secondary gain and the presence of a comorbid anxiety disorder 
were identified as being potentially relevant to treatment prognosis. 
Contrary to what was expected from prior research [22], patients who 
reported a hope of gaining external benefits actually had a lower chance of 
showing treatment non-response. These patients were found to suffer from 
more severe general psychopathology at the baseline. It may be that the 
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reported motives for secondary gain might reflect a genuine need for help in 
managing life. This suggests that as long as additional support is available in 
addition to the regular evidence-based care for anxiety disorders, for example 
the availability of a community psychiatric nurse, greater treatment effects can 
be achieved in these patients. Patients who suffered from a comorbid anxiety 
disorder at baseline were also found to have a lower likelihood of persistent 
functional impairments. On the other hand, patients who were less than satis-
fied with the accessibility of health care services had a substantially greater risk 
of persistent functional impairments. Actually, this was the only study result 
that was significant when maintaining the orthodox significance level of 5 
percent and therefore probably the most relevant result. 
There are some limitations to the results of the current study. One of the 
most important issues is the relatively small sample size used in this study. 
In addition, because of the small sample size and the explorative nature of 
our study we maintained a liberal significance level of .10 for the selection of 
predictors. This makes replication of our study necessary. The small sample 
size may explain why the results for some of the predictors of treatment prog-
nosis identified as relevant in other studies failed to reach significance in the 
current study. While this may be true, the size of the estimated Odds Ratio’s in 
our study do suggest however that the influence of these variables is probably 
not very strong. This is likely to be especially true in a situation where patients 
get to choose among recommended evidence-based treatment options and can 
also receive multiple evidence-based treatments at the same time, as is the case 
in everyday clinical practice, as opposed to the more controlled circumstances 
of most predictor studies. Another limitation of the current study might be 
the fact that the treatment results were measured only at the 1-year follow-up. 
Some of the variables studied may have predictive value when studied over a 
shorter time period. The one-year time period for measuring treatment results 
was chosen in this prediction study on guideline concordant care because one 
year is the minimum length of time for the main recommended treatment 
steps to be put in effect for most anxiety disorders, in order to determine if 
there has been a sufficient treatment response. 
There are several strengths to the present study. The patients included in 
the study sample are representative of “real world” mental health care. There 
were almost no exclusion criteria. To our knowledge the study presented here 
is also the first to look at the conglomerate of possible predictors of treatment 
response that have been identified as relevant to predicting treatment progno-
sis [2, 3] at the same time. This was done in a setting where patients were able 
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to choose among several available evidence-based treatment options and were 
also able to receive a combination of treatments when the clinician adhered to 
treatment guidelines for anxiety disorders.
From the results of the present study it can be concluded that it is hard to 
predict which anxiety disorder patients will or will not profit from guideline-ad-
herent treatment in terms of demonstrating adequate treatment response. 
Unfortunately, this means that for the time being selecting an effective cure for 
the individual patient will for the most part remain a process of trial and error. 
However, we may also conclude that with the knowledge currently available 
no one suffering from an anxiety disorder as a primary diagnosis should be 
prevented from being offered some form of evidence-based care according to 
the available evidence-based treatment guidelines, if one adapts to gender and 
removes barriers in attending treatment. 
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Chapter 6
General discussion
6.1. Introduction
As was set out in the introduction to this thesis, there is still much to be done to 
improve the quality of health care. Evidence-based practices are being adopted 
in clinical practice at a rate that is far too slow. This is also true of the care 
provided to patients with anxiety disorders, a prevalent and disabling group of 
mental disorders. Delays in implementing these practices come at the expense 
of potential health gains that could be achieved with the proper implementa-
tion of available evidence-based treatment interventions and at the expense 
of the well-being of this group of patients. The effective use of these types of 
interventions is commonly expected to improve treatment outcomes. 
The development and introduction of clinical practice guidelines has been 
a  significant reaction to the slow speed at which evidence-based practices have 
been adopted. In the Netherlands, a substantial investment has been made to 
develop such guidelines for mental health care. The first guidelines for mental 
health care, published in 2003, dealt with the treatment of anxiety disorders. 
The aim is that by publishing guidelines such as these, knowledge about the 
scientific evidence supporting specific practices will spread more easily among 
healthcare practitioners, leading to quicker adoption of evidence-based treat-
ments in clinical practice. Furthermore, the expectation is that the successful 
implementation of such guidelines will reduce unwanted variations in health 
care practices and improve the quality of care.
However, at the time the initial guidelines were published, little was known 
about how to achieve these aims. Actually, it was not even known whether 
the implementation of the available Dutch multidisciplinary guidelines for 
mental health care was feasible at all. Convincing evidence that adhering to 
such guidelines, and that the successful implementation of these guidelines 
in mental health care practice would indeed improve treatment results was 
scarce, and it was completely absent in the field of provision of care for anxiety 
disorder patients. Although the general expectation was that the successful 
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implementation of guidelines for anxiety disorders would lead to better treat-
ment outcomes, not every patient was expected to profit sufficiently from treat-
ment tailored to such guidelines. For clinical practice it would be very valuable 
to be able to identify reliable risk factors for non-response to treatment, even 
when treatment is delivered according to the multidisciplinary guidelines. 
An important question therefore was whether it is possible to predict which 
patients would not benefit from treatment adhering to the anxiety disorder 
guideline recommendations. 
Our research project focuses on improving mental health care for anxiety 
disorder patients by implementing clinical practice guidelines. Therefore, it 
aimed to: 1) evaluate the feasibility of implementing anxiety disorder guide-
lines and look at possible implementation strategies that can be helpful in 
doing so; 2) evaluate the added value to treatment outcome of adhering to such 
guidelines; 3) evaluate the effectiveness of the implementation of guidelines 
in specialized mental health care; and 4) identify factors that predict non-re-
sponse and persistent disability when treatment is guideline-adherent. 
In this chapter the results of our efforts to realize these four aims will be 
summarized below, point by point. The summary starts with a discussion of 
the limitations followed by an outline of the strengths of the evidence regard-
ing the different conclusions drawn from the studies that were performed to 
achieve these aims. Subsequently, recommendations for future research will be 
given. This chapter will close by summarizing the general conclusions of the 
research project and by highlighting the implications for clinical practice. 
6.2.  Discussion of key findings with respect to the feasibility 
of implementing clinical practice guidelines for anxiety 
disorders
Results from our case study (Chapter 2) regarding the implementation of the Dutch multi-
disciplinary guideline for anxiety disorders. 
The Dutch multidisciplinary guidelines for anxiety disorders were systemati-
cally implemented in a specialized treatment unit for anxiety disorders in the 
Almelo community mental health care centre. Following the suggestions of 
Grol and Wensing [1], a stepwise and tailor-made approach to guideline imple-
mentation was used that comprised several multifaceted implementation strat-
egies. As a first step quality of care was determined at baseline and goals for 
improvement were formulated. Also, a questionnaire to measure factors that 
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could hamper or facilitate implementation of the guidelines was developed 
and administered. The responses given by the members of the treatment unit 
for anxiety disorders on this questionnaire were used to direct the selection 
of interventions used to accommodate the implementation process. The main 
interventions that were used in the subsequent implementation steps included 
the following: redesign of the care process and standardization of the diagnos-
tic process; development and distribution of instruction materials; educational 
meetings and training of professionals in the skills needed to perform treat-
ment as suggested in the guidelines; and on-going monitoring of guideline 
adherence with regular provision of feedback on performance. After studying 
the medical records of 150 patients with an anxiety disorder or hypochondri-
asis who had been previously treated, and 181 patients who were treated after 
the start of the implementation activities, a significant increase was found in 
the number of patients who had been provided recommended forms of psycho-
therapeutic treatment over time. The percentage of guideline adherence 
with respect to the provision of recommended psychotherapeutic treatments 
increased by 43% to 54%, depending on the specific treatment method stud-
ied. Adherence to the recommended pharmacotherapeutic treatment steps 
remained stable during the process of implementation. However, adherence to 
the pharmacotherapeutic treatment steps was considered to be quite adequate 
even before the implementation was begun, and thus less relevant to change. 
Moreover, the number of patients indicated for these treatment steps appeared 
to be rather small. The increase in adherence to certain key recommendations 
of the guidelines could not be attributed to differences in patient character-
istics in the two patient samples that were compared. Taken together, these 
findings suggest that it is possible to achieve meaningful changes in healthcare 
provider behaviour with regard to guideline adherence, and that with goal-di-
rected and systematic efforts it is indeed feasible to implement clinical practice 
guidelines for anxiety disorders in a mental health care setting. 
Limitations
Although the results of our case study look promising with regard to the 
feasibility of implementing anxiety disorder guidelines, it must be noted that 
significant increases in guideline adherence were only found for aspects of 
care that were explicitly targeted for change. Overall practice of care in the 
treatment unit studied still had room for improvement with respect to the 
adequate provision of psychotherapeutic and especially pharmacotherapeu-
tic treatment, despite the systematic efforts aimed at implementation of the 
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guidelines. Whether it is possible to implement the guidelines almost perfectly 
and change care so that nearly 100% of the guideline recommendations are 
properly applied in clinical practice has not been definitively proven. One could 
argue that this limits our conclusion regarding the feasibility of implementing 
the guidelines. However the necessity for further improvement of certain aspects 
of care should have been used as input for another plan-do-check-act cycle to 
further increase guideline adherence. The implementation of guidelines must 
be viewed as a continuous process. The research group is quite confident that 
further improvements in adherence to the guideline recommendations could 
have been achieved with proper efforts and more time.
One limitation of the design of our case study is its dependence on patient 
medical files to assess guideline adherence. It leaves open the possibility that the 
improvements in adherence rates that were found over time do not reflect actual 
changes in health care provider behaviour, but only changes in record keeping. 
In addition, the set of process indicators, although carefully selected, constitute 
only rough measures of actual health care performance. However, this method 
of data collection and determining adherence to recommended treatment 
steps was chosen because it was relatively easy to carry out and did not require 
a special effort by the therapists involved in the study. We tried to increase the 
chances that the changes obtained would actually show the effect of the imple-
mentation strategies used instead of only an increased awareness of therapists 
being under scientific scrutiny. For instance, had we used audio or video tapes 
of treatment sessions to assess performance, the content of these sessions could 
possibly have been compromised by the fact that the professional would exhibit 
behaviour thought to be more ‘desirable’ because he/she felt under explicit 
scientific scrutiny. Additionally, we wanted to make sure that our implementation 
approach could be reproduced by other mental health care centres that want to 
implement the multidisciplinary anxiety disorder guidelines. We expected that if 
implementation necessitated recording treatment sessions to monitor guideline 
adherence, it could deter others from using this approach. 
A second methodological limitation is the use of a before-and-after design, and 
the absence of a proper control condition and randomisation procedure. Thus 
it is impossible to be certain that the increase in adherence to certain guideline 
recommendations reported in the case study actually resulted from our imple-
mentation efforts and the effectiveness of our implementation approach. The 
established changes in healthcare provider behaviour may reflect the passing 
of time and changing opinions. With regard to this reported shortcoming, it is 
important to note that the case study was designed primarily to assess the feasi-
van Dijk_Proefschrift Anxiety Disorders_v5_170x240.indd   108 03/10/2014   23:46
General discussion 109
bility of implementing the guidelines, and not set up to assess the actual effec-
tiveness of our implementation approach. However, as described in Chapter 2, 
studies by Bauer [4] and Weinmann and colleagues [5] show that without active 
efforts to ensure the implementation of a guideline, they adherence will only be 
marginal. Furthermore, recent research suggests that multidisciplinary guide-
lines in the Netherlands are actually rarely used by healthcare practitioners, 
despite their dissemination [6]. These findings suggest that the adherence rates 
found in our study have been influenced by our implementation activities.
Questions could be raised about the generalizability of the study results. The 
guidelines were implemented in one treatment unit only. The use of the specially 
developed questionnaire to measure factors that could hamper or facilitate 
implementation of the guidelines showed that members of this unit had atti-
tudes towards the guidelines that were quite positive, even before the start of the 
implementation activities, and they expressed strong intentions to begin using 
the guidelines. This could have meant that the implementation of the guidelines 
was easier in this setting than it would be in situations where this was not the 
case. In such situations it is to be expected that more time and focussed interven-
tions would be necessary to promote a positive attitude toward the guidelines, 
as an essential prerequisite for successful implementation. However, the results 
of the ‘Breakthrough project for anxiety disorders’ [2], which took place in the 
Netherlands between December 2006 and May 2008, can be seen as additional 
evidence of the feasibility of implementing recommended care according to anxi-
ety disorder guidelines in everyday clinical treatment settings. In this project, 13 
multidisciplinary teams from primary and secondary care collaborated with a 
panel of expert professionals to improve quality of care for patients with an anxi-
ety disorder. This was done by adopting a stepped-care approach incorporating 
several selected recommendations in the multidisciplinary guidelines for anxiety 
disorders [2]. The results of this project suggest that important improvements 
in healthcare practice can be achieved, and that healthcare providers can be 
assisted in further embracing evidence-based practices and practice guidelines 
for anxiety disorders [2]. In addition, the breakthrough project suggests that 
improvement generally requires a deliberate and quite intense effort that should 
be maintained over a longer period of time. 
 
Strengths 
Our case study was the first systematic evaluation of the feasibility of imple-
menting evidence-based practice guidelines for anxiety disorders worldwide. 
The study was carried out with more scientific rigor than the anxiety break-
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through project that was also performed in the Netherlands [2]. We evaluated 
guideline adherence by performing a thorough review of medical records and 
by using a carefully developed set of process indicators, which reflected recom-
mended treatment interventions based on high-quality scientific evidence. The 
final selection of recommended treatment options, on which the final set of 
process indicators used in this study was based, reflected parameters in need of 
change and relevant to quality of care, according to an expert group of profes-
sionals all of whom were members of the Dutch Knowledge Centre for Anxiety 
and Depressive Disorders (Nederlands Kenniscentrum Angst en Depressie). 
To judge whether guidelines were properly adhered to, additional assess-
ments were performed to establish whether the evidence-based interventions 
in the recommended treatment steps were carried out in accordance with 
state-of-the-art standards (for psychotherapeutic treatments this included: 
provision of a clear treatment rationale, appropriate homework assignments, 
and provision of treatment for the minimal recommended number of treat-
ment sessions for the treatment to be effective; for pharmacological treatment 
it included the prescription of the correct category and type of drug, prescrip-
tion of the correct dosage and the correct minimum duration of the medica-
tion before evaluation). The corresponding main process indicator was scored 
positively only when all of these additional performance assessments were 
fulfilled according to guideline recommendations. Furthermore, the study was 
carried out in a routine mental health care setting, using two representative 
and comparable patient samples to assess changes in guideline adherence 
over time. Actually, almost no formal exclusion criteria were used for patient 
inclusion. Any patient with a primary diagnosis of anxiety disorder or hypo-
chondriasis could be included in the study. This ensured that the feasibility 
of implementing practice guidelines for anxiety disorders could be evaluated 
in the widest possible range of patients, including patients with a foreign 
background. This factor does not appear to have hampered proper guideline 
adherence. 
The method of implementation described in our case study can be used in 
other situations. The implementation aids we developed, such as the desk-top 
guides and patient information materials, can be easily distributed and do 
not need to be developed all over again. Furthermore, in daily practice small 
samples of about ten medical records can be used as input for the plan-do-
check-act cycle to monitor progress in implementing the guidelines. The set 
of process indicators to measure guideline adherence is available, and only 
needs slight changes given the recent revision of the Dutch anxiety disorder 
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guidelines. Both the questionnaire and the set of process indicators have been 
published in Dutch [7, 8] and international journals [9] and are thereby read-
ily available to others. By performing our case study, we hope to have delivered 
an implementation methodology and a set of concrete implementation tools 
that makes replication of our study as easy as possible. 
6.3.  Discussion of key findings with respect to the added value 
of adhering to practice guidelines for anxiety disorders
Results from the cohort study (Chapter 3) that focused on the association between guide-
line adherence and treatment results 
Using data collected on the treatment results for 181 patients who were 
included after implementation activities were begun in the Almelo commu-
nity mental health centre, referred to in paragraph 6.2, we found that patients 
whose treatment adhered to the guidelines showed significantly greater symp-
tom reduction as measured with the SCL-90-R, compared to those patients 
whose treatment did not adhere to the guidelines. In addition, the first group 
of patients had significantly fewer treatment contacts. Patients who received 
guideline-adherent treatment also reported a greater degree of satisfaction 
with their treatment. Although a significant improvement in functioning, in 
patient-reported quality of life and in general health was attained in the total 
sample of patients, the influence of guideline-adherent care concerning these 
aspects of outcome was not significant. Taken together, the results of our study 
suggest that guideline adherence does matter, not only with regard to symptom 
reduction, but also in terms of patient satisfaction with treatment and possibly 
with regard to efficiency as well.
Limitations
A limitation of the study is that the impact of guideline adherence was studied 
only in the group of patients included after implementation of the guidelines 
was begun in the centre, acting as a closed cohort. Although care was taken 
to rule out the possible influence of confounding factors as much as possible, 
causal inferences should be made with caution. Because of the chosen research 
design, it is not certain that there is not an unmeasured background variable 
that explains the fact that, in the same group of patients, the healthcare 
providers involved deviated from the guideline recommendations and the 
poorer patient response to treatment. In the study, patients whose treatment 
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did not adhere to the guidelines were found to have higher levels of general 
psychopathology, as reflected by higher baseline SCL-90-R total scores, more 
comorbid depressive symptoms, and a more frequent incidence of personality 
pathology. These patients also had a higher number of treatment contacts. In 
the statistical analysis of all of these variables, only the number of treatment 
sessions was found to relevantly confound the relationship between guideline 
adherence and treatment outcome, which was measured using a residual gain 
score. The number of treatment contacts was therefore added as an additional 
independent variable in our regression analysis to correct for this confounding 
factor, to obtain the final results, which were still positive, regarding achieved 
symptom reduction in the guideline-adherent patient group. 
Strengths
Concerning the findings on the feasibility of implementing the anxiety disor-
der guidelines, the use of medical files and the use of the set of specially 
developed process indicators to determine adherence to key recommenda-
tions of the guidelines were brought up as a possible limitation of the study as 
described in paragraph 6.2. This means of measurement might provide only a 
superficial impression of the actual quality of care. With the above-mentioned 
cohort study it was possible to show that this type of measurement has clinical 
relevance, since a significant relationship could be established between the 
variable guideline adherence, based on the scores on the set of process indi-
cators and the final treatment results obtained. Almost 12% of the variance 
in the outcome measure of patients receiving treatment was explained by the 
variable guideline adherence. This suggests that the method used for deter-
mining proper guideline adherence actually has predictive value for treatment 
outcome and bares relevance as a measure of quality of care. 
Since data was collected in a routine mental health care setting, with patients 
representative of specialized mental health care in the Netherlands, this study 
permitted the assessment of the overall applicability of the anxiety disorder 
guidelines in everyday clinical practice. Some situations routinely encountered 
in clinical practice were considered proper justifications for a healthcare profes-
sional to decide not to apply a particular guideline recommendation: revision 
of the primary anxiety disorder diagnosis; a patient who refused recommended 
care or dropped out of treatment at a very early stage of treatment, making it 
impossible for the professional to provide adequate care; greatly interfering 
psychosocial problems; suicidality or addiction problems that had to take 
treatment priority. With pharmacotherapeutic treatment, additional legitimate 
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reasons for justifying that a particular recommended treatment step not be 
taken included: severe side effects, or a somatic contra-indication to pharma-
cotherapeutic treatment. In the sample used in the cohort study, it was estab-
lished that in only 13% of the cases none of the guideline recommendations 
could be applied, due to the presence of one or more of the above-mentioned 
reasons. This suggests that the Dutch multidisciplinary guidelines for anxiety 
disorders are actually very applicable in everyday outpatient clinical practice.
6.4.  Discussion of key findings with respect to the comparison 
in effectiveness of implementing practice guidelines
Results from the study described in Chapter 4, which compared adherence rates and 
treatment outcomes between two treatment centres for anxiety disorders during a two-year 
follow-up period. 
In the study presented in Chapter 4 guideline adherence rates and treatment 
outcomes between two treatment centres for anxiety disorders were compared. 
One of these was the Almelo community mental health care centre of in which 
the guidelines had been systematically implemented. The other was a special-
ized treatment centre for anxiety disorders located in Amsterdam in which 
only passive dissemination of these guidelines took place. This means that in 
the Amsterdam centre the anxiety disorder guidelines were distributed among 
the healthcare providers as printed booklets, which made it easier for them to 
become familiar with the content of the guidelines. The Amsterdam treatment 
centre participated in the NESDA study, a naturalistic cohort study on the 
long-term course and consequences of depressive and anxiety disorders [10]. 
Data about treatment outcome at a 1-year and 2-year follow-up was available for 
patients in this centre with a primary diagnosis of panic disorder with or with-
out agoraphobia, social phobia and generalized anxiety disorder. By confining 
the sample of patients of the cohort study that was performed in Almelo to 
study the added value of adhering to practice guidelines (see paragraph 6.3) to 
patients with one of these three disorders (intervention condition), it became 
possible to expand the original single cohort study and add a passive control 
group of patients treated in a setting in which only passive dissemination of 
the guidelines took place (control condition). Guideline adherence rates, as 
measured during the first year of treatment, were found to be significantly 
higher in the setting in which the guidelines were actively implemented. 
Patients in this intervention condition also showed superior treatment gains 
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on anxiety and avoidance symptoms at the 1-year follow-up, with small to 
medium between-group effect sizes on the anxiety disorder-specific outcome 
measures. At the 2-year follow-up, the difference in treatment gain from 
baseline to follow-up on anxiety symptoms between the two conditions was no 
longer significantly different. However the decrease in avoidance behaviour 
as measured from baseline to the 2-year follow-up still remained larger in the 
intervention condition. It was also established that in the control condition 
a significantly larger percentage of patients continued treatment after the 
first year of treatment. As a result, patients in the control condition seem to 
have partially caught up with the patients with respect to long-term treatment 
gain in terms of reducing anxiety symptoms. We are also able to demon-
strate in both conditions that adherent treatments yielded superior outcomes 
than non-adherent treatments. It is therefore plausible that the difference in 
outcome found between the two conditions could indeed be attributed to the 
difference in adherence. Overall the data suggest that the active and systematic 
implementation of guidelines leads to greater treatment gains with respect to 
anxiety symptomatology, especially in the short term. Moreover, treatments 
which were adherent to the guidelines were of shorter duration, indicating that 
implementation of guidelines might improve the efficiency of care from a long-
term perspective. 
Limitations
There are some limitations to the study that must be addressed. First, because 
of the non-randomized nature of this ‘double cohort’ study design, we have 
to take into account the possibility that our findings might be influenced by 
confounders and be alert to other possible explanations for the established 
results. Both treatment centres appear to have been quite similar with regard 
to the number, the mean age, and the type of health care professionals on 
staff. Where differences existed in the composition of professional staff in the 
centres at the start of our study, one would expect that these would actually 
favour the results obtained in the control condition. For instance, the staff 
in the control condition centre, especially the psychologists, had more years 
of experience in working with patients suffering from an anxiety disorder. 
Furthermore, the staff in the control condition centre also expressed that they 
experienced a greater degree of control over their work processes. They rated 
their knowledge of the guidelines as higher and said that they experienced 
more normative social pressure to adhere to the guidelines before the start of 
the implementation/dissemination of the guidelines. 
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Both cohorts of patients appeared to be quite similar in composition except 
that the patients in the control condition were more highly educated and 
reported less severe anxiety symptoms and avoidance behaviour at baseline. 
The difference in education was found not to confound the relationship 
between the treatment condition and treatment outcome, operationalized as 
raw change in symptom severity from baseline to follow-up on the different 
outcome measurements. This might give the impression that patients with 
more severe baseline anxiety and avoidance symptoms could be the ones to 
have the greatest treatment gains. If this was correct, the baseline difference 
between the two conditions would be responsible for the superior treatment 
effect of the intervention compared to the control condition. The relationship 
between the severity of baseline symptoms and treatment gain, however, is 
equivocal: there is a great deal of literature showing that more severely anxious 
patients might actually profit less from treatment. See for example the recent 
article by Taylor et al. that summarizes several studies providing evidence for 
this case [11]. Remember also that in our single-cohort study (see paragraph 
6.3), patients who were labelled as non-adherent cases were found to suffer 
from higher levels of general psychopathology and showed less treatment 
gain compared to patients who were labelled as having received guideline 
adherent treatment. Because of these findings, it can be argued that there is 
a lesser chance of finding superior results in the intervention condition, in 
terms of greater guideline adherence and treatment outcomes, because more 
severe anxiety symptomatology was reported by the patients at baseline in this 
condition. Due to the observational nature of our study, we wanted to be as 
transparent as possible about differences between the treatment settings and 
the patients treated there. Therefore we primarily reported the raw change 
scores and not ‘residual gain scores’ that can be calculated by using a patient’s 
mean change scores over time, after correction for the baseline severity scores. 
The use of residual change scores is appropriate when it is safe to assume that 
a patient actually has the same chance of being assigned to either an experi-
mental or control condition, and when baseline differences in patients between 
the two conditions can only be the result of chance. However, as a check we 
performed additional analyses using residual gain scores, correcting for the 
baseline differences between the two research conditions. These additional 
analyses for the most part corroborated the analyses with raw change scores 
and we therefore chose to report the uncorrected outcomes. Our results are 
also in line with the findings from the study by Verbeke et al., which investi-
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gated the influence of making baseline corrections when using longitudinal 
data and suggested that this makes no difference [12]. 
A direct relationship was also found between guideline adherence and treat-
ment outcome as measured at the patient level, yielding significant relation-
ships on all continuous outcome measures. This to a large extent rules out the 
possibility of an ecological inference fallacy and when studied more directly 
shows the relevance of adhering to the treatment guidelines. Possible alterna-
tive explanations for our findings concerning differences in treatment setting 
and patient characteristics are therefore considered less viable.
Strengths
Again, the use of two well-diagnosed cohorts of anxiety disorder patients, 
representative of secondary outpatient mental health care, can be seen as a 
methodological strength of our study. The patients we included are particu-
larly representative of ‘real life’’ because we applied only one exclusion crite-
rion (insufficient proficiency in the Dutch language), thereby enhancing the 
external validity of our study results. 
Concerning the case study described in paragraph 6.2, it was stated that 
the lack of a control group rendered it impossible to draw any conclusions 
on the effectiveness of the implementation approach used in terms of chang-
ing healthcare provider behaviour. The changes in provider behaviour that 
were found in this study could for instance merely reflect the passing of time, 
and the fact that the recommended treatments described in the guidelines 
slowly became more common practice. However, since adherence rates in the 
double-cohort study were significantly higher in the intervention condition 
than in the control condition and because of the fact that adherence was 
measured during the same period of time, this adds to the evidence that the 
change in healthcare provider behaviour could be the result of the systematic 
implementation of the guidelines in the intervention condition. This is even 
more likely if one considers the fact that the control condition had a somewhat 
more favourable starting position with respect to presence of certain factors 
that could promote proper guideline adherence by the involved healthcare 
providers (e.g. the healthcare providers in the control condition had more 
experience in treating anxiety disorders, were found to have more knowledge 
about the content of the guidelines, and experienced more social pressure to 
adhere to the guidelines before start of the implementation). Of course defin-
itive proof of the effectiveness of the implementation approach can only be 
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derived from a randomized controlled trial measuring changes in guideline 
adherence and changes in treatment results over time. 
6.5.  Discussion of key findings on the identification of factors 
that predict non-response and persistent disability when 
treatment is guideline-adherent
Results from the prediction study (Chapter 5) with respect to factors that can predict treat-
ment non-response and persistent disability, when treatment adheres to evidence-based 
practice guidelines for anxiety disorders
By confining the sample of the single cohort study referred to in paragraph 
6.3 to the 81 patients whose treatment was found to adhere to the anxiety 
disorder guidelines, it was possible to look at possible predictors of treatment 
non-response and persistent functional impairments when treatment properly 
adheres to the guidelines. The predictive value of several variables that are 
known to be able to influence treatment prognosis was studied, in conjunction, 
using multivariate logistic regression analyses. 
Of the demographic variables studied (such as age, gender, foreign back-
ground, educational level, employment status, income) only gender was identi-
fied as a potentially relevant predictor variable for treatment non-response as 
well as persistent functional impairments when it pertained to a rather liberal 
significance level of 10 percent. Male gender was found to be associated with 
a higher rate of treatment non-response and also a higher rate of persistent 
functional impairments at the 1-year follow-up. Of the other patient charac-
teristics (such as motivation for treatment, motives for secondary gain, the 
presence of comorbid depressive disorder, the presence of comorbid anxiety 
disorder, probable comorbid personality pathology), only secondary gain and 
the presence of a comorbid anxiety disorder were identified as having potential 
relevance to treatment prognosis when pertaining to the liberal significance 
level of 10 percent. Contrary to expectation, patients who at baseline reported 
hopes for gaining external benefits actually had a lower likelihood of non-re-
sponse to treatment. Patients who at baseline suffered from a comorbid anxiety 
disorder were found to have a lower likelihood of persistent functional impair-
ment after treatment. In addition, patients who were less than satisfied with 
the accessibility of the health care services were found to have a substantially 
higher rate of persistent functional impairment. 
van Dijk_Proefschrift Anxiety Disorders_v5_170x240.indd   117 03/10/2014   23:46
118 Multidisciplinary Guidelines for the  treatment of Anxiety Disorders
The predictive value of the constructed model for treatment non-response 
that contained the selected predictor variables of gender and secondary gain 
was found to discriminate poorly between treatment non-responders and 
responders. Therefore, it must be concluded that it is not entirely possible to 
predict which patients will or will not profit from a treatment that is tailored 
according to anxiety disorder guideline recommendations. 
The prediction model for persistent functional impairment that contained 
the selected predictor variables of gender, presence of a comorbid anxiety 
disorder and satisfaction with the accessibility of health services was found to 
discriminate excellently between patients with and without persistent func-
tional impairment. In terms of reducing the rate of persistent functional 
impairment, it seems that the most attention should be directed to situations 
in which a patient reports experiencing barriers that hamper treatment atten-
dance, or expresses dissatisfaction with the accessibility of health care services. 
Offering e-health interventions, or visiting the patient at home for treatment, 
may provide a solution to this problem. 
Limitations
One of the most important limitations of our study is the relatively small 
sample size used. Because of the small sample size and the explorative nature 
of our study we kept to a rather high significance level of .10 for the selection 
of predictors that were considered to be relevant. As a result some of the study 
findings could be the result of chance alone. Replication of our study will be 
necessary in order to assess whether the findings are generalizable to other 
patient samples. 
Another limitation of the current study might be the fact that the treatment 
results were measured only at the one-year follow-up. Some of the variables 
studied (such as treatment motivation for instance) may indeed have a predic-
tive value when studying treatment outcomes in the shorter run, but fail to 
show such an effect here due to the longer time-frame of the current study. 
The one-year time period for measuring treatment results was chosen because 
we wanted to investigate predictors of treatment non-response and persistent 
functional impairment in patients receiving guideline-concordant care accord-
ing to available treatment algorithms. For the main recommended treatment 
steps in most anxiety disorders to be put into effect a time period of at least 
one year is required in case there is an initial insufficient treatment response. A 
larger study sample might have permitted the exploration of differential effects 
of certain predictor variables for certain types or combinations of treatment, 
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for example when some patients received only a single recommended treat-
ment step and others a combination of multiple treatments. With the limited 
number of patients in this study we were not able to investigate this effect. 
Strengths
As stated before we included patients who are representative of those seen in 
day-to-day outpatient clinical practice in secondary mental health care in the 
Netherlands. There were almost no exclusion criteria. To our knowledge the 
study described above is the first to look at the conglomerate of possible predic-
tors of treatment response that have been identified as relevant to predicting 
treatment prognosis. Patients included in the study were able to choose among 
several available evidence-based treatment options for anxiety disorders and 
were also able to receive a combination of treatments that adhered to treat-
ment guidelines for anxiety disorders.
6.6. Recommendations for future research
6.6.1.  Issues concerning the implementation of practice guidelines for anxiety 
disorders
Although knowledge about effective interventions and strategies when aiming 
to implement guidelines for mental healthcare is slowly accumulating in 
the Netherlands (see for instance the 2009 Dutch Trend report for Mental 
Healthcare [6]), many questions regarding the implementation of these prac-
tice guidelines remain unanswered. One very important question is which 
implementation interventions are most effective and under what circum-
stances. Our implementation approach used interventions aimed at the orga-
nizational level for the most part (e.g. redesign of the care process) and the 
level of the health care provider (e.g. training, continuous feedback on perfor-
mance). Only one was explicitly focussed on the level of the individual patient 
(distribution of patient instruction materials that provided disorder-specific 
information and the different recommended treatment options they could 
choose from). The interventions used were carefully selected based on the 
results of a diagnostic phase, in which an effort was made to identify relevant 
context-specific factors that could hamper or promote guideline adherence in 
the setting in which the guidelines were implemented. Although the literature 
(see also paragraph 1.4) and our research show this to be a potentially useful 
approach, due to the enormous number and differing types of available imple-
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mentation interventions [13], other choices could easily have been made with 
respect to the specific interventions and the combination of interventions that 
were used in the present study. Factors that concern the macro and societal 
level, such as changes in legislation and financing issues (for instance, changes 
in the list of psychological interventions that are eligible for insurance reim-
bursement, designated by the Dutch Healthcare Insurance Board (CVZ)) may 
influence the uptake of recommended evidence-based treatments and adher-
ence to available practice guidelines to a great extent. Future research should 
focus more on identifying the interventions that are most effective, and under 
which specific conditions. This enables well-considered choices to be made in 
developing a specific guideline implementation approach for a given situation. 
For this purpose one ideally would perform a large-scale, cluster randomized 
controlled trial involving multiple specialized mental health care treatment 
centres/units, in which interventions take place at the level of the treatment 
setting. Before randomization these centres/units should be stratified accord-
ing to geographical region and size, and perhaps additionally according to 
factors such as current knowledge of the guidelines, attitude towards the 
guidelines, experienced behavioural control in ability to apply the guideline 
recommendations and experienced normative social pressure to adhere to 
the guidelines. Ideally, this research would include adherence measurements 
at the level of the healthcare provider and measurements for establishing 
treatment results at the patient level. Our recommendations would be that 
this research would encompass at least three phases: one to establish baseline 
levels of guideline adherence and treatment efficacy, an implementation phase 
to allow establishment of the short-term effectiveness of the implementation 
strategies used and a follow-up phase to establish long-term results. In contrast 
to our research, this type of research would permit causal inferences about 
the effectiveness of implementing guidelines for anxiety disorders to be made. 
Preferably this study would investigate different combinations of implementa-
tion interventions for similar baseline circumstances, and would also include 
a neutral control condition in which no active implementation of the guide-
lines takes place. This research would also encompass measures to determine 
the cost-effectiveness of the chosen implementation strategies. Our research 
has made it clear that the implementation of guidelines for clinical practice 
requires quite intensive efforts that should be maintained for longer periods of 
time; therefore it would be very valuable to know if implementation, and which 
implementation strategies, are cost-effective. Of course this type of research 
would require substantial investment. However, with our research providing 
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evidence for the potential value of implementing guidelines for the treatment 
of anxiety disorders and the expectation that the successful implementation of 
guidelines would probably make treatment more efficient, it is our opinion that 
this would be worthwhile scientifically and also to society at large.
6.6.2. Issues concerning the content of the anxiety disorder guidelines
The investigated anxiety disorder guidelines contain different treatment algo-
rithms that summarize the available evidence-based treatment options for a 
given anxiety disorder. These treatment options are put in order as recom-
mended treatment steps, based on the level of existing scientific evidence, 
long-term effectiveness, and considerations regarding the possible toxicity and 
risk of adverse side effects of the available medicines, and ultimately also reflect 
the consensus of the expert group responsible for devising the guidelines. In 
general the evidence for the effectiveness of the single treatment steps is quite 
strong. However, scientific evidence for the described sequence of steps is almost 
completely lacking. For instance, the algorithm described in the guideline for 
the treatment of Posttraumatic Stress Disorder (PTSD) advises switching from 
Eye-Movement-Desensitization-Reprocessing (EMDR) to cognitive behavioural 
therapy (CBT), or to pharmacotherapeutic treatment when there is an insuffi-
cient treatment response to EMDR. No studies have been published describing 
the effectiveness of CBT after EMDR. It is also unknown whether switching to 
pharmacotherapeutic treatment after non-response to EMDR as an evidence-
based form of psychological treatment might not prove to be a more effective 
strategy. Regarding pharmacotherapeutic treatment for most conditions, the 
anxiety disorder guidelines recommend trying several antidepressants, and 
in most cases two different SSRIs, before switching to another group of medi-
cations. For many anxiety disorders more than three pharmacotherapeutic 
treatment steps are described before the binding advice is given to switch to 
psychological treatment, before trying another, different type of medication. 
Our data suggest that most patients reject trying another type of medication, 
after having received two or three different drugs without sufficient treatment 
response. In other instances the practitioner considered switching medication 
that was contraindicated because of possible side effects. These findings stress 
the need for investigating the effectiveness of switching medication, within and 
between similar groups of drugs, after nonresponse. Ideally the effectiveness 
of these different recommended treatment steps, after insufficient treatment 
response to an earlier recommended treatment step, would be investigated in a 
randomized controlled trial. However, expanding the cluster randomized trial 
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as described in paragraph 6.6a, so that treatment results are measured after 
provision of each of the different treatment steps, could provide some insight 
into which sequence of treatment steps could improve effectiveness after an 
insufficient treatment response to one or more of the recommended treatment 
steps. A research project such as this might well be described as very ambitious. 
However, it is not much more ambitious than some of the projects funded by 
the National Institute of Mental Health (NIMH) in the United States (see 
www.nimh.nih.gov/funding/clinical-trials-for-researchers/practical/index.
shtml). Forty-one clinical sites were involved in the well-known STAR*D study 
(Sequenced Treatment Alternatives to Relieve Depression Study) for instance, 
in which medication algorithms were implemented to study treatment response 
to subsequent treatment steps in non-responsive patients who suffered from 
major depressive disorder. Initially more than 4000 depressive patients were 
included in this study, according to the NIMH website. Examples such as 
these suggest that projects such as the one we suggest are indeed feasible with 
sufficient funding. In the future we should be able to predict in advance the 
likelihood of patients having an adequate response to the various treatment 
steps, according to certain patient characteristics (for example, using genetic/
endophenotype profiles). 
6.7. General conclusions and implications for clinical practice 
Although the publication of the guidelines for mental health care in the 
Netherlands initially sparked an interest in their implementation and received 
a big impetus from the national breakthrough projects [3], in more recent 
years this interest seems to have diminished somewhat within specialized 
mental health care. Many mental health institutions nowadays seem to be 
occupied with other recent challenges, such as the large-scale introduction of 
Routine Outcome Monitoring (ROM), the changing financial structure and 
the decreasing budget for mental health care. The more recent development of 
the introduction of clinical care pathways may prove an alternative means for 
increasing the uptake of the recommended guideline interventions.
The budget for research/innovation grants that could help effectuate such 
projects also seems to be diminished. At the same time, one could also expect 
that these exact same developments would fuel the need to start to implement 
guidelines for mental health care on a far larger scale, and provide input to the 
scientific study of such implementation projects. 
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In an era in which health care services are increasingly held fiscally account-
able and efficiency of care is demanded, one would expect healthcare provid-
ers to embrace evidence-based practice guidelines more often because they 
provide for transparency in care. In paragraph 1.3 it was stated that the imple-
mentation of guidelines might be especially effective in the treatment of less 
complex psychiatric disorders, for which several potent evidence-based treat-
ment options exist. It has been shown that the results of implementation stud-
ies for severe mental illnesses, such as schizophrenia, are not entirely positive 
[13]. The results of our study on implementing guidelines for anxiety disorders 
are in line with the results of several newer studies on implementing guidelines 
for major depressive disorders that report positive results [14, 15, 16, 17]. Taken 
together, this line of research suggests that the implementation of practice 
guidelines, especially for affective disorders in clinical practice, is possible and 
also worthwhile. We would advise guidelines for this group of disorders to be 
implemented on a far larger scale. An essential prerequisite for achieving such 
a large-scale implementation is that insurance companies allow sufficient treat-
ment durations for these recommended treatment options to be put in effect, 
preferably in primary care so that the first recommended treatment steps can 
be provided according to the guidelines.
At this time the existing evidence suggests that a systematic, tailor-made 
approach to guideline implementation seems to offer the best likelihood of 
successful implementation. Selected implementation interventions should 
target specific barriers to implementation, or match certain factors that could 
promote guideline adherence in a given context. We found the recommended 
implementation steps suggested by Grol and Wensing [18] to be very helpful. 
Measuring healthcare provider performance and the regular provision of feed-
back seem to be critical components of this implementation approach, and an 
essential prerequisite to being able to adjust the implementation approach if 
necessary. As mentioned before, we developed several practical tools that can 
be helpful and can easily be borrowed from our study since they were made 
freely available through publications which should make it easier for others to 
implement the guidelines for the treatment of anxiety disorders [7, 8, 9]. 
For clinical practice it seems important to keep in mind that the implementa-
tion of practice guidelines for anxiety disorders and probably the implementa-
tion of guidelines in general require a deliberate approach and intensive effort 
that should be maintained for a substantial length of time. Maintenance of the 
established implementation results over the longer term might prove especially 
challenging. Health care organizations should try to integrate healthcare 
van Dijk_Proefschrift Anxiety Disorders_v5_170x240.indd   123 03/10/2014   23:46
124 Multidisciplinary Guidelines for the  treatment of Anxiety Disorders
provider performance measures and use process indicators in a regular feed-
back loop, in addition to measures of treatment outcome. In this way they will 
be better able to understand variations in treatment results while patient char-
acteristics remain constant. Subsequently, they have the ability to intervene 
in a timely fashion if important deviations from the care recommended by 
the guidelines are detected. Proper adherence to the guidelines and possible 
challenges to doing so should also be a topic of regularly held team meetings. 
Newcomers to a treatment unit should be educated on the content and proper 
usage of the guidelines. It seems wise to standardize this type of training and 
to offer it on a regular basis to keep all health care providers well-informed. 
Our research showed the guidelines to be highly applicable to most patients 
seen in clinical practice. In the study described in Chapter 3 only very few 
cases were identified where it was established that none of the guideline-rec-
ommended treatment options could be provided, after interpreting the justi-
fications for deviating from guideline recommendations recorded in patient 
records by the healthcare providers involved. As we did not find predictors 
to identify patients who run a clear risk of treatment non-response, we may 
conclude that we should be reluctant to deny a patient treatment according 
to the guidelines beforehand. Even in patients with various types of comorbid 
conditions it was possible to deliver at least some of the recommended treat-
ment steps. If necessary it may be better to augment treatment according to the 
guidelines with additional supportive interventions, rather than withholding 
treatment altogether. The help of a psychiatric nurse or referral to a crisis 
support service do not necessarily have to preclude treatment according to 
guidelines. Of course, in these instances, proper coordination of care might 
become more challenging.
In conclusion, the combined results of our research project suggest: 1) that 
the implementation of guidelines for the treatment of anxiety disorders in 
specialized mental health care is feasible; 2) that adhering to anxiety disor-
der guidelines is worthwhile; 3) that the implementation of anxiety disorder 
guidelines in this setting is effective (especially in the shorter run) and might 
possibly improve efficiency as well; and 4) that no patient should be denied 
treatment according to these guidelines as long as any barriers to treatment 
attendance are properly accounted for and care is taken to motivate patients 
who may be reluctant to switch therapies after a first treatment non-response 
especially in males, because no other factors were identified that could reliably 
predict treatment non-response or persisting functional impairments. 
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Chapter 7
Summary
Scientific studies have demonstrated unequivocally that evidence-based health-
care interventions generally take far too long to be implemented in practice. 
Such delays could undermine the efficacy of treatment and thus place patients 
at a disadvantage. Moreover, potentially sub-optimal interventions will place 
an unnecessary strain on the healthcare budget and therefore on society as a 
whole. This problem could be solved by applying treatment guidelines, system-
atically developed standards that enable the results of scientific research to be 
translated into concrete recommendations for the treatment of specific disor-
ders. 
Since 2003, fifteen disorder-specific multidisciplinary guidelines have been 
published for the treatment of various psychiatric problems in the Netherlands. 
Indeed, the Dutch are front-runners in the development of guidelines for the 
treatment of mental health disorders. But these guidelines have not escaped 
criticism. For example, some critics question the value of adopting the medical 
model with DSM-IV diagnostic classifications as a starting point. Others argue 
that too much attention is paid to treatments that have proven efficacious in 
studies and not enough to practical experience: as the populations for efficacy 
studies are often subject to stringent selection criteria, the external validity of 
the results is limited. 
The implementation of treatment guidelines is a challenge – which poses 
an underlying question. Will adherence to treatment guidelines actually pay 
off in general terms? This thesis focuses on the implementation of treatment 
guidelines for patients with anxiety disorders. The anxiety disorders in DSM-IV 
represent a phenomenally wide range of psychological conditions, all charac-
terized by frequent, excessive and irrational feelings of anxiety and/or fear, 
which lead to suffering and disability. With an estimated 1.3 million sufferers, 
anxiety disorders are among the most prevalent psychiatric conditions in the 
Netherlands and a drain on the healthcare system. At the start of this PhD proj-
ect, no research had been conducted on even the implementation of treatment 
guidelines for this patient population, let alone their effectiveness. 
The thesis answers the following questions: 
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1)  Is it feasible to implement the Dutch multidisciplinary guidelines for anxi-
ety disorders in everyday clinical practice and, if so, what kind of implemen-
tation strategy can be helpful in doing so? 
2)  Would adherence to these guidelines deliver better results than non-adher-
ence?
3)  Would active and systematic implementation of multidisciplinary guidelines 
for anxiety disorders go hand in hand with better adherence to these guide-
lines and better healthcare results as opposed to passive dissemination?
4)  Is it possible to predict which patients with an anxiety disorder will not 
respond to treatment in accordance with the guidelines and which patients 
will retain functional impairments?
Chapter 2 reports a case study that sought to determine whether the guidelines 
for treating anxiety disorders can be implemented in everyday mental health-
care practice and to identify the most effective ways of achieving this. The 
guidelines were systematically implemented in an ambulant team that treated 
anxiety disorders. This team, consisting of 16 professionals from different disci-
plines with varying degrees of seniority, formed part of a second-line treatment 
setting in Almelo. It applied Grol and Wensing’s stepped implementation plan, 
which consisted of a diagnostic analysis at baseline (prior to implementation), 
the formulation of goals, and a specifically chosen combination of implemen-
tation strategies. The effects were monitored regularly, so that any necessary 
adjustments could be made along the way. The aim each time was to deliver a 
tailor-made programme based on the chosen implementation strategies and to 
evaluate the outcomes for the desired effect.
One important tool in the implementation was a set of process indicators, 
which was developed with input from members of the Dutch Knowledge 
Centre for Anxiety and Depressive Disorders (NEDKAD). The indicators took 
information from patient files in order to measure how far the main treatment 
steps in the guidelines had been applied properly. Another important tool was 
a newly compiled questionnaire for determining where the professionals stood 
with regard to the different constructs from the Theory of Planned Behaviour. 
The ultimate aim was to identify facilitative and impeding factors in the imple-
mentation. Five actions were eventually defined for the plan-do-check-act cycle: 
1) Reorganize the care process so that the treatment plan is drawn up by the 
coordinator of the treatment team and not the intaker (who comes from an 
intake team); 2) Develop and disseminate instructions for care workers and 
patients about the recommended treatment in accordance with the guide-
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lines; 3) Organize instruction sessions to discuss the content of the guidelines 
and the scope of the recommendations; 4) Train professionals in the skills 
required for proper application of the guidelines; 5) Measure regularly the 
extent to which the interventions are actually applied. The fifth action figured 
in the discussions on the treatment plan between individual care workers and 
the coordinator and in the feedback sessions with the entire treatment team. 
These sessions were held every few months to co-evaluate the progress of the 
project and to identify new areas of treatment. 
A comparison of the results in the files of 150 patients who were treated in 
the anxiety disorder team prior to implementation with those of 181 patients 
who were treated in the same team after implementation pointed to significant 
improvements in adherence to the main recommendations in the guidelines. 
This demonstrates that it is possible to implement guidelines in a team that 
treats patients with anxiety disorders in a clinical setting. A stepped approach 
turned out to be useful here as it allowed specific obstacles to be addressed 
with tailor-made interventions. 
Chapter 3 reports a study in which the treatment results were determined for 
anxiety disorder patients who were incorporated in the study after the guide-
lines had been implemented in Almelo. The aim was to ascertain whether 
adherence to the guidelines delivered better results. After one year the treat-
ment results for 81 patients among whom the guidelines had been adhered 
to were compared with those of 58 patients among whom the guidelines had 
not been adhered to. The reduction in symptoms for the patients where the 
main guidelines had been adhered to was significantly greater than for the 
patients where they had not been adhered to. No significant difference in 
improvements to quality of life was found between the two groups. The group 
where the guidelines had been adhered to were, however, more satisfied with 
the treatment than the other group. The number of treatment contacts was 
also smaller in the group where the guidelines had been adhered to. The 
study concluded that the guidelines would be applicable to 87% of patients. 
Adherence to the guidelines can therefore lead to better results and more 
efficient healthcare. The study also showed that the recommendations in the 
guidelines can be applied across a broad spectrum. 
Chapter 4 presents the results of a study which compared the cohort of patients 
from Almelo, who were included after the start of the implementation, with 
a cohort that was treated in a similar setting in Amsterdam, where the guide-
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lines were disseminated only among the care workers that were employed 
there. The Amsterdam patients were part of the NESDA study (Netherlands 
Study on Depression and Anxiety). The aim of this comparative study was to 
ascertain whether systematic implementation of the guidelines – as described 
in Chapter 2 – would lead to better adherence and better treatment results 
than just passive dissemination. As the NESDA study was limited to patients 
with a primary diagnosis of panic disorder with or without agoraphobia, social 
phobia or generalized anxiety disorder, only patients with the same diagnosis 
were selected from the Almelo cohort for comparison. After a year of treat-
ment it appeared that adherence to the main treatment recommendations was 
greater for patients in the treatment setting where the guidelines were system-
atically implemented (intervention condition). After a year, the responses to a 
questionnaire indicated a significantly stronger decline in anxiety symptoms 
for the patients in the intervention condition than for the patients in the 
control condition. After two years, however, this significant difference had 
disappeared; presumably because more patients in the control condition had 
been treated for a longer period of time. No difference was found between the 
two conditions for a decline in comorbid depressive disorders. These results 
suggest that if the guidelines were better applied, there would be opportunities 
for further improvements in the care outcomes. The conclusion is that system-
atic implementation of the anxiety treatment guidelines can improve the qual-
ity and possibly also the efficiency of healthcare. 
Chapter 5 presents the results of a study on the possibility of predicting unfa-
vourable outcomes for the group of 81 patients from Almelo where the guide-
lines were adhered to. The aim was to determine which patients with an 
anxiety disorder would not respond to treatment and which patients would 
retain functional impairments after one year of treatment in accordance with 
the guidelines. The predictive value of variables which had been shown in 
another study to be capable of influencing the treatment prognosis for patients 
was examined. Typical examples were age, gender, ethnic origin, educational 
background, working situation, income, motivation for treatment, motives for 
secondary gains, the existence of a comorbid depressive disorder, a comorbid 
anxiety disorder or a comorbid personality disorder, and the level of satisfac-
tion with the accessibility of the care. The stepped selection procedure for 
developing a predictor of non-response to treatment delivered a model with 
only gender and motives for secondary gain as predictive variables. The like-
lihood of non-response to treatment after a year was slightly greater among 
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men and – surprisingly – smaller among patients with a secondary motive for 
seeking help. The predictive value of this model for non-response to treatment 
turned out to be very limited. The stepped selection procedure for developing 
a predictor of lasting functional impairments delivered a model with gender, a 
comorbid anxiety disorder, and satisfaction with the accessibility of the health-
care as predictive variables. The likelihood of lasting functional impairments 
after one year was greater among men and patients who were dissatisfied with 
the accessibility of the healthcare and smaller among patients with a comorbid 
anxiety disorder. The results indicate that this model, with its three predictive 
variables, is perfectly capable of distinguishing between patients with a greater 
or smaller likelihood of lasting functional impairments after one year. The 
conclusion for the time being is that, when we measure the outcomes on the 
basis of a response to treatment, it is not yet possible to predict which clients will 
not sufficiently benefit from treatment in accordance with the guidelines. This 
implies, at the same time, that with the current knowledge, there is little reason 
to deny such treatment to someone with an anxiety disorder as a primary diag-
nosis. To preclude long-term disability the care services should take on board 
the problems some people experience when trying to gain access to healthcare. 
Home visits or E-health interventions could offer a way forward in such cases. 
Chapter 6 draws together and discusses the results of different subsidiary stud-
ies. It is difficult to draw definite and hard causal conclusions from these stud-
ies, since they were observational in nature. Follow-up research on the imple-
mentation of guidelines for the treatment of anxiety should take the form of 
a multi-centre, cluster-randomized, controlled experiment. It would also be 
useful to look into the added value of offering the successive recommended 
treatment steps in the guidelines. Ideally, better predictors of the success of the 
different treatment steps should be developed as more knowledge in this area 
would further improve healthcare efficiency. 
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Samenvatting: De toepasbaarheid en 
 effectiviteit van de Nederlandse multi-
disciplinaire richtlijnen voor de  behandeling 
van angststoornissen in de dagelijkse 
 klinische praktijk
Introductie (hoofdstuk 1). Studies maken duidelijk dat bewezen effectieve inter-
venties in de regel in een veel te laag tempo tot de zorgverleningspraktijk 
doordringen. Dit heeft nadelige consequenties voor patiënten doordat behan-
delresultaten kunnen tegenvallen. Als gevolg van het aanbod van mogelijk 
suboptimale interventies worden ook onnodig hoge ziektekosten gemaakt, 
hetgeen vooral nadelig is vanuit maatschappelijk perspectief. Een oplossing 
voor dit probleem vormt de ontwikkeling van behandelrichtlijnen. Binnen 
deze systematisch ontwikkelde standaarden wordt de vertaalslag gemaakt van 
resultaten uit wetenschappelijk onderzoek naar concrete aanbevelingen voor 
het handelen bij een bepaalde aandoening. 
Sinds 2003 zijn inmiddels 15 van dergelijke stoornis specifieke multidisci-
plinaire richtlijnen voor de behandeling van diverse psychiatrische problemen 
gepubliceerd. Waar het gaat om de ontwikkeling van behandelrichtlijnen voor 
de Geestelijke gezondheidszorg (GGZ), behoort Nederland daarmee tot de 
koplopers. Deze richtlijnen zijn echter niet vrij van kritiek. Er worden verschil-
lende tekortkomingen genoemd. Het medisch model als uitgangspunt met de 
DSM-IV classificaties als aangrijpingspunt voor de ontwikkeling van de richt-
lijnen worden door sommigen bijvoorbeeld niet als optimaal gezien. Een andere 
tekortkoming zou de eenzijdige nadruk zijn op behandelingen die bewezen 
effectief zijn, zonder recht te doen aan ervaringen vanuit de praktijk. Doordat 
effectiviteit vaak onderzocht wordt in efficacy studies met streng geselecteerde 
onderzoekspopulaties, zou de externe validiteit van de resultaten beperkt zijn. 
De implementatie van behandelrichtlijnen vormt een uitdaging, waarbij een 
belangrijke vraag is of het nastreven er van in algemene zin ook daadwerkelijk 
de moeite waard is. In dit proefschrift ligt het focus op de implementatie van 
behandelrichtlijnen voor patiënten met een angststoornis. De groep van angst-
stoornissen zoals onderscheiden binnen de DSM-IV omvat een fenomenologi-
sche diverse groep van psychische stoornissen, waarbij de patiënten die hier 
aan lijden als centraal kenmerk delen dat sprake is van frequent voorkomende, 
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overmatige en onredelijke angstgevoelens en/of buitensporige vrees, welke 
een duidelijk lijden en invalidatie met zich meebrengen. De schattingen zijn 
dat in Nederland ongeveer 1, 3 miljoen mensen aan een angststoornis lijden. 
Angststoornissen behoren daarmee tot de meest voorkomende psychiatrische 
stoornissen en gaan gepaard met een grote ziektelast. Ten tijde van de start van 
het onderzoeksproject, waarvan dit proefschrift verslag doet, bestond er geen 
onderzoek naar de mogelijkheid richtlijnen voor deze patiëntenpopulatie te 
implementeren laat staan naar de effectiviteit van een dergelijke implementa-
tie. 
Onderhavig proefschrift geeft antwoord op de volgende onderzoeksvragen: 
1)  Is het mogelijk de Nederlandse multidisciplinaire richtlijnen voor angst-
stoornissen in de dagelijkse klinische praktijk te implementeren en welke 
aanpak is daarbij behulpzaam? 
2)  Levert het naleven van deze richtlijnen superieure uitkomsten op vergele-
ken met niet naleven van deze richtlijnen?
3)  Gaat actieve en systematische implementatie van de multidisciplinaire 
richtlijnen voor angststoornissen gepaard met betere adherentie aan deze 
richtlijnen en met betere uitkomsten van zorg, vergeleken met passieve 
disseminatie?
4)  Is het mogelijk te voorspellen welke patiënten met een angststoornis niet 
zullen reageren op een behandeling volgens de richtlijn en welke patiënten 
functionele beperkingen zullen blijven houden?
In hoofdstuk 2 wordt verslag gedaan van een casestudie waarmee getracht is 
antwoord te vinden op de vraag of de richtlijnen voor angststoornissen in de 
alledaagse praktijk van de GGZ geïmplementeerd kunnen worden. Onderzocht 
werd wat effectieve manieren zijn om dit voor elkaar te krijgen. De richtlijnen 
werden systematisch geïmplementeerd binnen een ambulant behandelteam 
voor angststoornissen. Dit team vormde onderdeel van een tweedelijns behan-
delsetting in Almelo, bestaande uit 16 professionals van verschillende disci-
plines en niveau van senioriteit. Er werd gebruik gemaakt van de stapsgewijze 
aanpak voor implementatie beschreven door Grol en Wensing. Hierbij wordt 
na een diagnostische analyse van de uitgangssituatie voor implementatie en 
het formuleren van veranderdoelen, een gerichte keuze gemaakt werd voor 
een combinatie van implementatie-strategieën. Het effect werd met regelmaat 
gemonitord. Uitkomsten van het periodieke monitoren, konden aanleiding 
vormen om het implementatie plan bij te stellen. 
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Een belangrijk hulpmiddel bij de implementatie was een set van procesin-
dicatoren. Deze indicatoren werden ontwikkeld door input van leden van het 
NEDerlands Kenniscentrum voor Angst en Depressie (NEDKAD). De indica-
toren werden gebruikt om met de informatie uit de dossiers van patiënten een 
indruk te krijgen van de mate waarin de belangrijkste aanbevolen behandel-
stappen uit de richtlijnen goed toegepast werden. Een ander belangrijk hulp-
middel vormde een nieuw ontwikkelde vragenlijst voor het in kaart brengen 
van de positie van de professionals op de verschillende constructen uit de theo-
rie van planmatig handelen, zodat belemmerende en bevorderende factoren 
voor de implementatie in kaart gebracht konden worden. Als onderdeel van 
de gevolgde plan-do-check-act cyclus bij de implementatie werden uiteindelijk 
de volgende interventies gebruikt: 1) Reorganisatie van het zorgproces waarbij 
niet langer de intaker, als lid van een apart intake-team, maar de behandel-
coördinator van het behandelteam voor angststoornissen verantwoordelijk 
werd voor het opstellen van het behandelplan; 2) Het ontwikkelen en versprei-
den van instructie materiaal voor hulpverleners en patiënten over de aanbevo-
len behandelingen volgens de richtlijnen; 3) Organisatie van instructiebijeen-
komsten om de inhoud van de richtlijnen en de reikwijdte van de richtlijnaan-
bevelingen te bespreken; 4) Het trainen van professionals in relevante vaar-
digheden om de richtlijnen goed te kunnen toepassen; 5) Het routine matig 
vaststellen van de mate waarin aanbevolen interventies daad werkelijk werden 
toegepast. Dit laatste als onderdeel van de behandelplanbesprekingen op het 
niveau van de individuele hulpverleners met de behandelcoördinator en ook 
als onderdeel van feedbacksessies met het hele behandelteam. Deze sessies 
vonden telkens plaats na enkele maanden om de gezamenlijk de voortgang van 
het project te evalueren en om nieuwe aandachtspunten voor het handelen te 
bepalen . 
Op grond van de vergelijking van de resultaten van dossieronderzoek uitge-
voerd bij 150 patiënten die werden behandeld binnen het angststoornissen 
team voor de start van de implementatie van de richtlijnen en 181 patiënten 
die werden behandeld binnen dit zelfde team na de start van de implementatie, 
werden significante verbeteringen vastgesteld bij het naleven van de belangrijk-
ste kernaanbevelingen volgens de richtlijn, waarop een verbetering werd nage-
streefd. Dit vormt een bewijs dat implementatie van richtlijnen in een behan-
delteam dat zich richt op patiënten met angststoornissen in een praktijksetting 
mogelijk is. Een stapsgewijze implementatie aanpak lijkt hierbij behulpzaam te 
zijn. Bij deze aanpak worden met op maat gemaakte interventies de specifieke 
knelpunten aangepakt. 
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In hoofdstuk 3 wordt verslag gedaan van een beloopstudie waarin de uitkom-
sten van zorg vastgesteld werden van patiënten, die na de start van de imple-
mentatie van de angstrichtlijnen in Almelo voor de implementatie studie 
geïncludeerd werden. Doel van deze studie was na te gaan of het naleven van 
de richtlijnen superieure uitkomsten oplevert. Na 1 jaar werden daarvoor de 
behandelresultaten van 81 patiënten bij wie de richtlijnen correct waren nage-
leefd, vergeleken met die van 58 patiënten bij wie de richtlijnen ten onrechte 
niet waren nageleefd. Het bleek dat de bereikte klachtenreductie bij de cate-
gorie patiënten bij wie kon worden vastgesteld dat de belangrijkste, door de 
richtlijn voorgeschreven behandelstappen goed waren uitgevoerd, significant 
groter was in vergelijking met de categorie patiënten bij wie bij het zorgaanbod 
van de richtlijnen was afgeweken. Er werd tussen beide groepen patiënten geen 
significant verschil gevonden in verbeteringen in kwaliteit van leven. De groep 
patiënten waarbij de richtlijnen goed waren nageleefd, bleek wel meer tevre-
den te zijn over de gevolgde behandeling in vergelijking met de andere groep. 
Tevens was het aantal behandelcontacten geringer in de groep patiënten die 
correct volgens de richtlijnen behandeld werden. In de studie werd vastgesteld 
dat de richtlijnen bij 87% van de patiënten toepasbaar zouden zijn geweest. 
Het naleven van richtlijnen kan dus tot betere resultaten leiden en kan de zorg 
ook efficiënter maken. Tevens laat de studie zien dat de aanbevelingen uit de 
angstrichtlijnen breed toepasbaar zijn. 
In hoofdstuk 4 worden de resultaten van een studie gepresenteerd waarin het 
cohort patiënten uit Almelo, geïncludeerd na de start van de implementa-
tie van de richtlijnen, vergeleken werd met een cohort patiënten dat werd 
behandeld binnen een vergelijkbare behandelsetting in Amsterdam alwaar de 
angstrichtlijnen alleen verspreid waren onder de daar werkende hulpverleners. 
De Amsterdamse patiënten waren geïncludeerd in de NESDA studie. Doel 
van deze vergelijkende studie was te bepalen of systematische implementatie 
van de angstrichtlijnen - zoals beschreven in hoofdstuk 2 - gepaard zou gaan 
met een betere adherentie aan deze richtlijnen en betere behandel resultaten, 
vergeleken met de situatie dat alleen passieve disseminatie van de richtlijnen 
plaatsvindt. Omdat in de NESDA studie alleen patiënten geïncludeerd werden 
die leden aan een primaire diagnose paniekstoornis met of zonder agorafobie, 
sociale fobie of gegeneraliseerde angststoornis, werden uit het Almelose cohort 
alleen deze patiënten geselecteerd voor de vergelijking. Na een jaar behande-
ling bleken de richtlijnen voor wat betreft de belangrijkste aanbevolen behan-
delstappen vaker nageleefd te worden bij patiënten behandeld binnen de 
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setting waar systematische implementatie van de richtlijnen plaatsvond (actieve 
conditie). Na een jaar lieten patiënten in de actieve conditie een significant 
sterkere daling zien op een vragenlijst voor het meten van angstklachten dan 
de patiënten in de controle conditie. Na twee jaar was dit significante verschil 
echter verdwenen, vermoedelijk omdat de patiënten uit de controle conditie 
vaker langer doorbehandeld werden. Er werd geen verschil tussen beide condi-
ties gevonden voor wat betreft de afname van comorbide depressieve klach-
ten. Deze resultaten suggereren dat als richtlijnen beter worden toegepast er 
ruimte is voor verdere verbetering van de resultaten van de zorg. De conclusie 
is dat systematische implementatie van de angstrichtlijnen de kwaliteit van de 
zorg en mogelijk ook de efficiëntie ervan kan verbeteren.
In hoofdstuk 5 worden de resultaten gepresenteerd van een studie waarin geke-
ken is naar de mogelijkheid om ongunstige uitkomsten van zorg te voorspellen 
bij de groep van 81 patiënten uit Almelo, waarbij vastgesteld kon worden dat de 
angstrichtlijnen goed waren nageleefd. Doel van het onderzoek was om vast te 
stellen of het mogelijk is te voorspellen welke patiënten met een angststoornis 
niet zullen reageren op een behandeling volgens de richtlijn en welke patiënten 
functionele beperkingen zullen blijven houden na 1 jaar behandeling, terwijl 
zij wel een behandeling volgens de richtlijnen hebben gehad. De voorspel-
lende waarde van variabelen waarvan uit ander onderzoek bekend is dat ze de 
behandelprognose van patiënten met een angststoornis kunnen beïnvloeden 
werden in deze studie onderzocht. Voorbeelden van dergelijke variabelen zijn: 
leeftijd, geslacht, allochtone afkomst, opleidingsniveau, arbeidssituatie, inko-
men, motivatie voor behandeling, aanwezigheid van motieven voor secundaire 
winst, de aanwezigheid van een comorbide depressieve stoornis, een comorbide 
angststoornis of een comorbide persoonlijkheidsproblemen en de mate van 
tevredenheid met de toegankelijkheid van de zorg. De stapsgewijze selectie-
procedure voor het ontwikkelen van een predictie-model voor behandel non-
respons, leverde een model op met alleen geslacht en aanwezigheid van motie-
ven voor secundaire ziektewinst als voorspellende variabelen. Mannen hadden 
een iets grotere kans op een behandel non-respons na 1 jaar en patiënten met 
een nevenmotief bij het zoeken van hulp verrassen genoeg een kleinere kans. 
De voorspellende waarde van dit predictie model voor behandel non-respons 
bleek echter zeer beperkt te zijn. De stapsgewijze selectieprocedure voor het 
ontwikkelen van een predictie model voor blijvende functionele beperkingen, 
leverde een model op met geslacht, de aanwezigheid van een comorbide angst-
stoornis en tevredenheid met de toegankelijkheid van zorg als voorspellende 
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variabelen. Mannen leken een grotere kans op blijvende functionele beper-
king te hebben na 1 jaar en patiënten met een comorbide angststoornis een 
kleinere kans. Patiënten die ontevreden zijn met de toegankelijkheid van de 
zorg, hadden een grotere kans op blijvende functionele beperkingen. De mate 
waarin dit model met deze 3 voorspellende variabelen in staat lijkt onderscheid 
te maken tussen patiënten die een kleine dan wel grote kans lijken te hebben 
op blijvende functionele beperkingen na 1 jaar, blijkt op grond van de gevon-
den resultaten uitstekend. De conclusie moet voorlopig zijn dat het vooralsnog 
slecht mogelijk is te voorspellen welke cliënten onvoldoende van een behande-
ling volgens de richtlijnen zullen profiteren. Dit als gekeken wordt naar het 
optreden van behandelresponse als uitkomstmaat. Dit suggereert gelijktijdig 
dat met de huidige kennis er dus ook weinig reden is iemand met een angst-
stoornis als primaire diagnose, een dergelijke behandeling te onthouden. 
Vanuit het perspectief van het voorkómen van langdurende invaliditeit lijkt 
daarbij als aangrijpingspunt voor de hulpverlening vooral rekening gehouden 
te moeten worden met eventueel ervaren problemen bij de toegankelijkheid 
van zorg. Het aanbieden van huisbezoeken of de inzet van E-health interventies 
zou in die voorkomende gevallen wellicht uitkomst kunnen bieden 
In hoofdstuk 6 worden de resultaten van verschillende deelstudies samenge-
vat en besproken. Uit het huidige onderzoek kunnen moeilijk harde causale 
conclusies getrokken worden. Dat komt door het observationele karakter van 
de studies. Vervolgonderzoek naar de implementatie van de angstrichtlijnen 
zal opgezet moeten worden als een multicenter, cluster-gerandomiseerd, 
gecontroleerd experiment. Het lijkt voor de toekomst ook zinvol de toege-
voegde waarde van het aanbieden van de opeenvolgende aanbevolen behan-
delstappen uit de richtlijn te onderzoeken. Idealiter zou er daarbij ook gekeken 
worden naar betere voorspellers van het behandelsucces, van de verschillende 
aanbevolen behandelstappen. Kennis hierover zou de doelmatigheid van zorg 
immers verder kunnen verbeteren. 
In hoofdstuk 7 wordt de Engelstalige samenvatting van dit proefschrift gegeven. 
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Mensen die geen weet hebben van mijn interesse in de Japanse geschiedenis 
en dan vooral die van de Japanse krijgskunsten, zal de keuze voor een Japanse 
prent op de omslag wellicht verbazen. De anderen daarentegen zouden zich 
kunnen verwonderen over de keuze voor de specifieke prent van een karper 
die tegen een waterval opzwemt. Het is niettemin een weldoordachte keuze. 
De karper die tegen een waterval opzwemt wordt in Japan geassocieerd met 
moed, doorzettingsvermogen, wijsheid, geluk, en succes. Het is inmiddels mijn 
ervaring dat de implementatie van richtlijnen in de ggz, moed, doorzettings-
vermogen, wijsheid en geluk vraagt om deze succesvol te laten zijn, hetgeen de 
zwemmende karper een passende metafoor maakt. 
De genoemde kwaliteiten zijn evenzeer onontbeerlijk geweest bij mijn 
persoonlijke tocht van de afgelopen 10 jaar, waarvan deze dissertatie het 
eindpunt vormt. Ook daarom sprak het beeld op de omslag mij zo aan. Mijn 
enthousiasme voor mijn vak kende de afgelopen jaren nauwelijks grenzen. 
Eigenlijk ben ik na mijn afstuderen daarbij voortdurend nieuwe uitdagingen 
aangegaan, waaronder het combineren van hulpverleners- en onderzoeksta-
ken, het volgen van diverse opleidingen en uiteindelijk ook het aanvaarden van 
de functie van hoofd van wetenschappelijk bureau bij HSK. De duur van dit 
promotietraject maakt tegelijkertijd duidelijk dat ik mij daarbij uiteindelijk ook 
wel behoorlijk heb verkeken op de hoeveelheid werk, die het aangaan van al 
deze uitdagingen met zich meebracht. Zeker waar het de observationele opzet 
van mijn promotie onderzoek betreft, deden zich de nodige uitdagingen voor 
waar het ging om het geplaatst krijgen van de artikelen waaruit dit proefschrift 
bestaat. Hierbij was het voor mij persoonlijk dan ook heel nadrukkelijk vaak 
een kwestie van tegen de stroom inzwemmen en flink doorzetten. Het beeld 
van de karper op de omslag is daarbij alleen misleidend in die zin dat deze 
karper toch wel erg alleen is in zijn tocht omhoog. Dit in tegenstelling tot de 
steun en hulp die van velen heb ontvangen bij het succesvol afronden van het 
proefschrift. Ik kan oprecht zeggen dat ik zonder de betrokkenheid van de 
meeste van deze personen zelfs helemaal nooit tot de afronding van dit promo-
tieonderzoek gekomen zou zijn. 
Allereerst ben ik dankbaar voor alle patiënten die bereid waren aan het 
onderzoek mee te werken. De medewerking van het team hulpverleners uit 
Almelo, waarbinnen de angstrichtlijnen geïmplementeerd werd, was uiteraard 
ook essentieel. Zonder ieder van deze hulpverleners apart bij naam te noemen, 
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weet dat ik enorm waardeer dat jullie geregeld uit jullie comfortzone traden door 
te proberen gedisciplineerd de angstrichtlijnen te volgen. Hoewel dit nergens 
expliciet in dit proefschrift beschreven staat weet ik dat voor sommigen de 
gunfactor naar mij toe daarbij een belangrijke motivatie was. Mijn dank aan 
deze hulpverleners uit Almelo is daarom extra groot. Ik hoop dat dit proef-
schrift in ieder geval duidelijk maakt dat jullie werk hierin niet onbeloond is 
gebleven getuige de positieve resultaten die het heeft opgeleverd! 
Uiteraard ben ik daarbij ook dankbaarheid verschuldigd aan Adhesie en het 
latere Dimence, voor het faciliteren van mijn onderzoek. Specifiek gaat mijn 
dank hierbij uit naar de voormalige directie in de personen van Roelof ten 
Doesschate, Peter Koopman en Sybren Bangma. Dank voor de kans die mij 
geboden werd, om het onderzoek uit te voeren waar deze dissertatie verslag 
van doet en voor de interesse in het verloop van het traject gedurende onze 
samenwerking. Peter Goossens ben ik erkentelijk, die als penningmeester de 
verantwoordelijkheid had om toe te zien op de juiste besteding van het onder-
zoeksgeld voor het project.  
In dit kader moet zeker ook HSK genoemd worden als sponsor van het 
promotietraject gedurende de laatste jaren waarin ik aan de afronding ervan 
heb gewerkt en als voornaamste financier van de kosten voor het opmaken en 
drukken van mijn proefschrift. Bij HSK werd ik aangenomen in de verwachting 
dat de afronding van mijn proefschrift nog slechts een jaar zou duren. Het 
werden er veel meer. Ik ben de directie, in het bijzonder in de personen van 
Eddy van Doorn en vooral ook Marc Verbraak, erg dankbaar voor de finan-
ciële ondersteuning die ik kreeg en het geduld. Maásja Verbraak en Patrick 
de Lusenet als mijn managers bij mijn werk als therapeut, ben ik hierbij zeer 
erkentelijk voor hun flexibiliteit waar het ging om de organisatie van mijn 
therapie-uren. Zeker in de laatste fase hielp het me om flinke slagen te maken 
bij het schrijven van de artikelen van mijn proefschrift, als ik mij weer eens 
een week thuis kon terugtrekken om te schrijven. Dank daarvoor! Ook kon ik 
aanspraak maken op extra middelen voor onderzoeksuren vanuit GGZinGeest 
en het VUmc; ook daarvoor mijn erkentelijkheid! 
Dit onderzoek zou er uiteindelijk in het geheel niet zijn geweest zonder de 
financiële steun van het OOG-programma, behorend bij Geestkracht van 
ZonMw.Als beoogd bruggenbouwer tussen de zorgverleningspraktijk en de 
wetenschap werd mij een subsidie toegekend die het startpunt vormde van het 
onderzoek. Ik hoop dat ik met dit proefschrift en mijn huidige werk die eer 
inmiddels recht doe! 
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Heel veel dank gaat uit naar mijn begeleidingscommissie, bestaande uit Prof. 
Dr. Ton van Balkom, Prof. Dr. Marc Verbraak en Dr. Desiree Oosterbaan. Ton 
van Balkom als eerste promotor ben ik erg dankbaar voor het feit dat hij met 
mij al die tijd heeft doorgezet en voor alle geboden steun die nodig was om 
het traject succesvol af te ronden. Beste Ton, ik heb veel van je mogen leren 
over wetenschappelijk onderzoek, vooral ook waar het soms ook gaat om het 
hanteren van een gezonde vorm van pragmatisme. Waar ik de neiging heb om 
erg gedetailleerd te zijn in het schrijven van mijn artikelen om daarmee geen 
nuance ongenoemd te laten, zal ik nooit vergeten dat je me de opdracht gaf om 
eens naar mijn werk te kijken zoals je ernaar zou kijken vanaf de maan. Dank 
ook in dit verband voor al het kritische revisie werk aan mijn stukken, zeker ook 
in de latere fase van mijn promotietraject en je begeleidende rol op afstand. 
Mijn dank aan Desireé Oosterbaan als copromotor en dagelijks begeleider is 
eveneens zeer groot. Beste Desireé, zeker na het vertrek van Marc bij Adhesie 
was jij de motor die het onderzoek tijdens de fase van de data-verzameling 
draaiende hielp houden. Ik heb je leren kennen als een echte vakvrouw zonder 
pretenties, met een enorm hart voor haar patiënten. Ook bij het ontwikkelen 
van alle materialen voor het onderzoek was jij een stuwende kracht. Dank voor 
al je enorme hulp bij de totstandbrengingen en het voltooien van dit project. 
Marc Verbraak neemt als tweede promotor een extra bijzondere plaats in. 
Deels vanwege onze gedeelde professionele achtergrond maar vooral omdat 
mijn aspiraties voor dit specifieke promotietraject in de eerste plaats bij jou 
zijn begonnen. Beste Marc, als pas afgestudeerd psycholoog belde ik jou met 
de gewaagde boodschap dat alles wat jij in je werkende leven op dat moment 
deed, datgene was wat ik mijzelf uiteindelijk ook het liefste zag doen. Ik wilde 
ook zorgtaken, wetenschappelijk onderzoek en onderwijstaken combineren. 
Daarbij had ik ook nog de moed om te vragen of je me daarbij op weg kon 
helpen. Wat een geluk dat al mijn wensen wat dat betreft inmiddels voor het 
merendeel in vervulling zijn gegaan. Je hebt wat dat betreft veel meer gedaan 
dan me op weg helpen! Ik dank je voor je indrukwekkende werk bij de totstand-
koming en de voltooiing van dit project, waarbij je bijdrage als behandelcoördi-
nator bij ADAPT ook niet onvermeld mag blijven om met name de psychologen 
in het begin mee te krijgen in het werken in het spoor zoals beschreven in de 
richtlijnen. Dank voor al je vertrouwen in me! Ik kan me verheugen op de extra 
ruimte die de afronding van deze dissertatie gaat opleveren, om nieuwe initia-
tieven te starten vanuit mijn functie als hoofd van het wetenschappelijk bureau 
bij HSK. Ik hoop daarbij ook nog lang met je kunnen blijven samenwerken en 
van je te kunnen blijven leren. 
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Veel dank ben ik ook verschuldigd aan de verschillende studenten en onder-
zoeksassistenten die me hebben bijgestaan bij de praktische taak van de data-
verzameling en data-invoer. In het bijzonder wil ik daarbij bedanken: Matthijs 
Oud, Agnes Blom, Marleen Visser, Mark Roelofs, en Celine Paulissen, die van 
alle helpende krachten wat deze taak betreft de grootste hoeveelheid werk 
verzet hebben. Prof. dr. Brenda Penninx ben ik dankbaar vanwege de mogelijk-
heid om gebruik te kunnen maken van gegevens verzameld binnen de NESDA 
studie en haar bijdrage aan het artikel beschreven in hoofdstuk 6. Dr. Adriaan 
Hoogendoorn ben ik zeer dankbaar voor zijn hulp bij de statistische analyses 
voor de artikelen die in hoofdstuk 5 en 6 beschreven staan. Mijn lieve nicht, 
Marjon van Winkelhof, dank ik voor haar hulp bij het helpen verbeteren van 
het Engels van stukken tekst van dit proefschrift. 
De leden van de leescommissie; Prof. dr. Aartjan Beekman, Prof. dr. Richard 
van Dyck, Prof. dr. Gerrit Glas, Prof. dr. Giel Hutschemaekers, Prof. dr. Aart 
Schene en Prof. dr. Sako Visser ben ik zeer erkentelijk voor het lezen van het 
manuscript en het groene licht dat ze me daarna gaven. 
Hiernaast is er een aantal belangrijke personen, die voor mij meer op de 
achtergrond een rol van betekenis hebben gespeeld gedurende mijn promotie-
traject. Geluk speelde niet alleen een rol bij de totstandkoming en de voltooi-
ing van mijn promotieonderzoek en de daaraan gekoppelde ontwikkeling van 
mijn carrière maar ook in de vorm van dierbare contacten die ik heb opgedaan 
en die een blijvende rol van betekenis spelen in mijn leven. Uit mijn tijd bij 
Adhesie in het Almelose, noem ik daarbij speciaal Sietske van Haren. Lieve 
Sietske, je bent een dierbare vriendin geworden. Onze vriendschap begon met 
gedeelde ambities en een gemeenschappelijke professionele visie, waarna we 
gaandeweg alleen nog maar meer – niet in het minst persoonlijke - raakvlaken 
vonden. Ik hoop dat onze beide gezinnen nog lang met elkaar op mogen trek-
ken. Dank ook voor al je support en meeleven tijdens de uitvoering van mijn 
promotieonderzoek. 
Vanuit mijn werkperiode bij Adhesie in het Deventerse noem ik graag Heleen 
Beumer, Sarah Hecht, Dorine Sanders-Langendijk en Marensia Starke en 
gedenk ik Vico Braeckman. Ik zal nooit het warme onthaal vergeten dat ik van 
jullie ontving toen ik als therapeut de overstap vanuit Almelo naar Deventer 
maakte, vanwege de start van de dataverzameling van mijn onderzoek. Mijn 
werkperiode in Deventer is voor mij als hulpverlener een zeer vormende peri-
ode geweest en een belangrijke fase van mijn leven. Vanuit het Deventerse kon 
ik ook beter met de nodige afstand naar mijn onderzoek kijken. 
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De ontwikkeling van mijn carrière en het onderzoek bracht me ook in 
contact met de bijzonder getalenteerd CGT supervisor, Erik ten Broeke. Beste 
Erik, dat ik je daarbij inmiddels niet alleen als leermeester maar ook tot een 
van mijn meest hechte vrienden mag rekenen, ervaar ik als een groot geluk. 
Ik hoop daarbij dat we nog veel meer lol en plezier zullen hebben samen en 
ook nog vele inspirerende gesprekken. Bijzonder veel dank ook voor het actief 
meeleven in de laatste fase van de afronding van mijn proefschrift. Ik voel me 
gesteund door het feit dat jij net als mijn broer Stephan, mijn paranimf wil zijn. 
Verder ben ik blij met de collega’s op de vestiging Arnhem, die mij na de 
overstap van Dimence naar HSK, als toch wat vreemde eend in de bijt, als 
therapeut op de vestiging inmiddels helemaal thuis doen voelen. Heel dank-
baar ben ik ook voor de zeer prettige samenwerking met alle leden van het 
wetenschappelijk bureau van HSK, met wie ik tot nog toe heb mogen werken. 
Het is met name deze samenwerking geweest, die mij tijdens de laatste zware 
fase van mijn promotietraject hielp om enthousiast te blijven over het doen van 
onderzoek en ik hoop dit enthousiasme nog lang met jullie te kunnen blijven 
delen. Annelies Ekelschot-Manuel, dank voor al je praktische ondersteuning 
ook bij alle lopende onderzoeksprojecten en ook voor je hulp bij mijn promo-
tieonderzoek. 
Aangezien het leven niet alleen om werken kan draaien, is een prettige vlucht 
voor mij ook altijd het contact met vrienden die niets met mijn werk te maken 
hebben. Wezenlijk voor mij zijn daarbij vooral ook mijn vrienden; Bjorn, Imre, 
Joris, Venu, Jasper, Matthijs, Thomas, Stefan, David en Dennis. Dank voor jullie 
kameraadschap! Ik hoop op weer meer contact en tijd om het leven samen te 
vieren! Nu het werk voor mijn promotieonderzoek nu eindelijk klaar is moet 
dat kunnen. 
Bjorn, met name jou wil ik er hierbij nog even apart uitlichten als mijn oudste 
en hechtste vriend. Ik ben blij met de interesse en het respect voor elkaars 
levenswandel; hoe anders lopen onze paden momenteel dan in de tijd dat we 
nog ‘gabber’ waren. Desondanks neem ik jouw oordeel nog als die van geen 
ander serieus en voel je als mijn grootste zielsverwant. Het maakt daarbij niet 
uit dat we aan onze drive en levenslust op zo’n andere manier uiting geven. 
Waar ik niet in de eerste plaats een rol voor je zag als paranimf, vanwege onze 
zo verschillende professionele achtergrond, ben ik wel erg blij dat je mijn eerste 
getuige bij mijn huwelijk zal zijn. Dank voor je bijzondere vriendschap al die 
jaren, waarbij ik wens dat we die nog vele jaren zo zullen voortzetten. 
Nog verder terug naar de basis van mijn bestaan, wil ik stil staan bij mijn 
familie. Lieve ouders, jullie hebben als geen ander meegeleefd. Aan jullie 
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dank ik in de basis het zelfvertrouwen en de drive om de dingen te doen die ik 
doe. Door jullie voorbeeld ervaar ik het geluk van wat het betekent om jezelf 
in te zetten voor het welzijn van je medemens en te werken met je hart en je 
verstand. Dank voor alle steun en liefde, en voor het bijspringen in de zorg 
voor onze jongens. Han dank ik specifiek ook voor zijn vele adviezen als erva-
ren wetenschapper. Lieve Marlene, ik wordt telkens weer getroffen door jouw 
puurheid en je openheid naar de wereld. Het is fijn een zus te hebben waarbij 
de trots altijd zo direct voelbaar is. Lieve Stephan, mijn kanjer van een broer. 
Jij weet als geen ander wat het is om te moeten ploeteren om een promotieon-
derzoek af te krijgen. Het was erg fijn daarin onze ervaringen te kunnen delen. 
Al zien en spreken we elkaar te weinig, ik voel een verwantschap waar niet aan 
te ontkomen valt. Ik ben ook blij dat je mijn paranimf wilt zijn, wetende dat je 
altijd mijn rug zult dekken. Dank ook aan mijn schoonzus Stefanie voor haar 
warme betrokkenheid.
Dankbaar ben ik ook naar mijn schoonfamilie. Ik heb het bijzonder getrof-
fen met mijn zwagers en “schoonzussen”; Matthias, Annelinde, Igor en Megan, 
dank voor jullie support. Lieve schoonouders Nico en Ingrid, altijd waren 
jullie bereid Maria en de kinderen op te vangen in Almere, als toch weer tijd 
gecreëerd moest worden om mij de ruimte geven het boekwerk uiteindelijk 
klaar te krijgen. Jullie waren altijd bereid om in Deventer bij te springen, als 
onverhoopt toch weer een tijdtekort moest worden goedgemaakt. Ik kan mijn 
dankbaarheid hiervoor niet genoeg laten blijken; jullie zijn me goud waard.
Lieve Mats en Jiro, ik acht me gezegend met twee mooie, levenslustige jongens 
zoals jullie. Het vervult me met plezier en trots om jullie te zien opgroeien. 
Vormden jullie nog geen reden om aan mijn promotieonderzoek te beginnen, 
jullie vormden wel mede een reden om het af te ronden en dan vooral ook snel. 
Fijn dat er nu wat meer rust komt zodat ik nog meer van jullie kan genieten. 
Lieve Maria, na mij ben jij - denk ik - degene die het meest op de proef is 
gesteld door mijn inspanningen tijdens dit promotieonderzoek. Zeker sinds 
onze zoons er zijn. Ondanks dat heb je me altijd gesteund. Hoogtepunten en 
dieptepunten tijdens mijn promotietraject heb je met me meebeleefd. Je bent 
mijn eerste steun en toeverlaat. Je hebt altijd in de succesvolle afronding van 
mijn traject geloofd. Ik weet me gezien door jou als door geen ander. Eigenlijk 
zijn er daarbij geen woorden die uitdrukking kunnen geven aan mijn dank-
baarheid daarvoor maar ik zal je dat proberen te laten voelen. Weet dat het 
leven mooier is met jou aan mijn zijde. Nu de ballast van de afronding van het 
proefschrift van me afvalt, is het mijn intentie om nog meer van het leven met 
jou te gaan genieten.
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Maarten Kornelis van Dijk werd op 2 januari 1980 geboren in Groningen. 
De middelbare school volgde hij in Baarn bij de scholengemeenschap Het 
Baarnsch Lyceum, alwaar hij in 1998 zijn VWO-diploma behaalde. Na het 
afronden van de algemene gamma propedeuse bij de Universiteit van Utrecht, 
ging hij bij dezelfde universiteit Klinische en Gezondheidspsychologie stude-
ren. Zijn doctoraal examen psychologie ronde hij uiteindelijk in 2003 af. 
Tijdens zijn studie psychologie deed hij zijn eerste ervaring met het werk in de 
geestelijke gezondheidszorg op. Eerst door vanaf 2000 met grote regelmaat 
als groepsleider in te vallen op diverse verblijfsafdelingen voor kinder en 
jeugdpychiatrie van zorginstelling Zonnehuizen, te Zeist. Later vanaf 2002 als 
invalkracht in de functie van helpende op verschillende klinische afdelingen 
voor volwassenen, binnen Altrecht. 
Vanaf 2004 ging hij ook daadwerkelijk als psycholoog aan de slag binnen 
een ambulant team voor de behandeling van angststoornissen in Almelo, van 
het voormalige Adhesie, nu onderdeel van Dimence. Eind 2004 werd hem een 
subsidie van ZonMw toegekend en begon zijn promotietraject. Dit promotietra-
ject werd gecombineerd met de opleiding tot Gezondheidspsycholoog, in het 
kader waarvan hij breder binnen Dimence werkervaring opdeed en waarbij hij 
in 2008 uiteindelijk zijn BIG-registratie als GZ-psycholoog behaalde. Hij volgde 
min of meer gelijktijdig ook de basis- en vervolgcursus EMDR. Ook ronde hij 
in 2009 met succes het cursorisch gedeelte van de Post-initiële Masteropleiding 
Epidemiologie van het EMGO af. 
Vanaf januari 2010 werkt hij als hoofd van het wetenschappelijk bureau van 
HSK, waarbij hij onderzoek- en zorgtaken met elkaar blijft combineren. Zijn 
ervaring strekt vooral uit naar de behandeling van de zogenaamde ’common 
mental disorders’. Maarten verwacht na afronding van het bijbehorend oplei-
dingstraject in de loop van dit jaar zijn registratie als cognitief-gedragsthera-
peut te behalen, zoals erkend door de Vereniging voor Gedragstherapie en 
Cognitieve therapie (VGCT). Per januari 2013 startte hij met de opleiding tot 
klinisch psycholoog, welke hij eind 2016 zal afronden. 
Maarten woont samen en heeft twee zoons, 1 van 2 en 1 van 4 jaar oud. 
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Appendice 1. 
Process and treatment indicators
Table A. The definitive selection of process indicators for each disorder
Panic 
disorder
Percentage of patients with a panic disorder with co morbid severe depres-
sion and an indication for treatment with an antidepressant, who have been 
prescribed one of the antidepressants recommended in the guideline first of 
all
Percentage of patients with a panic disorder with (moderately) severe agora-
phobia with an indication for treatment with an antidepressant and who were 
prescribed one of the antidepressants recommended in the guideline first of 
all
Percentage of patients with a panic disorder with an indication for treatment 
with an SSRI who have been prescribed an SSRI
Percentage of patients with a panic disorder with an indication for treatment 
with a TCA, who have been prescribed a TCA
Percentage of patients with a panic disorder with (moderately) severe agora-
phobia with an indication for treatment with in vivo exposure, who have been 
offered in vivo exposure
Percentage of patients with a panic disorder with (moderately) severe 
agoraphobia who have been offered in vivo exposure in combination with a 
pharmacotherapeutic treatment
Percentage of patients with a panic disorder without (or with only mild) ago-
raphobia with an indication for treatment with panic-management training, 
who have been offered panic-management training
Social 
phobia
Percentage of patients with a social phobia of the generalized subtype with 
an indication for treatment with an SSRI, who have been prescribed an SSRI
Percentage of patients with a social phobia of the generalized subtype with 
an indication for monotherapy with a benzodiazepine, who have been pre-
scribed monotherapy with a benzodiazepine
Percentage of patients with a social phobia of the specific subtype with an 
indication for treatment with a beta blocker, who have been prescribed a beta 
blocker
Percentage of patients with a social phobia with an indication for treatment 
with in vivo exposure, who have been offered in vivo exposure
Percentage of patients with a social phobia with an indication for cognitive 
therapy, who have been offered cognitive therapy
Percentage of patients with a social phobia of the generalized subtype with 
an indication for following a social skills training, who have been offered a 
social skills training
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Obsessive 
Compulsive 
Disorder
Percentage of patients with OCD with co morbid severe depression and an 
indication for treatment with an antidepressant, who have been prescribed 
one of the antidepressants recommended in the guideline first of all
Percentage of patients with OCD with an indication for treatment with an 
SSRI, whom have been prescribed an SSRI
Percentage of patients with OCD who did not respond to treatment with a 
second SSRI with an indication for treatment with an antipsychotic, whose 
treatment with an SSRI has been supplemented with an antipsychotic
Percentage of patients with OCD with an indication for treatment with clo-
mipramine, who have been prescribed clomipramine
Percentage of patients with OCD with an indication for treatment with 
exposure and response prevention, who have been offered treatment with 
exposure and response prevention
Percentage of patients with OCD with an indication for treatment with cogni-
tive therapy, who have been offered cognitive therapy
GAD Percentage of patients with a generalized anxiety disorder with an indication 
for treatment with paroxetine, who have been prescribed paroxetine
Percentage of patients with a generalized anxiety disorder with an indication 
for treatment with venlafaxine, who have been prescribed venlafaxine
Percentage of patients with a generalized anxiety disorder with an indication 
for treatment with buspiron, who have been prescribed buspiron
Percentage of patients with a generalized anxiety disorder with an indication 
for treatment with cognitive therapy, who have been offered cognitive therapy
Percentage of patients with a generalized anxiety disorder with an indication 
for treatment with exposure, who have been offered treatment with exposure
Percentage of patients with a generalized anxiety disorder with an indica-
tion for treatment with applied relaxation, who have been offered applied 
relaxation
PTSD Percentage of patients with PTSD with an indication for treatment with an 
SSRI, who have been offered an SSRI
Percentage of patients with PTSD with an indication for treatment with a TCA, 
who have been offered a TCA
Percentage of patients with PTSD with an indication for treatment with 
EMDR, who have been prescribed EMDR
Percentage of patients with PTSD with an indication for treatment with imag-
inary exposure, who have been offered treatment with imaginary exposure
Percentage of patients with PTSD with an indication for treatment with cog-
nitive therapy, who have been offered cognitive therapy
Specific 
phobia
Percentage of patients with a specific phobia with an indication for treatment 
with exposure, who have been offered treatment with exposure
Percentage of patients with a specific phobia with an indication for treatment 
with cognitive therapy, who have been offered cognitive therapy
Hypo- 
chondria
Percentage of patients with hypochondria with an indication for treatment 
with cognitive therapy, who have been offered cognitive therapy
Percentage of patients with hypochondria with an indication for treatment 
with exposure and response prevention, who have been offered treatment 
with exposure and response prevention
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Table B.  Treatment indicators applicable when pharmacotherapeutic treatment 
is offered
Percentage of patients with an anxiety disorder who have been prescribed a certain 
type of medication (e.g. a TCA), where it has been decided to prescribe one of the medi-
cations recommended in the guideline (e.g. Clomipramine).
Percentage of patients with an anxiety disorder who have been treated with one of the 
recommended medications and who have been prescribed the medication according to 
the target dosage 
Percentage of patients with an anxiety disorder who have been treated with one of the 
recommended medications and who had been prescribed the medication for the rec-
ommended number of weeks before the effects of the treatment were evaluated
Table C. Treatment indicators applicable when a form of exposure is offered
Percentage of patients with an anxiety disorder who have been offered a form of expo-
sure, and who were given an explanation of the treatment before it began
Percentage of patients with an anxiety disorder to whom a form of exposure has been 
offered and who have been given exposure homework assignments on a consistent 
basis 
Percentage of patients with an anxiety disorder who have been offered a form of expo-
sure and in whom the effect of the treatment was evaluated after they had received it 
for the recommended number of weeks
Table D.  Treatment indicators which are applicable when cognitive therapy is 
offered
Percentage of patients with an anxiety disorder who have been offered a form of cogni-
tive therapy, and who were given an explanation of the treatment before it began
Percentage of patients with an anxiety disorder who have been offered a form of cogni-
tive therapy and who have been given homework assignments associated with this 
therapy on a consistent basis 
Percentage of patients with an anxiety disorder who have been offered a form of cogni-
tive therapy, and in whom the effect of the treatment was evaluated after they had 
received it for the recommended number of weeks
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Appendice 2. 
Questionnaire relating to factors that 
impede or promote the application of 
the anxiety disorder guidelines
Instructions:
The following questionnaire is designed to look at your opinion about using 
the guideline. This is to determine whether in your view there are any partic-
ular problem areas, or whether you see using the guideline as an opportunity. 
This information will help to determine whether it is worthwhile considering 
introducing the guideline more widely and, if so, which particular points will 
require attention. Please tick the answer that corresponds most closely to your 
own situation and/or opinion. 
1. Do you have a copy of the 
guidelines?
£ yes £ no
2. Do you have a summary of the 
guidelines?
£ yes £ no
not at all hardly in part most of it all of it
3. To what extent have you read 
the guidelines?
£ £ £ £ £
poor limited reason-
able
good very 
good
4. How do you evaluate your own 
knowledge of the contents of 
the guidelines?
£ £ £ £ £
never some-
times
regularly often always
5. How often do you currently use 
the guideline when treating 
patients?
£ £ £ £ £
I think that working according 
to the guidelines is:
Strongly 
disagree
Disagree Neither 
agree nor 
disagree
Agree Strongly 
agree
6. sensible £ £ £ £ £
7. a good thing £ £ £ £ £
To what extent do you agree 
with the following statements?
Strongly 
disagree
Disagree Neither 
agree nor 
disagree
Agree Strongly 
agree
8. I think that following the guide-
lines would improve the quality 
of my work
£ £ £ £ £
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9. My patients think that they 
should be treated according to 
the guidelines
£ £ £ £ £
10. I intend to (continue to) use the 
guidelines to treat the majority 
of my patients with an anxiety 
disorder
£ £ £ £ £
11. I am able to organize my work 
in such a way that I can apply 
these guidelines
£ £ £ £ £
12. I am able to maintain the cho-
sen treatment approach over 
several successive treatment 
meetings with the patient
£ £ £ £ £
13. Others in my profession think 
that I should work according to 
the guideline
£ £ £ £ £
14. My aim is to try to (continue to) 
comply with the guidelines for 
the majority of the patients who 
I treat
£ £ £ £ £
To what extent do you agree 
with the following statements?
Strongly 
disagree
Disagree Neither 
agree nor 
disagree
Agree Strongly 
agree
15. I am able to apply the guide-
lines
£ £ £ £ £
16. Colleagues within my team 
think that I should work accord-
ing to the guidelines
£ £ £ £ £
17. My superiors think that I should 
work according to the guide-
lines
£ £ £ £ £
18. I expect that I will (continue to) 
follow the recommendations in 
the guidelines for the majority 
of patients
£ £ £ £ £
19. It is difficult for me to adapt 
my normal working methods in 
order to use the guidelines
£ £ £ £ £
20. I think that in most cases, I will 
(continue to) use the guidelines
£ £ £ £ £
21. Following the guidelines makes 
the work of medical service 
providers more transparent, 
both for each other and for the 
outside world
£ £ £ £ £
22. Within the professional as-
sociation which I have the most 
contact with, people think that 
patients should be treated ac-
cording to the guidelines
£ £ £ £ £
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23. Patients do not want to be 
treated according to the ap-
proach recommended in the 
guidelines
£ £ £ £ £
24. I will (continue to) design most 
of my treatment according to 
the recommendations in the 
guidelines
£ £ £ £ £
25. I expect that healthcare for pa-
tients with an anxiety disorder 
will improve through the use of 
the guidelines
£ £ £ £ £
Original distribution of items:
¡  5 items which indicate the extent to which professionals are familiar with 
the guidelines (1, 2, 3, 4, 5)
¡  5 items which reflect the ‘attitude’ of professionals to working according to 
the guidelines (items 6, 7, 8, 21, 25)
¡  5 items which give an impression of the ‘social pressure’ to use the guide-
lines experienced by professionals (items 9, 13, 16, 17, 22)
¡  5 items which reflect a professional’s assessment of their ability to adhere to 
the guidelines in terms of being able to control their own actions (items 11, 
12, 15, 19, 23)
¡  5 items which give an impression of a professional’s actual intention to 
(continue to) use the guidelines (items 10, 14, 18, 20, 24)
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